0000730464--06-30 2020 Q1 false DE true true P3Y P1Y 1 IL 0000730464 srt:MaximumMember atge:AuthorizedOnNovemberSevenTwoThousandEighteenMember 2019-09-30 0000730464 srt:MaximumMember atge:AuthorizedOnNovemberSevenTwoThousandEighteenMember 2018-11-07 0000730464 us-gaap:TreasuryStockMember 2019-09-30 0000730464 us-gaap:RetainedEarningsMember 2019-09-30 0000730464 us-gaap:CommonStockMember 2019-09-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000730464 us-gaap:TreasuryStockMember 2019-06-30 0000730464 us-gaap:RetainedEarningsMember 2019-06-30 0000730464 us-gaap:CommonStockMember 2019-06-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000730464 us-gaap:TreasuryStockMember 2018-09-30 0000730464 us-gaap:RetainedEarningsMember 2018-09-30 0000730464 us-gaap:CommonStockMember 2018-09-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000730464 us-gaap:TreasuryStockMember 2018-06-30 0000730464 us-gaap:RetainedEarningsMember 2018-06-30 0000730464 us-gaap:CommonStockMember 2018-06-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000730464 us-gaap:StockOptionMember 2019-06-30 0000730464 us-gaap:StockCompensationPlanMember 2018-07-01 2018-09-30 0000730464 us-gaap:StockOptionMember 2019-07-01 2019-09-30 0000730464 us-gaap:StockOptionMember 2019-09-30 0000730464 srt:MinimumMember atge:NonPerformanceBasedSharesMember 2019-07-01 2019-09-30 0000730464 srt:MaximumMember atge:NonPerformanceBasedSharesMember 2019-07-01 2019-09-30 0000730464 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0000730464 us-gaap:RestrictedStockUnitsRSUMember 2019-06-30 0000730464 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0000730464 us-gaap:PerformanceSharesMember 2019-07-01 2019-09-30 0000730464 atge:NonPerformanceBasedSharesMember 2019-07-01 2019-09-30 0000730464 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0000730464 srt:MaximumMember us-gaap:StockCompensationPlanMember 2019-07-01 2019-09-30 0000730464 atge:OncourseLearningMember 2019-07-01 2019-09-30 0000730464 atge:TestPreparationOrCertificationsMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:TestPreparationOrCertificationsMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:TestPreparationOrCertificationsMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 atge:OtherServicesMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:OtherServicesMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:OtherServicesMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 atge:MembershipsSubscriptionsMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:MembershipsSubscriptionsMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:MembershipsSubscriptionsMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 atge:HigherEducationMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:HigherEducationMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:HigherEducationMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 atge:ConferencesSeminarsMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:ConferencesSeminarsMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:ConferencesSeminarsMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:TestPreparationOrCertificationsMember 2019-07-01 2019-09-30 0000730464 atge:OtherServicesMember 2019-07-01 2019-09-30 0000730464 atge:MembershipsSubscriptionsMember 2019-07-01 2019-09-30 0000730464 atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:InternationalOperationsMember 2019-07-01 2019-09-30 0000730464 atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 atge:HigherEducationMember 2019-07-01 2019-09-30 0000730464 atge:DomesticOperationsMember 2019-07-01 2019-09-30 0000730464 atge:ConferencesSeminarsMember 2019-07-01 2019-09-30 0000730464 atge:BarbadosDominicaSt.KittsAndSt.MaartenMember 2019-07-01 2019-09-30 0000730464 atge:TestPreparationOrCertificationsMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:TestPreparationOrCertificationsMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:TestPreparationOrCertificationsMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 atge:OtherServicesMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:OtherServicesMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:OtherServicesMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 atge:MembershipsSubscriptionsMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:MembershipsSubscriptionsMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:MembershipsSubscriptionsMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 atge:HigherEducationMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:HigherEducationMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:HigherEducationMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 atge:ConferencesSeminarsMember us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:ConferencesSeminarsMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:ConferencesSeminarsMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:TestPreparationOrCertificationsMember 2018-07-01 2018-09-30 0000730464 atge:OtherServicesMember 2018-07-01 2018-09-30 0000730464 atge:MembershipsSubscriptionsMember 2018-07-01 2018-09-30 0000730464 atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:InternationalOperationsMember 2018-07-01 2018-09-30 0000730464 atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 atge:HigherEducationMember 2018-07-01 2018-09-30 0000730464 atge:DomesticOperationsMember 2018-07-01 2018-09-30 0000730464 atge:ConferencesSeminarsMember 2018-07-01 2018-09-30 0000730464 atge:BarbadosDominicaSt.KittsAndSt.MaartenMember 2018-07-01 2018-09-30 0000730464 srt:MaximumMember 2019-09-30 0000730464 atge:AdtalemGlobalEducationIncMember 2019-09-30 0000730464 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2019-07-01 0000730464 2019-07-01 0000730464 us-gaap:RealEstateOtherMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 us-gaap:RealEstateOtherMember atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 us-gaap:RealEstateOtherMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 us-gaap:EmployeeSeveranceMember us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 us-gaap:EmployeeSeveranceMember atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 us-gaap:RealEstateOtherMember 2019-07-01 2019-09-30 0000730464 us-gaap:EmployeeSeveranceMember 2019-07-01 2019-09-30 0000730464 us-gaap:RealEstateOtherMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 us-gaap:RealEstateOtherMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 us-gaap:EmployeeSeveranceMember atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 us-gaap:EmployeeSeveranceMember atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 us-gaap:RealEstateOtherMember 2018-07-01 2018-09-30 0000730464 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-09-30 0000730464 atge:DevryUniversityMember 2019-09-30 0000730464 srt:MinimumMember 2019-07-01 2019-09-30 0000730464 srt:MaximumMember 2019-07-01 2019-09-30 0000730464 atge:DominicaCampusMember atge:RossUniversitySchoolOfMedicineMember 2019-09-30 0000730464 atge:DeVryUniversityAndCarringtonCollegeMember 2018-09-30 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-07-31 2019-07-31 0000730464 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-07-01 0000730464 atge:AuthorizedOnNovemberSevenTwoThousandEighteenMember 2019-07-01 2019-09-30 0000730464 atge:AuthorizedOnNovemberSevenTwoThousandEighteenMember 2019-01-01 2019-09-30 0000730464 us-gaap:ParentMember 2019-07-01 2019-09-30 0000730464 us-gaap:ParentMember 2018-07-01 2019-06-30 0000730464 atge:OperatingLeasesIncludingAdtalemBrazilMember 2019-06-30 0000730464 2017-07-01 2018-06-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:PerformingFinancingReceivableMember 2019-09-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:NonperformingFinancingReceivableMember 2019-09-30 0000730464 us-gaap:CreditConcentrationRiskMember 2019-09-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:PerformingFinancingReceivableMember 2019-06-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:NonperformingFinancingReceivableMember 2019-06-30 0000730464 us-gaap:CreditConcentrationRiskMember 2019-06-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:PerformingFinancingReceivableMember 2018-09-30 0000730464 us-gaap:CreditConcentrationRiskMember us-gaap:NonperformingFinancingReceivableMember 2018-09-30 0000730464 us-gaap:CreditConcentrationRiskMember 2018-09-30 0000730464 us-gaap:OtherAssetsMember 2019-09-30 0000730464 us-gaap:OtherAssetsMember 2019-06-30 0000730464 us-gaap:OtherAssetsMember 2018-09-30 0000730464 us-gaap:AccountsReceivableMember 2019-09-30 0000730464 us-gaap:AccountsReceivableMember 2019-06-30 0000730464 us-gaap:AccountsReceivableMember 2018-09-30 0000730464 atge:OtherInternationalOperationsMember 2019-09-30 0000730464 atge:InternationalOperationsMember 2019-09-30 0000730464 atge:DomesticOperationsMember 2019-09-30 0000730464 atge:BarbadosDominicaSt.KittsAndSt.MaartenMember 2019-09-30 0000730464 atge:OtherInternationalOperationsMember 2018-09-30 0000730464 atge:InternationalOperationsMember 2018-09-30 0000730464 atge:DomesticOperationsMember 2018-09-30 0000730464 atge:BarbadosDominicaSt.KittsAndSt.MaartenMember 2018-09-30 0000730464 atge:AdtalemBrazilMember 2019-09-30 0000730464 atge:AdtalemBrazilMember 2019-06-30 0000730464 atge:EdupristineMember atge:KaizenMember 2019-09-30 0000730464 atge:AdtalemBrazilMember atge:AdtalemBrazilSeniorManagementGroupMember 2019-06-30 0000730464 atge:AdtalemBrazilMember 2019-07-01 2019-09-30 0000730464 us-gaap:HurricaneMember 2019-07-01 2019-09-30 0000730464 us-gaap:HurricaneMember 2018-07-01 2018-09-30 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-09-30 0000730464 us-gaap:LetterOfCreditMember 2018-04-13 0000730464 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2019-07-01 2019-09-30 0000730464 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2019-07-01 2019-09-30 0000730464 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2019-07-01 2019-09-30 0000730464 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2019-07-01 2019-09-30 0000730464 srt:WeightedAverageMember 2019-09-30 0000730464 srt:WeightedAverageMember us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000730464 2018-04-13 2018-04-13 0000730464 us-gaap:TradeNamesMember 2019-09-30 0000730464 us-gaap:IntellectualPropertyMember 2019-09-30 0000730464 atge:RossTitleFourEligibilityAndAccreditationsMember 2019-09-30 0000730464 atge:ChamberlainTitleFourEligibilityAndAccreditationsMember 2019-09-30 0000730464 atge:AmericanUniversityOfCaribbeanTitleFourEligibilityAndAccreditationsMember 2019-09-30 0000730464 us-gaap:TradeNamesMember 2019-06-30 0000730464 us-gaap:IntellectualPropertyMember 2019-06-30 0000730464 atge:RossTitleFourEligibilityAndAccreditationsMember 2019-06-30 0000730464 atge:ChamberlainTitleFourEligibilityAndAccreditationsMember 2019-06-30 0000730464 atge:AmericanUniversityOfCaribbeanTitleFourEligibilityAndAccreditationsMember 2019-06-30 0000730464 atge:DominicaCampusMember atge:RossUniversitySchoolOfMedicineMember 2018-07-01 2018-09-30 0000730464 atge:DeVryUniversityAndCarringtonCollegeMember 2018-07-01 2018-09-30 0000730464 2019-05-01 2019-05-31 0000730464 us-gaap:FinancialServiceMember 2018-06-30 0000730464 atge:MedicalAndHealthcareMember 2018-06-30 0000730464 us-gaap:FinancialServiceMember 2018-10-01 2019-06-30 0000730464 atge:MedicalAndHealthcareMember 2018-10-01 2019-06-30 0000730464 2018-10-01 2019-06-30 0000730464 atge:RossUniversityMember 2019-09-30 0000730464 atge:ChamberlainUniversityMember 2019-09-30 0000730464 atge:AmericanUniversityOfCaribbeanMember 2019-09-30 0000730464 us-gaap:FinancialServiceMember 2019-06-30 0000730464 us-gaap:FinancialServiceMember 2019-06-30 0000730464 atge:RossUniversityMember 2019-06-30 0000730464 atge:MedicalAndHealthcareMember 2019-06-30 0000730464 atge:ChamberlainUniversityMember 2019-06-30 0000730464 atge:AmericanUniversityOfCaribbeanMember 2019-06-30 0000730464 us-gaap:FinancialServiceMember 2018-09-30 0000730464 atge:RossUniversityMember 2018-09-30 0000730464 atge:ChamberlainUniversityMember 2018-09-30 0000730464 atge:AmericanUniversityOfCaribbeanMember 2018-09-30 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:ColumbusOhioCampusMember 2019-09-27 2019-09-27 0000730464 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-07-01 2019-09-30 0000730464 us-gaap:CustomerRelationshipsMember 2019-07-01 2019-09-30 0000730464 atge:CurriculumSoftwareMember 2019-07-01 2019-09-30 0000730464 atge:CourseDeliveryTechnologyMember 2019-07-01 2019-09-30 0000730464 us-gaap:FinancialServiceMember 2019-09-30 0000730464 us-gaap:CustomerRelationshipsMember 2019-09-30 0000730464 atge:CurriculumSoftwareMember 2019-09-30 0000730464 atge:CourseDeliveryTechnologyMember 2019-09-30 0000730464 us-gaap:CustomerRelationshipsMember 2019-06-30 0000730464 atge:CurriculumSoftwareMember 2019-06-30 0000730464 atge:CourseDeliveryTechnologyMember 2019-06-30 0000730464 us-gaap:TradeNamesMember 2018-09-30 0000730464 us-gaap:PatentedTechnologyMember 2018-09-30 0000730464 us-gaap:IntellectualPropertyMember 2018-09-30 0000730464 us-gaap:CustomerRelationshipsMember 2018-09-30 0000730464 atge:RossTitleFourEligibilityAndAccreditationsMember 2018-09-30 0000730464 atge:CurriculumSoftwareMember 2018-09-30 0000730464 atge:ChamberlainTitleFourEligibilityAndAccreditationsMember 2018-09-30 0000730464 atge:AmericanUniversityOfCaribbeanTitleFourEligibilityAndAccreditationsMember 2018-09-30 0000730464 us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-09-30 0000730464 us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-09-30 0000730464 us-gaap:FinancingReceivables1To29DaysPastDueMember 2019-09-30 0000730464 atge:FinancingReceivablesGreaterThan90DaysPastDueMember 2019-09-30 0000730464 us-gaap:FinancingReceivables60To89DaysPastDueMember 2019-06-30 0000730464 us-gaap:FinancingReceivables30To59DaysPastDueMember 2019-06-30 0000730464 us-gaap:FinancingReceivables1To29DaysPastDueMember 2019-06-30 0000730464 atge:FinancingReceivablesGreaterThan90DaysPastDueMember 2019-06-30 0000730464 us-gaap:FinancingReceivables60To89DaysPastDueMember 2018-09-30 0000730464 us-gaap:FinancingReceivables30To59DaysPastDueMember 2018-09-30 0000730464 us-gaap:FinancingReceivables1To29DaysPastDueMember 2018-09-30 0000730464 atge:FinancingReceivablesGreaterThan90DaysPastDueMember 2018-09-30 0000730464 us-gaap:NonperformingFinancingReceivableMember 2019-09-30 0000730464 us-gaap:NonperformingFinancingReceivableMember 2019-06-30 0000730464 us-gaap:NonperformingFinancingReceivableMember 2018-09-30 0000730464 us-gaap:OtherLiabilitiesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-07-31 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-07-31 0000730464 us-gaap:OtherAssetsMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-07-31 0000730464 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:OtherNoncurrentLiabilitiesMember 2019-07-01 0000730464 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:AccruedLiabilitiesMember 2019-07-01 0000730464 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000730464 atge:TermBLoanMember 2019-06-30 0000730464 2018-04-13 0000730464 atge:TermLoanMember 2019-09-30 0000730464 atge:TermLoanMember 2019-06-30 0000730464 atge:TermLoanMember 2018-09-30 0000730464 atge:TermLoanMember 2018-04-13 0000730464 us-gaap:RevolvingCreditFacilityMember 2019-09-30 0000730464 atge:TermLoanMember 2019-09-30 0000730464 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000730464 atge:TermLoanMember 2019-06-30 0000730464 atge:TermLoanMember 2018-09-30 0000730464 atge:TermLoanMember us-gaap:BaseRateMember 2019-07-01 2019-09-30 0000730464 atge:TermLoanMember atge:EurocurrencyRateMember 2019-07-01 2019-09-30 0000730464 us-gaap:RevenueFromContractWithCustomerMember 2019-07-01 2019-09-30 0000730464 us-gaap:RevenueFromContractWithCustomerMember 2018-07-01 2018-09-30 0000730464 atge:OtherInternationalOperationsMember 2019-07-01 2019-09-30 0000730464 atge:OtherInternationalOperationsMember 2018-07-01 2018-09-30 0000730464 us-gaap:StockCompensationPlanMember 2019-09-30 0000730464 2018-06-30 0000730464 atge:OncourseLearningMember us-gaap:CustomerRelationshipsMember 2019-05-31 0000730464 atge:OncourseLearningMember atge:CurriculumSoftwareMember 2019-05-31 0000730464 atge:OncourseLearningMember atge:CourseDeliveryTechnologyMember 2019-05-31 0000730464 atge:OncourseLearningMember atge:TradeNameMember 2019-05-31 0000730464 atge:OncourseLearningMember 2019-05-31 0000730464 us-gaap:FinancialServiceMember 2019-09-30 0000730464 us-gaap:DiscontinuedOperationsHeldforsaleMember 2019-09-30 0000730464 atge:MedicalAndHealthcareMember 2019-09-30 0000730464 atge:HomeOfficeAndOtherMember 2019-09-30 0000730464 us-gaap:FinancialServiceMember 2018-09-30 0000730464 us-gaap:DiscontinuedOperationsHeldforsaleMember 2018-09-30 0000730464 atge:MedicalAndHealthcareMember 2018-09-30 0000730464 atge:HomeOfficeAndOtherMember 2018-09-30 0000730464 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000730464 atge:CostOfEducationalServicesMember 2019-07-01 2019-09-30 0000730464 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000730464 atge:CostOfEducationalServicesMember 2018-07-01 2018-09-30 0000730464 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000730464 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000730464 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000730464 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000730464 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000730464 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0000730464 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000730464 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000730464 atge:OncourseLearningMember 2019-05-31 2019-05-31 0000730464 atge:OncourseLearningMember us-gaap:CustomerRelationshipsMember 2019-05-01 2019-05-31 0000730464 atge:OncourseLearningMember atge:CurriculumSoftwareMember 2019-05-01 2019-05-31 0000730464 atge:OncourseLearningMember atge:CourseDeliveryTechnologyMember 2019-05-01 2019-05-31 0000730464 us-gaap:NoncontrollingInterestMember 2019-09-30 0000730464 us-gaap:NoncontrollingInterestMember 2019-06-30 0000730464 us-gaap:ParentMember 2018-09-30 0000730464 us-gaap:NoncontrollingInterestMember 2018-09-30 0000730464 us-gaap:ParentMember 2019-09-30 0000730464 us-gaap:ParentMember 2019-06-30 0000730464 us-gaap:RevolvingCreditFacilityMember 2019-09-30 0000730464 2019-10-22 0000730464 2018-07-01 2019-02-28 0000730464 us-gaap:StockCompensationPlanMember 2019-07-01 2019-09-30 0000730464 atge:EdupristineMember 2019-09-30 0000730464 atge:CarlsonCaseMember 2019-04-04 2019-04-04 0000730464 atge:CarlsonCaseMember 2019-07-16 2019-07-16 0000730464 atge:TLaniRobinsonCaseMember 2019-04-03 2019-04-03 0000730464 atge:RobbyBrownCaseMember 2019-03-29 2019-03-29 0000730464 atge:CarlsonCaseMember 2019-01-02 2019-01-02 0000730464 atge:CarlsonCaseMember 2018-06-27 2018-06-27 0000730464 atge:StoltmannCaseMember 2018-06-21 2018-06-21 0000730464 atge:CarlsonCaseMember 2018-05-08 2018-05-08 0000730464 atge:NicoleVersettoMember 2018-04-13 2018-04-13 0000730464 2018-12-10 0000730464 atge:StoltmannCaseMember 2019-05-23 2019-05-23 0000730464 atge:PetrizzoAndJaraCaseMember 2016-11-28 2016-11-28 0000730464 atge:JaraCaseMember 2016-10-28 2016-10-28 0000730464 atge:PetrizzoCaseMember 2016-10-14 2016-10-14 0000730464 atge:HarrietMyersCaseMember 2017-01-17 0000730464 2019-06-14 0000730464 us-gaap:FinancialServiceMember 2019-07-01 2019-09-30 0000730464 atge:ReconciliationToConsolidatedFinancialStatementsMember 2019-07-01 2019-09-30 0000730464 atge:MedicalAndHealthcareMember 2019-07-01 2019-09-30 0000730464 atge:HomeOfficeAndOtherMember 2019-07-01 2019-09-30 0000730464 us-gaap:FinancialServiceMember 2018-07-01 2018-09-30 0000730464 atge:ReconciliationToConsolidatedFinancialStatementsMember 2018-07-01 2018-09-30 0000730464 atge:MedicalAndHealthcareMember 2018-07-01 2018-09-30 0000730464 atge:HomeOfficeAndOtherMember 2018-07-01 2018-09-30 0000730464 us-gaap:RevolvingCreditFacilityMember 2018-04-13 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:DepaulCollegePrepMember 2019-07-01 2019-09-30 0000730464 atge:DevryUniversityMember 2019-07-01 2019-09-30 0000730464 atge:TermBLoanMember 2019-09-30 0000730464 atge:DevryUniversityMember 2018-12-01 2018-12-11 0000730464 2018-07-01 2019-06-30 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:AdtalemEducacionalDoBrasilMember 2019-10-18 0000730464 us-gaap:RevolvingCreditFacilityMember 2018-04-13 2018-04-13 0000730464 atge:TermLoanMember 2018-04-13 2018-04-13 0000730464 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember atge:CarringtonCollegeMember 2018-10-01 2018-12-31 0000730464 atge:DevryUniversityMember 2018-07-01 2019-06-30 0000730464 2019-09-30 0000730464 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 0000730464 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 0000730464 srt:ScenarioPreviouslyReportedMember us-gaap:AccountingStandardsUpdate201602Member 2019-06-30 0000730464 2019-06-30 0000730464 2018-09-30 0000730464 2019-07-01 2019-09-30 0000730464 2018-07-01 2018-09-30 atge:segment xbrli:shares iso4217:USD xbrli:shares iso4217:USD xbrli:pure atge:facility atge:claim atge:state atge:individual atge:lawsuit atge:item atge:class

Table of Contents

​

​

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One) |  |
☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the quarterly period ended: September 30, 2019 |
| OR |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from _____ to _____ |
| Commission file number: 1-13988 |

Adtalem Global Education Inc.

(Exact name of registrant as specified in its charter)

DELAWARE | 36-3150143
(State or other jurisdiction of | (I.R.S. Employer
incorporation or organization) | Identification No.)
500 WEST MONROE STREET |
CHICAGO, ILLINOIS | 60661
(Address of principal executive offices) | (Zip Code)

(866) 374-2678

(Registrant’s telephone number; including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock $0.01 Par Value | ATGE | NYSE, CSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| ​ |  |  |
Large accelerated filer | þ |  | Accelerated filer | ☐
Non-accelerated filer | ◻ |  | Smaller reporting company | ☐
| ​ |  | Emerging growth company | ☐

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

October 22, 2019 — 53,995,000 shares of Common Stock, $0.01 par value

​

​

​

​

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019

TABLE OF CONTENTS

|  | Page #
| PART I – FINANCIAL INFORMATION |
Item 1 | Financial Statements (unaudited) | ​
| Consolidated Balance Sheets | 3
| Consolidated Statements of Income (Loss) | 4
| Consolidated Statements of Comprehensive Loss | 5
| Consolidated Statements of Cash Flows | 6
| Consolidated Statements of Shareholders’ Equity | 7
| Notes to Consolidated Financial Statements | 8
Item 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 40
Item 3 | Quantitative and Qualitative Disclosures About Market Risk | 56
Item 4 | Controls and Procedures | 57
|  | ​
| PART II – OTHER INFORMATION | ​
Item 1 | Legal Proceedings | 58
Item 1A | Risk Factors | 58
Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 58
Item 3 | Defaults Upon Senior Securities | 59
Item 4 | Mine Safety Disclosures | 59
Item 5 | Other Information | 59
Item 6 | Exhibits | 59
|  | ​
Signatures |  | 60

​

​

​

2

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | June 30, | ​ | September 30,
​ |  | 2019 |  | 2019 |  | 2018
​ | ​ | (in thousands, except share and par value amounts)
ASSETS: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and Cash Equivalents | ​ | $ | 121,079 | ​ | $ | 204,202 | ​ | $ | 334,222
Investments in Marketable Securities | ​ |  | 8,763 | ​ |  | 8,680 | ​ |  | 8,402
Restricted Cash | ​ |  | 710 | ​ |  | 1,022 | ​ |  | 877
Accounts Receivable, Net | ​ |  | 116,212 | ​ |  | 83,560 | ​ |  | 108,213
Prepaid Expenses and Other Current Assets | ​ |  | 39,476 | ​ |  | 29,313 | ​ |  | 60,031
Current Assets Held for Sale | ​ |  | 169,873 | ​ |  | 177,923 | ​ |  | 227,641
Total Current Assets | ​ |  | 456,113 | ​ |  | 504,700 | ​ |  | 739,386
Land, Building and Equipment: | ​ |  |  | ​ |  |  | ​ |  | ​
Land | ​ |  | 41,441 | ​ |  | 41,938 | ​ |  | 41,183
Building | ​ |  | 309,893 | ​ |  | 322,657 | ​ |  | 288,438
Equipment | ​ |  | 235,027 | ​ |  | 228,533 | ​ |  | 221,294
Construction in Progress | ​ |  | 8,681 | ​ |  | 13,545 | ​ |  | 25,799
​ | ​ |  | 595,042 | ​ |  | 606,673 | ​ |  | 576,714
Accumulated Depreciation | ​ |  | (314,219) | ​ |  | (323,240) | ​ |  | (306,340)
Land, Building and Equipment Held for Sale, Net | ​ |  | 73,763 | ​ |  | 81,250 | ​ |  | 81,029
Land, Building and Equipment, Net | ​ |  | 354,586 | ​ |  | 364,683 | ​ |  | 351,403
Noncurrent Assets: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Operating Lease Assets | ​ |  | 195,238 | ​ |  | — | ​ |  | —
Deferred Income Taxes | ​ |  | 14,977 | ​ |  | 18,314 | ​ |  | 31,080
Intangible Assets, Net | ​ |  | 295,324 | ​ |  | 297,989 | ​ |  | 240,166
Goodwill | ​ |  | 686,992 | ​ |  | 687,256 | ​ |  | 627,239
Other Assets, Net | ​ |  | 91,086 | ​ |  | 52,113 | ​ |  | 45,201
Other Assets Held for Sale | ​ |  | 366,008 | ​ |  | 317,641 | ​ |  | 315,390
Total Noncurrent Assets | ​ |  | 1,649,625 | ​ |  | 1,373,313 | ​ |  | 1,259,076
TOTAL ASSETS | ​ | $ | 2,460,324 | ​ | $ | 2,242,696 | ​ | $ | 2,349,865
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
LIABILITIES: | ​ |  |  | ​ |  |  | ​ |  |
Current Liabilities: | ​ |  |  | ​ |  |  | ​ |  |
Accounts Payable | ​ | $ | 44,674 | ​ | $ | 53,385 | ​ | $ | 48,087
Accrued Salaries, Wages and Benefits | ​ |  | 30,071 | ​ |  | 46,664 | ​ |  | 32,056
Accrued Liabilities | ​ |  | 61,966 | ​ |  | 76,529 | ​ |  | 80,591
Deferred Revenue | ​ |  | 168,533 | ​ |  | 95,944 | ​ |  | 173,856
Current Operating Lease Liabilities | ​ |  | 54,057 | ​ |  | — | ​ |  | —
Current Portion of Long-Term Debt | ​ |  | 3,000 | ​ |  | 3,000 | ​ |  | 3,000
Current Liabilities Held for Sale | ​ |  | 50,174 | ​ |  | 36,109 | ​ |  | 121,496
Total Current Liabilities | ​ |  | 412,475 | ​ |  | 311,631 | ​ |  | 459,086
Noncurrent Liabilities: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Long-Term Debt | ​ |  | 327,600 | ​ |  | 398,094 | ​ |  | 289,579
Long-Term Operating Lease Liabilities | ​ |  | 192,055 | ​ |  | — | ​ |  | —
Deferred Income Taxes | ​ |  | 29,094 | ​ |  | 29,426 | ​ |  | 29,378
Other Liabilities | ​ |  | 92,252 | ​ |  | 86,326 | ​ |  | 101,561
Noncurrent Liabilities Held for Sale | ​ |  | 76,468 | ​ |  | 16,146 | ​ |  | 21,412
Total Noncurrent Liabilities | ​ |  | 717,469 | ​ |  | 529,992 | ​ |  | 441,930
TOTAL LIABILITIES | ​ |  | 1,129,944 | ​ |  | 841,623 | ​ |  | 901,016
COMMITMENTS AND CONTINGENCIES (NOTE 14) | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
NONCONTROLLING INTEREST | ​ |  | 3,187 | ​ |  | 9,543 | ​ |  | 8,814
SHAREHOLDERS’ EQUITY: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Common Stock, $0.01 Par Value, 200,000,000 Shares Authorized; 54,649,000, 55,303,000 and 59,120,000 Shares Outstanding at September 30, 2019, June 30, 2019 and September 30, 2018, respectively | ​ |  | 805 | ​ |  | 801 | ​ |  | 798
Additional Paid-in Capital | ​ |  | 492,151 | ​ |  | 486,061 | ​ |  | 469,545
Retained Earnings | ​ |  | 2,027,263 | ​ |  | 2,012,902 | ​ |  | 1,908,465
Accumulated Other Comprehensive Loss | ​ |  | (176,739) | ​ |  | (137,290) | ​ |  | (163,168)
Treasury Stock, at Cost, 25,862,000, 24,830,000 and 20,727,000 Shares at September 30, 2019, June 30, 2019 and September 30, 2018, respectively | ​ |  | (1,016,287) | ​ |  | (970,944) | ​ |  | (775,605)
TOTAL SHAREHOLDERS’ EQUITY | ​ |  | 1,327,193 | ​ |  | 1,391,530 | ​ |  | 1,440,035
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY | ​ | $ | 2,460,324 | ​ | $ | 2,242,696 | ​ | $ | 2,349,865

​

The accompanying notes are an integral part of these consolidated financial statements.

​

3

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
​ | ​ | (in thousands, except per share amounts) | ​
REVENUE | ​ | $ | 254,613 | ​ | $ | 236,939 | ​
OPERATING COST AND EXPENSE: | ​ |  |  | ​ |  |  | ​
Cost of Educational Services | ​ |  | 128,034 | ​ |  | 111,534 | ​
Student Services and Administrative Expense | ​ |  | 99,087 | ​ |  | 89,164 | ​
Restructuring Expense | ​ |  | 6,530 | ​ |  | 39,473 | ​
Gain on Sale of Assets | ​ |  | (4,779) | ​ |  | — | ​
Total Operating Cost and Expense | ​ |  | 228,872 | ​ |  | 240,171 | ​
Operating Income (Loss) from Continuing Operations | ​ |  | 25,741 | ​ |  | (3,232) | ​
OTHER INCOME (EXPENSE): | ​ |  |  | ​ |  |  | ​
Interest and Dividend Income | ​ |  | 678 | ​ |  | 969 | ​
Interest Expense | ​ |  | (5,328) | ​ |  | (4,918) | ​
Investment Gain | ​ | ​ | 23 | ​ | ​ | — | ​
Net Other Expense | ​ |  | (4,627) | ​ |  | (3,949) | ​
Income (Loss) from Continuing Operations Before Income Taxes | ​ |  | 21,114 | ​ |  | (7,181) | ​
Income Tax (Provision) Benefit | ​ |  | (3,706) | ​ |  | 2,330 | ​
Income (Loss) from Continuing Operations | ​ |  | 17,408 | ​ |  | (4,851) | ​
DISCONTINUED OPERATIONS (NOTE 2): | ​ |  |  | ​ |  |  | ​
Loss from Discontinued Operations Before Income Taxes | ​ |  | (2,883) | ​ |  | (5,719) | ​
Income Tax (Provision) Benefit | ​ |  | (273) | ​ |  | 985 | ​
Loss from Discontinued Operations | ​ |  | (3,156) | ​ |  | (4,734) | ​
NET INCOME (LOSS) | ​ |  | 14,252 | ​ |  | (9,585) | ​
Net Loss Attributable to Noncontrolling Interest from Continuing Operations | ​ |  | 109 | ​ |  | 64 | ​
Net Income Attributable to Noncontrolling Interest from Discontinued Operations | ​ |  | — | ​ |  | (9) | ​
NET INCOME (LOSS) ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION | ​ | $ | 14,361 | ​ | $ | (9,530) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
AMOUNTS ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION: | ​ |  |  | ​ |  |  | ​
Income (Loss) from Continuing Operations | ​ | $ | 17,517 | ​ | $ | (4,787) | ​
Loss from Discontinued Operations | ​ |  | (3,156) | ​ |  | (4,743) | ​
NET INCOME (LOSS) ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION | ​ | $ | 14,361 | ​ | $ | (9,530) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
EARNINGS (LOSS) PER COMMON SHARE ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION SHAREHOLDERS: | ​ |  |  | ​ |  |  | ​
Basic: | ​ |  |  | ​ |  |  | ​
Continuing Operations | ​ | $ | 0.32 | ​ | $ | (0.08) | ​
Discontinued Operations | ​ | $ | (0.06) | ​ | $ | (0.08) | ​
Total | ​ | $ | 0.26 | ​ | $ | (0.16) | ​
Diluted: | ​ |  |  | ​ |  |  | ​
Continuing Operations | ​ | $ | 0.31 | ​ | $ | (0.08) | ​
Discontinued Operations | ​ | $ | (0.06) | ​ | $ | (0.08) | ​
Total | ​ | $ | 0.26 | ​ | $ | (0.16) | ​

​

The accompanying notes are an integral part of these consolidated financial statements.

​

4

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended | ​
​ | ​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
​ | ​ | (in thousands) | ​
NET INCOME (LOSS) | ​ | $ | 14,252 | ​ | $ | (9,585) | ​
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX | ​ |  | ​ | ​ |  | ​ | ​
Currency Translation Loss | ​ |  | (39,494) | ​ |  | (20,615) | ​
Change in Fair Value of Available-For-Sale Securities | ​ |  | 45 | ​ |  | (4) | ​
COMPREHENSIVE LOSS | ​ |  | (25,197) | ​ |  | (30,204) | ​
COMPREHENSIVE LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST | ​ |  | 184 | ​ |  | 669 | ​
COMPREHENSIVE LOSS ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION | ​ | $ | (25,013) | ​ | $ | (29,535) | ​

​

The accompanying notes are an integral part of these consolidated financial statements.

​

​

5

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | September 30,
​ |  | 2019 |  | 2018
​ | ​ | (in thousands)
CASH FLOW FROM OPERATING ACTIVITIES: |  | ​ |  | ​ | ​ | ​
Net Income (Loss) | ​ | $ | 14,252 | ​ | $ | (9,585)
Loss from Discontinued Operations | ​ |  | 3,156 | ​ |  | 4,734
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities: | ​ |  |  | ​ |  |
Stock-Based Compensation Expense | ​ |  | 5,223 | ​ |  | 4,137
Amortization and Adjustments to Operating Lease Assets | ​ | ​ | 12,804 | ​ | ​ | —
Depreciation | ​ |  | 8,393 | ​ |  | 7,727
Amortization of Intangible Assets | ​ |  | 2,534 | ​ |  | 1,605
Amortization of Deferred Debt Issuance Costs | ​ |  | 392 | ​ |  | 392
Provision for Bad Debts | ​ | ​ | 5,554 | ​ | ​ | 1,203
Deferred Income Taxes | ​ |  | 2,991 | ​ |  | 7,915
Loss on Disposals, Accelerated Depreciation and Adjustments to Land, Building and Equipment | ​ |  | 1,053 | ​ |  | 37,984
Realized Loss on Investments | ​ | ​ | 11 | ​ | ​ | —
Unrealized Gain on Investments | ​ | ​ | (33) | ​ | ​ | —
Realized Gain on Sale of Assets | ​ | ​ | (4,779) | ​ | ​ | —
Changes in Assets and Liabilities: | ​ |  |  | ​ |  |
Accounts Receivable | ​ |  | (38,206) | ​ |  | (39,199)
Prepaid Expenses and Other Current Assets | ​ |  | (13,646) | ​ |  | (11,308)
Accounts Payable | ​ |  | (7,566) | ​ |  | 1,397
Accrued Salaries, Wages, Benefits and Liabilities | ​ |  | (19,010) | ​ |  | (14,257)
Deferred Revenue | ​ |  | 72,589 | ​ |  | 74,909
Operating Lease Liabilities | ​ | ​ | (13,681) | ​ | ​ | —
Other Assets and Liabilities | ​ |  | 1,270 | ​ |  | (14,137)
Net Cash Provided by Operating Activities-Continuing Operations | ​ |  | 33,301 | ​ |  | 53,517
Net Cash Provided by Operating Activities-Discontinued Operations | ​ |  | 14,167 | ​ |  | 24,497
NET CASH PROVIDED BY OPERATING ACTIVITIES | ​ |  | 47,468 | ​ |  | 78,014
CASH FLOWS FROM INVESTING ACTIVITIES: | ​ |  |  | ​ |  |
Capital Expenditures | ​ |  | (10,436) | ​ |  | (13,321)
Sales of Marketable Securities | ​ | ​ | 290 | ​ | ​ | —
Purchases of Marketable Securities | ​ |  | (292) | ​ |  | (4,152)
Proceeds from Sale of Assets | ​ |  | 6,421 | ​ |  | —
Net Cash Used in Investing Activities-Continuing Operations | ​ |  | (4,017) | ​ |  | (17,473)
Net Cash Used in Investing Activities-Discontinued Operations | ​ |  | (1,728) | ​ |  | (2,946)
NET CASH USED IN INVESTING ACTIVITIES | ​ |  | (5,745) | ​ |  | (20,419)
CASH FLOWS FROM FINANCING ACTIVITIES: | ​ |  |  | ​ |  |
Proceeds from Exercise of Stock Options | ​ |  | 828 | ​ |  | 10,492
Employee Taxes Paid on Withholding Shares | ​ |  | (5,045) | ​ |  | (5,188)
Proceeds from Stock Issued Under Colleague Stock Purchase Plan | ​ |  | — | ​ |  | 159
Repurchase of Common Stock for Treasury | ​ |  | (40,255) | ​ |  | (59,175)
Borrowings Under Credit Facility | ​ |  | 30,000 | ​ |  | —
Repayments Under Credit Facility | ​ |  | (100,750) | ​ |  | (750)
Proceeds from Down Payment on Seller Loan | ​ | ​ | 5,200 | ​ | ​ | —
Payment for Purchase of Noncontrolling Interest of Subsidiary | ​ |  | (6,247) | ​ |  | —
Net Cash Used in Financing Activities-Continuing Operations | ​ |  | (116,269) | ​ |  | (54,462)
Net Cash Used in Financing Activities-Discontinued Operations | ​ |  | (480) | ​ |  | (470)
NET CASH USED IN FINANCING ACTIVITIES | ​ |  | (116,749) | ​ |  | (54,932)
Effects of Exchange Rate Differences | ​ |  | (6,750) | ​ |  | (1,579)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | ​ |  | (81,776) | ​ |  | 1,084
Cash, Cash Equivalents and Restricted Cash at Beginning of Period | ​ |  | 300,467 | ​ |  | 444,405
Cash, Cash Equivalents and Restricted Cash at End of Period | ​ |  | 218,691 | ​ |  | 445,489
Less: Cash, Cash Equivalents and Restricted Cash of Discontinued Operations at End of Period | ​ |  | 96,902 | ​ |  | 110,390
Cash, Cash Equivalents and Restricted Cash at End of Period | ​ | $ | 121,789 | ​ | $ | 335,099
Non-cash Investing and Financing Activity: | ​ |  |  | ​ |  |
Decrease in Redemption Value of Noncontrolling Interest Put Option | ​ | $ | — | ​ | $ | (241)

​

The accompanying notes are an integral part of these consolidated financial statements.

​

6

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Other | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common | ​ | Paid-In | ​ | Retained | ​ | Comprehensive | ​ | Treasury | ​ | ​ | ​
​ |  | Stock |  | Capital |  | Earnings |  | Loss |  | Stock |  | Total
Three Months Ended | ​ | (in thousands)
Balance at June 30, 2019 | ​ | $ | 801 | ​ | $ | 486,061 | ​ | $ | 2,012,902 | ​ | $ | (137,290) | ​ | $ | (970,944) | ​ | $ | 1,391,530
Net income |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 14,361 | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | 14,361
Foreign currency translation |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (39,494) | ​ | ​ | ​ |  | ​ | (39,494)
Unrealized investment gains, net of tax |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 45 | ​ | ​ | ​ |  | ​ | 45
Stock-based compensation |  | ​ | ​ | ​ | ​ | 5,225 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | 5,225
Net activity from stock-based compensation awards |  | ​ | 4 | ​ | ​ | 865 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (5,088) |  | ​ | (4,219)
Repurchase of common shares for treasury |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (40,255) |  | ​ | (40,255)
Balance at September 30, 2019 | ​ | $ | 805 | ​ | $ | 492,151 | ​ | $ | 2,027,263 | ​ | $ | (176,739) | ​ | $ | (1,016,287) | ​ | $ | 1,327,193
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Three Months Ended | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at June 30, 2018 | ​ | $ | 793 | ​ | $ | 454,653 | ​ | $ | 1,917,373 | ​ | $ | (142,168) | ​ | $ | (711,365) | ​ | $ | 1,519,286
Cumulative effect adjustment upon the adoption of ASU 2016-01 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 381 | ​ | ​ | (381) | ​ | ​ | ​ | ​ | ​ | —
Net loss |  | ​ | ​ |  | ​ | ​ |  | ​ | (9,530) |  | ​ |  |  | ​ |  |  | ​ | (9,530)
Foreign currency translation |  | ​ | ​ |  | ​ | ​ |  | ​ |  |  | ​ | (20,615) |  | ​ |  |  | ​ | (20,615)
Unrealized investment losses, net of tax |  | ​ | ​ |  | ​ | ​ |  | ​ |  |  | ​ | (4) |  | ​ |  |  | ​ | (4)
Change in noncontrolling interest put option |  | ​ | ​ |  | ​ | ​ |  | ​ | 241 |  | ​ |  |  | ​ |  |  | ​ | 241
Stock-based compensation |  | ​ | ​ |  | ​ | 4,369 |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ | 4,369
Net activity from stock-based compensation awards |  | ​ | 5 |  | ​ | 10,487 |  | ​ | ​ |  | ​ | ​ |  | ​ | (5,188) |  | ​ | 5,304
Proceeds from stock issued under Colleague Stock Purchase Plan |  | ​ | ​ |  | ​ | 36 |  | ​ | ​ |  | ​ | ​ |  | ​ | 123 |  | ​ | 159
Repurchase of common shares for treasury |  | ​ | ​ |  | ​ | ​ |  | ​ |  |  | ​ |  |  | ​ | (59,175) |  | ​ | (59,175)
Balance at September 30, 2018 | ​ | $ | 798 | ​ | $ | 469,545 | ​ | $ | 1,908,465 | ​ | $ | (163,168) | ​ | $ | (775,605) | ​ | $ | 1,440,035

​

The accompanying notes are an integral part of these consolidated financial statements.

​

7

Table of Contents

ADTALEM GLOBAL EDUCATION INC.

Notes to Consolidated Financial Statements

(unaudited)

NOTE 1: INTERIM FINANCIAL STATEMENTS

For purposes of this report, “Adtalem,” “we,” “our,” “us,” or similar references refers to Adtalem Global Education Inc. and its consolidated subsidiaries, unless the context requires otherwise. The interim Consolidated Financial Statements include accounts of Adtalem and its wholly-owned and majority-owned subsidiaries. Adtalem’s wholly-owned subsidiaries include:

| ● | Chamberlain University (“Chamberlain”)

| ● | American University of the Caribbean School of Medicine (“AUC”)

| ● | Ross University School of Medicine (“RUSM”)

| ● | Ross University School of Veterinary Medicine (“RUSVM”)

| ● | Association of Certified Anti-Money Laundering Specialists (“ACAMS”)

| ● | Becker Professional Education (“Becker”)

| ● | OnCourse Learning (“OCL”)

​

In addition, Adtalem maintains a 69% ownership interest in EduPristine.

In addition, Adtalem had a 97.9% ownership interest in Adtalem Education of Brazil (“Adtalem Brazil”) as of June 30, 2019. On July 1, 2019, the Adtalem Brazil management noncontrolling interest members exercised their put options and sold their remaining ownership interests in Adtalem Brazil to Adtalem. As of the first quarter of fiscal year 2020, Adtalem owns 100% of Adtalem Brazil. On October 18, 2019, Adtalem entered into a definitive agreement to sell Adtalem Brazil. Adtalem Brazil is presented as discontinued operations, see “Note 2: Discontinued Operations and Assets Held for Sale” for further details.

On December 4, 2018, Adtalem completed the sale of its previously wholly-owned subsidiary Carrington College (“Carrington”). On December 11, 2018, Adtalem completed the sale of its previously wholly-owned subsidiary DeVry University. Carrington and DeVry University are presented as discontinued operations. See “Note 2: Discontinued Operations and Assets Held for Sale” for additional details.

These financial statements are unaudited but, in the opinion of management, contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial condition and results of operations of Adtalem.

The interim Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in Adtalem's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, as filed with the Securities and Exchange Commission (“SEC”).

The results of operations for the three months ended September 30, 2019 are not necessarily indicative of results to be expected for the entire fiscal year.

​

NOTE 2: DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE

On December 4, 2018, Adtalem completed the sale of Carrington to San Joaquin Valley College, Inc. (“SJVC”) for de minimis consideration. As the sale represented a strategic shift that has a major effect on Adtalem’s operations and financial results, Carrington is presented in Adtalem’s financial reporting as a discontinued operation. Adtalem has retained certain leases associated with the Carrington operations. Adtalem remains the primary lessee on these leases and subleases to Carrington. Adtalem records the proceeds from these subleases as an offset to operating costs. Adtalem also assigned certain leases to Carrington but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $11.3 million on the sale of Carrington and transferred $9.9 million of cash and restricted cash balances to Carrington in the second quarter of fiscal year 2019, subject to post-closing adjustments to be completed in fiscal year 2020.

8

Table of Contents

On December 11, 2018, Adtalem completed the sale of DeVry University to Cogswell Education, LLC (“Cogswell”) for de minimis consideration. As the sale represented a strategic shift that has a major effect on Adtalem’s operations and financial results, DeVry University is presented in Adtalem’s financial reporting as a discontinued operation. The purchase agreement includes an earn-out entitling Adtalem to payments of up to $20 million over a ten-year period payable based on DeVry University’s free cash flow. In connection with the closing of the sale, Adtalem loaned to DeVry University $10.0 million under the terms of the promissory note, dated as of December 11, 2018 (the “Note”). The Note bears interest at a rate of 4% per annum, payable annually in arrears and has a maturity date of January 1, 2022. DeVry University may make prepayments on the Note. This loan is presented as Other Assets, Net on the Consolidated Balance Sheet. Adtalem has retained certain leases associated with DeVry University operations. Adtalem remains the primary lessee on these leases and subleases to DeVry University. In addition, Adtalem owns the buildings for certain DeVry University operating and administrative office locations and leases space to DeVry University under one-year operating leases, renewable annually at DeVry University’s option. Adtalem records the proceeds from these leases and subleases as an offset to operating costs. Adtalem also assigned certain leases to DeVry University but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $22.3 million on the sale of DeVry University and transferred $40.2 million of cash and restricted cash balances to DeVry University in fiscal year 2019.

On October 18, 2019, Adtalem entered into a Stock Purchase Agreement (“Purchase Agreement”) with Estácio Participações S.A. (“Estácio”) and Sociedade de Ensino Superior Estaćio de Sá Ltda, a wholly owned subsidiary of Estácio (“Purchaser”). Pursuant to the terms and subject to the conditions set forth in the Purchase Agreement, Adtalem will sell all of the issued and outstanding shares of Adtalem Brasil Holding S.A. (a/k/a Adtalem Brazil) to the Purchaser for approximately $465 million in cash. In addition, Adtalem expects to receive approximately $74 million in settlement of cash balances as of June 30, 2019 of $89 million, net of indebtedness of $15 million, resulting in total proceeds of $539 million. This transaction is expected to be completed in the first half of fiscal year 2021. This sale advances Adtalem’s strategy to become a leading workforce solutions provider in the medical and healthcare and financial services industries, aligning Adtalem’s portfolio to better address the global workforce skills gap and serve its markets in a more competitive and comprehensive way. As the potential sale represents a strategic shift that will have a major effect on Adtalem’s operations and financial results, Adtalem Brazil is presented in Adtalem’s financial reporting as a discontinued operation. All prior periods presented disclose Adtalem Brazil’s assets and liabilities as held for sale, and operations and cash flows of Adtalem Brazil, which were previously included as the only component of the Business and Law reportable segment, as discontinued operations. In connection with the announced proposed sale of Adtalem Brazil, Adtalem entered into certain deal contingent foreign exchange forward contracts to economically hedge the Brazilian Real denominated purchase price through mitigation of the currency exchange rate risk. Management does not expect this contract to qualify for hedge accounting treatment under Accounting Standards Codification (“ASC”) 815, and as a result, all changes in fair value will be recorded to the income statement.

9

Table of Contents

The following is a summary of balance sheet information of assets and liabilities reported as held for sale (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | June 30, | ​ | September 30,
​ |  | 2019 |  | 2019 |  | 2018
ASSETS: |  | ​ |  |  | ​ |  |  | ​ |
Current Assets: |  | ​ |  |  | ​ |  |  | ​ |
Cash and Cash Equivalents | ​ | $ | 96,902 | ​ | $ | 95,243 | ​ | $ | 94,423
Restricted Cash | ​ |  | — | ​ |  | — | ​ |  | 15,967
Accounts Receivable, Net | ​ |  | 64,915 | ​ |  | 74,269 | ​ |  | 98,089
Prepaid Expenses and Other Current Assets | ​ |  | 8,056 | ​ |  | 8,411 | ​ |  | 19,162
Total Current Assets Held for Sale | ​ |  | 169,873 | ​ |  | 177,923 | ​ |  | 227,641
Land, Building and Equipment Held for Sale, Net | ​ | ​ | 73,763 | ​ | ​ | 81,250 | ​ | ​ | 81,029
Noncurrent Assets: | ​ |  | ​ | ​ |  |  | ​ |  |
Operating Lease Assets | ​ |  | 72,261 | ​ |  | — | ​ |  | —
Intangible Assets, Net | ​ |  | 110,711 | ​ |  | 120,108 | ​ |  | 115,429
Goodwill | ​ |  | 173,064 | ​ |  | 187,195 | ​ |  | 178,046
Perkins Program Fund, Net | ​ |  | — | ​ |  | — | ​ |  | 13,450
Other Assets, Net | ​ |  | 9,972 | ​ |  | 10,338 | ​ |  | 8,465
Total Noncurrent Assets Held for Sale | ​ |  | 366,008 | ​ |  | 317,641 | ​ |  | 315,390
Total Assets Held for Sale | ​ | $ | 609,644 | ​ | $ | 576,814 | ​ | $ | 624,060
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
LIABILITIES: | ​ |  | ​ | ​ |  |  | ​ |  |
Current Liabilities: | ​ |  | ​ | ​ |  |  | ​ |  |
Accounts Payable | ​ | $ | 2,857 | ​ | $ | 4,242 | ​ | $ | 25,896
Accrued Salaries, Wages and Benefits | ​ |  | 16,239 | ​ |  | 17,828 | ​ |  | 22,526
Accrued Liabilities | ​ |  | 9,800 | ​ |  | 10,193 | ​ |  | 14,580
Deferred Revenue | ​ |  | 11,104 | ​ |  | 3,846 | ​ |  | 58,494
Current Operating Lease Liabilities | ​ |  | 10,174 | ​ |  | — | ​ |  | —
Total Current Liabilities Held for Sale | ​ |  | 50,174 | ​ |  | 36,109 | ​ |  | 121,496
Noncurrent Liabilities: | ​ |  | ​ | ​ |  |  | ​ |  | ​
Long-Term Operating Lease Liabilities | ​ |  | 62,367 | ​ |  | — | ​ |  | —
Deferred Income Taxes | ​ |  | — | ​ |  | — | ​ |  | 216
Other Liabilities | ​ |  | 14,101 | ​ |  | 16,146 | ​ |  | 21,196
Total Noncurrent Liabilities Held for Sale | ​ |  | 76,468 | ​ |  | 16,146 | ​ |  | 21,412
Total Liabilities Held for Sale | ​ | $ | 126,642 | ​ | $ | 52,255 | ​ | $ | 142,908

​

10

Table of Contents

The following is a summary of income statement information of operations reported as discontinued operations (in thousands). The results include Carrington's and DeVry University's operations through the date of each respective sale.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
REVENUE | ​ | $ | 45,652 | ​ | $ | 159,554 | ​
OPERATING COST AND EXPENSE: | ​ |  |  | ​ |  |  | ​
Cost of Educational Services | ​ |  | 33,948 | ​ |  | 98,460 | ​
Student Services and Administrative Expense | ​ |  | 14,373 | ​ |  | 64,706 | ​
Restructuring Expense (Gain) | ​ |  | 35 | ​ |  | (443) | ​
Asset Impairment Charge - Building and Equipment | ​ |  | — | ​ |  | 2,242 | ​
Total Operating Cost and Expense | ​ |  | 48,356 | ​ |  | 164,965 | ​
Operating Loss from Discontinued Operations | ​ |  | (2,704) | ​ |  | (5,411) | ​
OTHER INCOME (EXPENSE): | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest and Dividend Income | ​ | ​ | 978 | ​ | ​ | 976 | ​
Interest Expense | ​ | ​ | (1,157) | ​ | ​ | (1,284) | ​
Net Other Expense | ​ |  | (179) | ​ |  | (308) | ​
Loss from Discontinued Operations Before Income Taxes | ​ | ​ | (2,883) | ​ | ​ | (5,719) | ​
Income Tax (Provision) Benefit | ​ |  | (273) | ​ |  | 985 | ​
Loss from Discontinued Operations | ​ | ​ | (3,156) | ​ | ​ | (4,734) | ​
Net Income Attributable to Noncontrolling Interest | ​ | ​ | — | ​ | ​ | (9) | ​
Loss from Discontinued Operations Attributable to Adtalem Global Education | ​ | $ | (3,156) | ​ | $ | (4,743) | ​

​

​

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Adtalem and its wholly-owned and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Where our ownership interest is less than 100%, but greater than 50%, the noncontrolling ownership interest is reported on our Consolidated Balance Sheets. The noncontrolling ownership interest earnings portion is classified as “Net Loss Attributable to Noncontrolling Interest from Continuing Operations” and “Net Income Attributable to Noncontrolling Interest from Discontinued Operations” in our Consolidated Statements of Income (Loss). Unless indicated, or the context requires otherwise, references to years refer to Adtalem’s fiscal years.

Investments in Equity Securities

For an investment in equity securities where we do not have the ability to influence the operating and financial decisions of the investee, the initially recorded cost basis is adjusted upon the occurrence of an observable transaction in the security. Generally, an investment in an equity security is defined as an ownership interest of less than 20%. The equity investment is classified as Other Assets, Net on the Consolidated Balance Sheets.

Cash and Cash Equivalents

Cash and cash equivalents can include time deposits, high-grade commercial paper, money market funds and bankers acceptances with original maturities of three months or less. Short-term investment objectives are to minimize risk and maintain liquidity. These investments are stated at cost (which approximates fair value) because of their short duration or liquid nature. Adtalem places its cash and temporary cash investments with high credit quality institutions. Cash and cash equivalent balances in U.S. bank accounts are generally in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit. Adtalem has not experienced any losses on its cash and cash equivalents. Management periodically evaluates the creditworthiness of the security issuers and financial institutions with which it invests and maintains deposit accounts.

11

Table of Contents

Financial Aid and Restricted Cash

A significant portion of cash is received from students who participate in government financial aid and assistance programs which are subject to political and governmental budgetary considerations. There is no assurance that such funding will be maintained at current levels. Extensive and complex regulations in the U.S. govern all of the government financial assistance programs in which students participate. Administration of these programs is periodically reviewed by various regulatory agencies. Any regulatory violation could be the basis for disciplinary action, which could include the suspension, limitation or termination from such financial aid programs.

Restricted cash represents amounts received from federal and state governments under various student aid grant and loan programs and such restricted funds are held in separate bank accounts. Once the financial aid authorization and disbursement process for the student has been completed, the funds are transferred to unrestricted accounts, and these funds then become available for use in Adtalem’s operations. This authorization and disbursement process that precedes the transfer of funds generally occurs within the period of the academic term for which such funds were authorized.

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to our customers (students and members), in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services.

The following tables disaggregate revenue by source (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019
​ | ​ | Medical and | ​ | Financial | ​ | Home Office | ​ | ​
​ |  | Healthcare |  | Services |  | and Other |  | Consolidated
Higher Education |  | $ | 201,453 |  | $ | — |  | $ | — |  | $ | 201,453
Test Preparation/Certifications | ​ | ​ | — | ​ | ​ | 24,972 | ​ | ​ | — | ​ | ​ | 24,972
Conferences/Seminars | ​ | ​ | — | ​ | ​ | 17,070 | ​ | ​ | — | ​ | ​ | 17,070
Memberships/Subscriptions | ​ | ​ | — | ​ | ​ | 4,867 | ​ | ​ | — | ​ | ​ | 4,867
Other | ​ | ​ | 6,034 | ​ | ​ | 217 | ​ | ​ | — | ​ | ​ | 6,251
Total |  | $ | 207,487 |  | $ | 47,126 |  | $ | — |  | $ | 254,613

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2018
​ | ​ | Medical and | ​ | Financial | ​ | Home Office | ​ | ​
​ |  | Healthcare |  | Services |  | and Other |  | Consolidated
Higher Education |  | $ | 201,173 |  | $ | — |  | $ | — |  | $ | 201,173
Test Preparation/Certifications | ​ | ​ | — | ​ | ​ | 28,716 | ​ | ​ | (807) | ​ | ​ | 27,909
Conferences/Seminars | ​ | ​ | — | ​ | ​ | 2,868 | ​ | ​ | — | ​ | ​ | 2,868
Memberships/Subscriptions | ​ | ​ | — | ​ | ​ | 3,936 | ​ | ​ | — | ​ | ​ | 3,936
Other | ​ | ​ | 927 | ​ | ​ | 126 | ​ | ​ | — | ​ | ​ | 1,053
Total |  | $ | 202,100 |  | $ | 35,646 |  | $ | (807) |  | $ | 236,939

​

In addition, see “Note 15: Segment Information” for a disaggregation of revenue by geographical region.

Performance Obligations and Revenue Recognition

Higher Education: Higher education revenue consists of tuition, fees, books and other educational products. The majority of revenue is derived from tuition and fees, which is recognized on a straight-line basis over the term as instruction is delivered. Books and other educational product revenue is recognized when products are shipped or students receive access to electronic materials. Under certain circumstances, we report revenue from these transactions on a net basis because our performance obligation is to facilitate a transaction between the student and a vendor.

Test Preparation/Certifications: Test preparation revenue consists of test preparation course instruction and self-study materials sales. Becker test preparation revenue is recognized when access to the course materials is delivered to the customer. EduPristine test preparation course instruction revenue is recognized on a straight-line basis over the applicable

12

Table of Contents

instruction delivery periods. Certification revenue consists of exam preparation guides, seminars, exam sitting fees and recertification fees. We recognize revenue for each of these items at a point in time when the applicable performance obligation is satisfied.

Conferences/Seminars: Conference revenue consists of revenue from attendees, sponsors and exhibitors. We recognize revenue for all items related to conferences at the time of the conference. Seminar revenue consists of seminars delivered in live, live-online, or on-demand online formats. We recognize revenue for live and live-online seminars on the day of the seminar. On-demand online seminars, in which customers have access to a webcast of a seminar, are recognized on the day the customer places the order.

Memberships/Subscriptions: Membership revenue is recognized on a straight-line basis over the membership period. Subscription revenue is recognized on a straight-line basis over the subscription period.

Other: Other revenue consists of housing and other miscellaneous services. Other revenue is recognized over the period in which the applicable performance obligation is satisfied.

Customer contracts generally have separately stated prices for each performance obligation contained in the contract. Therefore, each performance obligation generally has its own standalone selling price. For higher education students, arrangements for payment are agreed to prior to registration of the student’s first academic term. The majority of U.S. students obtain Title IV or other financial aid resulting in institutions receiving a significant amount of the transaction price at the beginning of the academic term. Students utilizing private funding or funding through Adtalem’s institutional loan programs (see “Note 6: Financing Receivables” for further discussion) generally pay during or after the academic term is complete. For non-higher education customers, payment is typically due and collected at the time a customer places an order.

Transaction Price

Revenue, or transaction price, is measured as the amount of consideration expected to be received in exchange for transferring goods or services.

For higher education, students may receive discounts, scholarships or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the transaction price is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged. Upon withdrawal, a student may be eligible to receive a refund, or partial refund, the amount of which is dependent on the timing of the withdrawal during the academic term. If a student withdraws prior to completing an academic term, federal and state regulations and accreditation criteria permit Adtalem to retain only a set percentage of the total tuition received from such student, which varies with, but generally equals or exceeds, the percentage of the academic term completed by such student. Payment amounts received by Adtalem in excess of such set percentages of tuition are refunded to the student or the appropriate funding source. For contracts with similar characteristics and historical data on refunds, the expected value method is applied in determining the variable consideration related to refunds. Estimates of Adtalem’s expected refunds are determined at the outset of each academic term, based upon actual refunds in previous academic terms. Reserves related to refunds are presented as refund liabilities within Accrued Liabilities on the Consolidated Balance Sheets. All refunds are netted against revenue during the applicable academic term.

Management reassesses collectability throughout the period revenue is recognized by the Adtalem institutions, on a student-by-student basis. This reassessment is based upon new information and changes in facts and circumstances relevant to a student’s ability to pay. Management also reassesses collectability when a student withdraws from the institution and has unpaid tuition charges. Such unpaid charges do not meet the threshold of reasonably collectible and are recognized as revenue on a cash basis.

For test preparation and other Financial Services products, the transaction price is equal to the amount charged to the customer, which is the standard rate, less any discounts and an estimate for returns or refunds.

We believe it is probable that no significant reversal will occur in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved. Therefore, the estimate of variable consideration is not constrained.

13

Table of Contents

Contract Balances

For higher education institutions, students are billed at the beginning of each academic term and payment is due at that time. Adtalem’s performance obligation is to provide educational services in the form of instruction during the academic term. As instruction is provided, deferred revenue is reduced. A significant portion of student payments are from Title IV financial aid and other programs and are generally received during the first month of the respective academic term. For students utilizing Adtalem’s institutional loan programs (see “Note 6: Financing Receivables”), payments are generally received after the academic term, and the corresponding performance obligation, is complete. When payments are received, accounts receivable is reduced.

For our Financial Services businesses, customers are billed and payment is due at the time of order placement. In most cases, performance obligations are delivered subsequent to payments received. Delivering our performance obligations reduces deferred revenue, and accounts receivable is reduced upon payments received. Becker offers flexible payment plans with terms of up to 18-months as a financing option for the Becker CPA Exam Review Course (see “Note 6: Financing Receivables”). In this case, payment is received after satisfying the performance obligation.

Revenue of $79.4 million was recognized during the first three months of fiscal year 2020 that was included in the deferred revenue balance at the beginning of fiscal year 2020. Revenue recognized from performance obligations that were satisfied, or partially satisfied, in prior periods was not material.

The difference between the opening and closing balances of deferred revenue includes decreases from revenue recognized during the period and increases from charges and payments received related to the start of academic terms beginning during the period.

Allowance for bad debts as of September 30, 2019, June 30, 2019 and September 30, 2018 were $18.8 million, $14.5 million and $13.3 million, respectively.

Practical Expedients

As our performance obligations have an original expected duration of one year or less, we have applied the practical expedient (as provided in ASC 606-10-50-14) to not disclose the information in ASC 606-10-50-13, which requires disclosure of the amount of the transaction price allocated to our performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period and when the entity expects to recognize this amount as revenue. All consideration from contracts with customers is included in the transaction price.

Internal-Use Software Development Costs

Adtalem capitalizes certain internal-use software development costs that are amortized using the straight-line method over the estimated lives of the software, not to exceed seven years. Capitalized costs include external direct costs of equipment, materials and services consumed in developing or obtaining internal-use software and payroll-related costs for employees directly associated with the internal-use software development project. Capitalization of such costs ceases at the point at which the project is substantially complete and ready for its intended purpose. Capitalized internal-use software development costs for projects not yet complete are included as Construction in Progress in the Land, Building and Equipment section of the Consolidated Balance Sheets. Once the project is complete, capitalized internal-use software development costs are included as Equipment on the Consolidated Balance Sheets. As of September 30, 2019, June 30, 2019 and September 30, 2018, the net balance of capitalized internal-use software development costs was $11.1 million, $10.6 million and $12.4 million, respectively.

Impairment of Long-Lived Assets

Adtalem evaluates the carrying amount of its significant long-lived assets whenever changes in circumstances or events indicate that the value of such assets may not be fully recoverable. Events that may trigger an impairment analysis could include a decision by management to exit a market or a line of business or to consolidate operating locations. During the first quarter of fiscal year 2019, we recorded impairment charges of $2.2 million to write-down building, building improvements, furniture and equipment to zero based on the fair market value of the DeVry University operations, which are classified within discontinued operations. In the first quarter of fiscal year 2019, Adtalem announced its decision to

14

Table of Contents

relocate RUSM’s campus operations to Barbados and not return to RUSM’s Dominica campus. Adtalem recorded impairment charges of $37.8 million in the first quarter of fiscal year 2019, to fully impair the land, buildings and equipment in Dominica as management determined the market value less the costs to sell the facilities or move the equipment is zero (see “Note 10: Restructuring Charges”). The impairment charges are included in Restructuring Expense in the Consolidated Statements of Income (Loss). For a discussion of the impairment review of goodwill and intangible assets see “Note 9: Intangible Assets.”

Foreign Currency Translation

The financial position and results of operations of the AUC, RUSM and RUSVM Caribbean operations are measured using the U.S. dollar as the functional currency. As such, there is no translation gain or loss associated with these operations. Adtalem Brazil’s and EduPristine’s operations and ACAMS international operations are measured using the local currency as the functional currency. Assets and liabilities of these entities are translated to U.S. dollars using exchange rates in effect at the balance sheet dates. Income and expense items are translated at monthly average exchange rates. The resulting translation adjustments are included in the component of Shareholders’ Equity designated as Accumulated Other Comprehensive Loss. Transaction gains or losses during each of the three-month periods ended September 30, 2019 and 2018 were not material.

Noncontrolling Interest

As of June 30, 2019, Adtalem maintained a 97.9% ownership interest in Adtalem Brazil with the remaining 2.1% owned by members of the Adtalem Brazil senior management group. Since July 1, 2015, Adtalem has had the right to exercise a call option and purchase any remaining Adtalem Brazil stock from Adtalem Brazil management. Likewise, Adtalem Brazil management has had the right to exercise a put option and sell its remaining ownership interest in Adtalem Brazil to Adtalem.

In addition, Adtalem currently maintains a 69% ownership interest in EduPristine with the remaining 31% owned by Kaizen Management Advisors (“Kaizen”), an India-based private equity firm.

The adjustment to increase or decrease the Adtalem Brazil and EduPristine noncontrolling interests for their respective proportionate shares of Adtalem Brazil’s and EduPristine’s profit (loss) flows through the Consolidated Statements of Income (Loss) each reporting period based on Adtalem’s noncontrolling interest accounting policy.

Beginning on March 26, 2020, Adtalem will have the right to exercise a call option and purchase any remaining EduPristine stock from Kaizen. Likewise, Kaizen will have the right to exercise a put option and sell up to 33% of its remaining ownership interest in EduPristine to Adtalem. Beginning on March 26, 2022, Kaizen will have the right to exercise a put option and sell its remaining ownership interest in EduPristine to Adtalem.

Since the put options are out of the control of Adtalem, authoritative guidance requires the noncontrolling interests, which includes the value of the put options, to be displayed outside of the equity section of the Consolidated Balance Sheets.

On July 1, 2019, the Adtalem Brazil management noncontrolling members exercised their put option and sold their remaining ownership interest in Adtalem Brazil to Adtalem. In the first quarter of fiscal year 2020, $6.2 million of noncontrolling interest was removed from the Consolidated Balance Sheet as a result of the put option exercise and Adtalem currently owns 100% of Adtalem Brazil.

Prior to July 1, 2019, the Adtalem Brazil management put option was being accreted to its fair value in accordance with the terms of the related stock purchase agreement. The adjustments to increase or decrease the put option to its expected redemption value each reporting period was recorded in retained earnings in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). Adtalem has not adjusted the redemption value related to the Kaizen put option as management believes the redemption value has not materially changed since acquiring a majority stake in EduPristine.

15

Table of Contents

The following is a reconciliation of the noncontrolling interest balance (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
Balance at Beginning of Period | ​ | $ | 9,543 | ​ | $ | 9,110 | ​
Net Loss Attributable to Noncontrolling Interest | ​ |  | (109) | ​ |  | (55) | ​
Decrease in Redemption Value of Noncontrolling Interest Put Option | ​ |  | — | ​ |  | (241) | ​
Payment for Purchase of Noncontrolling Interest of Subsidiary | ​ | ​ | (6,247) | ​ | ​ | — | ​
Balance at End of Period | ​ | $ | 3,187 | ​ | $ | 8,814 | ​

​

Earnings per Common Share

Basic earnings per share is computed by dividing net income or loss attributable to Adtalem by the weighted average number of common shares outstanding during the period plus unvested participating restricted stock units (“RSUs”). Diluted earnings per share is computed by dividing net income or loss attributable to Adtalem by the weighted average number of shares assuming dilution. As required by GAAP, because the three months ended September 30, 2018 resulted in a loss from continuing operations, diluted earnings per share was computed by dividing the net loss attributable to Adtalem by the weighted average number of basic shares. Diluted shares are computed using the Treasury Stock Method and reflect the additional shares that would be outstanding if dilutive stock-based grants were exercised during the period. Excluded from the computations of diluted earnings per share were outstanding stock-based grants representing 329,000 and 272,000 shares of common stock for the three months ended September 30, 2019 and 2018, respectively. These outstanding stock-based grants were excluded because the exercise prices were greater than the average market price of the common shares or the assumed proceeds upon exercise under the Treasury Stock Method resulted in the repurchase of more shares than would be issued; thus, their effect would be anti-dilutive.

The following is a reconciliation of basic shares to diluted shares (in thousands):

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
Weighted Average Shares Outstanding |  | 55,018 |  | 59,722 |
Unvested Participating RSUs |  | 475 |  | 606 |
Basic Shares |  | 55,493 |  | 60,328 |
Effect of Dilutive Stock Options |  | 647 |  | 874 |
Diluted Shares |  | 56,140 |  | 61,202 |

​

Treasury Stock

Adtalem’s Board of Directors (the “Board”) has authorized share repurchase programs on eleven occasions (see “Note 7: Share Repurchase Programs”). The eleventh share repurchase program was approved on November 7, 2018 and commenced in January 2019. Shares that are repurchased by Adtalem are recorded as Treasury Stock at cost and result in a reduction of Shareholders’ Equity.

From time to time, shares of our common stock are delivered back to Adtalem under a swap arrangement resulting from employees’ exercise of incentive stock options pursuant to the terms of the Adtalem Stock Incentive Plans (see “Note 4: Stock-Based Compensation”). In addition, shares of our common stock are delivered back to Adtalem for payment of withholding taxes from employees for vesting RSUs. These shares are recorded as Treasury Stock at cost and result in a reduction of Shareholders’ Equity.

Prior to March 2019, treasury shares were reissued on a monthly basis, at market value, less a 5% discount, to the Adtalem Colleague Stock Purchase Plan in exchange for employee payroll deductions. When treasury shares are reissued, Adtalem uses an average cost method to reduce the Treasury Stock balance. Gains on the difference between the average cost and the reissuance price are credited to Additional Paid-in Capital. Losses on the difference are charged to Additional

16

Table of Contents

Paid-in Capital to the extent that previous net gains from reissuance are included therein, otherwise such losses are charged to Retained Earnings.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amounts of revenue and expense reported during the period. Actual results could differ from those estimates.

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss is composed of the change in cumulative translation adjustment, primarily at Adtalem Brazil, and unrealized gains on available-for-sale marketable securities, net of the effects of income taxes.

The Accumulated Other Comprehensive Loss balance at September 30, 2019, consists of $176.9 million of cumulative translation losses ($176.6 million attributable to Adtalem and $0.3 million attributable to noncontrolling interest) and $0.1 million of unrealized gains on available-for-sale marketable securities, net of tax of $0.0 million and all attributable to Adtalem. At June 30, 2019, this balance consisted of $137.4 million of cumulative translation losses ($134.3 million attributable to Adtalem and $3.1 million attributable to noncontrolling interest) and $0.1 million of unrealized gains on available-for-sale marketable securities, net of tax of $0.0 million and all attributable to Adtalem. As of September 30, 2018, this balance consisted of $163.2 million of cumulative translation losses ($159.4 million attributable to Adtalem and $3.8 million attributable to noncontrolling interest) and unrealized gains on available-for-sale marketable securities were immaterial.

Advertising Expense

Advertising costs are recognized as expense in the period in which materials are purchased or services are performed. Advertising expense, which is included in Student Services and Administrative Expense in the Consolidated Statements of Income (Loss), was $20.2 million and $16.8 million for the three months ended September 30, 2019 and 2018, respectively.

Hurricane Expense

In September 2017, Hurricanes Irma and Maria caused damage and disrupted operations at AUC and RUSM. Adtalem recorded expenses of $6.9 million in the first quarter of fiscal year 2019 associated with incremental costs of teaching at alternative sites. No hurricane-related costs were recorded in the first quarter of fiscal year 2020. Received and expected insurance proceeds of $6.9 million were recorded to offset these expenses in the first quarter of fiscal year 2019.

Restructuring Charges

Adtalem’s financial statements include charges related to severance and related benefits for workforce reductions in staff. These charges also include early lease termination or cease-of-use costs, accelerated depreciation and losses on disposals of property and equipment related to campus and administrative office consolidations (see “Note 10: Restructuring Charges”). When estimating the costs of exiting lease space, estimates are made which could differ materially from actual results and result in additional restructuring charges or reversals in future periods.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13: “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This guidance was issued to provide financial statement users with more decision-useful information about the expected losses on financial instruments by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses by requiring a broader range of reasonable and supportable information to inform credit loss estimates. The amendments are effective for financial statements issued for fiscal years beginning after December 15,

17

Table of Contents

2019, and interim periods within those fiscal years. Management is evaluating the impact the guidance will have on Adtalem’s Consolidated Financial Statements.

In February 2016, FASB issued ASU No. 2016-02: “Leases (Topic 842).” This guidance was issued to increase transparency and comparability among organizations by recognizing right-of-use assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The amendments are effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. We adopted this guidance, along with the related clarifications and improvements, effective July 1, 2019 using the modified retrospective approach without adjusting prior comparative periods. The adoption of this standard significantly impacts our Consolidated Balance Sheets, but did not impact our Consolidated Statements of Income (Loss). We elected the practical expedients package which allows us to forego reassessing (i) whether any expired or existing contracts are or contain leases; (ii) the lease classification for any expired or expiring leases; and (iii) initial direct costs for any existing leases. We did not elect the hindsight practical expedient, which permits the use of hindsight when determining the lease term and impairment of operating lease assets. See “Note 11: Leases” for the disclosures related to this new accounting standard.

​

18

Table of Contents

The impact on the Consolidated Balance Sheet upon adoption of ASC 842 is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | Adjustments due to | ​ | July 1,
​ |  | 2019 |  | adoption of ASC 842 |  | 2019
​ | ​ | (in thousands, except share and par value amounts)
ASSETS: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and Cash Equivalents | ​ | $ | 299,445 | ​ | $ | — | ​ | $ | 299,445
Investments in Marketable Securities | ​ |  | 8,680 | ​ |  | — | ​ |  | 8,680
Restricted Cash | ​ |  | 1,022 | ​ |  | — | ​ |  | 1,022
Accounts Receivable, Net | ​ |  | 157,829 | ​ |  | — | ​ |  | 157,829
Prepaid Expenses and Other Current Assets | ​ |  | 37,724 | ​ |  | (3,483) | ​ |  | 34,241
Total Current Assets | ​ |  | 504,700 | ​ |  | (3,483) | ​ |  | 501,217
Land, Building and Equipment: | ​ |  |  | ​ |  |  | ​ |  | ​
Land | ​ |  | 44,609 | ​ |  | — | ​ |  | 44,609
Building | ​ |  | 383,331 | ​ |  | — | ​ |  | 383,331
Equipment | ​ |  | 281,551 | ​ |  | — | ​ |  | 281,551
Construction in Progress | ​ |  | 16,222 | ​ |  | — | ​ |  | 16,222
​ | ​ |  | 725,713 | ​ |  | — | ​ |  | 725,713
Accumulated Depreciation | ​ |  | (361,030) | ​ |  | — | ​ |  | (361,030)
Land, Building and Equipment, Net | ​ |  | 364,683 | ​ |  | — | ​ |  | 364,683
Noncurrent Assets: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Operating Lease Assets | ​ |  | — | ​ |  | 282,978 | ​ |  | 282,978
Deferred Income Taxes | ​ |  | 18,314 | ​ |  | — | ​ |  | 18,314
Intangible Assets, Net | ​ |  | 418,097 | ​ |  | — | ​ |  | 418,097
Goodwill | ​ |  | 874,451 | ​ |  | — | ​ |  | 874,451
Other Assets, Net | ​ |  | 62,451 | ​ |  | — | ​ |  | 62,451
Total Noncurrent Assets | ​ |  | 1,373,313 | ​ |  | 282,978 | ​ |  | 1,656,291
TOTAL ASSETS | ​ | $ | 2,242,696 | ​ | $ | 279,495 | ​ | $ | 2,522,191
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
LIABILITIES: | ​ |  |  | ​ |  |  | ​ |  |
Current Liabilities: | ​ |  |  | ​ |  |  | ​ |  |
Accounts Payable | ​ | $ | 57,627 | ​ | $ | — | ​ | $ | 57,627
Accrued Salaries, Wages and Benefits | ​ |  | 64,492 | ​ |  | — | ​ |  | 64,492
Accrued Liabilities | ​ |  | 86,722 | ​ |  | (16,946) | ​ |  | 69,776
Deferred Revenue | ​ |  | 99,790 | ​ |  | — | ​ |  | 99,790
Current Operating Lease Liabilities | ​ |  | — | ​ |  | 66,707 | ​ |  | 66,707
Current Portion of Long-Term Debt | ​ |  | 3,000 | ​ |  | — | ​ |  | 3,000
Total Current Liabilities | ​ |  | 311,631 | ​ |  | 49,761 | ​ |  | 361,392
Noncurrent Liabilities: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Long-Term Debt | ​ |  | 398,094 | ​ |  | — | ​ |  | 398,094
Long-Term Operating Lease Liabilities | ​ |  | — | ​ |  | 269,387 | ​ |  | 269,387
Deferred Income Taxes | ​ |  | 29,426 | ​ |  | — | ​ |  | 29,426
Other Liabilities | ​ |  | 102,472 | ​ |  | (39,653) | ​ |  | 62,819
Total Noncurrent Liabilities | ​ |  | 529,992 | ​ |  | 229,734 | ​ |  | 759,726
TOTAL LIABILITIES | ​ |  | 841,623 | ​ |  | 279,495 | ​ |  | 1,121,118
NONCONTROLLING INTEREST | ​ |  | 9,543 | ​ |  | — | ​ |  | 9,543
SHAREHOLDERS’ EQUITY: | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Common Stock, $0.01 Par Value | ​ |  | 801 | ​ |  | — | ​ |  | 801
Additional Paid-in Capital | ​ |  | 486,061 | ​ |  | — | ​ |  | 486,061
Retained Earnings | ​ |  | 2,012,902 | ​ |  | — | ​ |  | 2,012,902
Accumulated Other Comprehensive Loss | ​ |  | (137,290) | ​ |  | — | ​ |  | (137,290)
Treasury Stock, at Cost | ​ |  | (970,944) | ​ |  | — | ​ |  | (970,944)
TOTAL SHAREHOLDERS’ EQUITY | ​ |  | 1,391,530 | ​ |  | — | ​ |  | 1,391,530
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY | ​ | $ | 2,242,696 | ​ | $ | 279,495 | ​ | $ | 2,522,191

​

Upon the adoption of ASC 842, the following balances were removed from the Consolidated Balance Sheet as of July 1, 2019: (i) $3.5 million of prepaid rent balances within Prepaid Expenses and Other Current Assets; (ii) $6.8 million of current deferred rent liability balances within Accrued Liabilities; (iii) $10.1 million of current restructure liability balances within Accrued Liabilities; (iv) $24.8 million of noncurrent deferred rent liability balances within Other Liabilities; and (v) $14.9 million of noncurrent restructure liability balances within Other Liabilities.

​

Reclassifications

Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See “Note 2: Discontinued Operations and Assets Held for Sale” for further information. Prior period amounts have been revised to conform to the current classification. Certain expenses in prior periods previously allocated to Adtalem Brazil within our former Business and Law segment have been reclassified to the Home Office and Other segment based on

19

Table of Contents

discontinued operation reporting guidance regarding allocation of corporate overhead. See “Note 15: Segment Information” for additional information.

NOTE 4: STOCK-BASED COMPENSATION

Adtalem maintains two stock-based incentive plans: the Amended and Restated Incentive Plan of 2005 and the Fourth Amended and Restated Incentive Plan of 2013. Under these plans, directors, key executives and managerial employees are eligible to receive incentive stock or nonqualified options to purchase shares of Adtalem’s common stock. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 also permit the granting of stock appreciation rights, RSUs, performance-based RSUs and other stock and cash-based compensation. Although options remain outstanding under the 2005 incentive plan, no further stock-based grants will be issued under this plan. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 are administered by the Compensation Committee of the Board. Options are granted for terms of up to ten years and can vest immediately or over periods of up to five years. The requisite service period is equal to the vesting period. The option price under the plans is the fair market value of the shares on the date of the grant.

Stock-based compensation expense is measured at the grant date based on the fair value of the award. Adtalem accounts for stock-based compensation granted to retirement eligible employees that fully vests upon an employee’s retirement under the non-substantive vesting period approach. Under this approach, the entire stock-based compensation expense is recognized at the grant date for stock-based grants issued to retirement eligible employees. For non-retirement eligible employees, stock-based compensation expense is recognized as expense over the employee requisite service period. We account for forfeitures of outstanding but unvested grants in the period they occur.

As of September 30, 2019, 6,735,482 authorized but unissued shares of common stock were reserved for issuance under Adtalem’s stock-based incentive plans.

The following is a summary of options activity for the three months ended September 30, 2019:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ |  | ​ |  | Weighted |  | Average |  | Aggregate
​ | ​ | ​ | ​ | Average | ​ | Remaining | ​ | Intrinsic
​ | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | Value
​ | ​ | Options | ​ | Price | ​ | Life (in Years) | ​ | (in thousands)
Outstanding at July 1, 2019 |  | 1,488,478 | ​ | $ | 31.33 |  |  |  | ​ |
Granted |  | 229,125 | ​ |  | 43.39 |  |  |  | ​ |
Exercised |  | (37,889) | ​ |  | 28.94 |  |  |  | ​ |
Forfeited |  | (15,576) | ​ |  | 42.51 |  |  |  | ​ |
Expired |  | (65,274) | ​ |  | 52.28 |  |  |  | ​ |
Outstanding at September 30, 2019 |  | 1,598,864 | ​ |  | 32.15 |  | 7.15 | ​ | $ | 12,512
Exercisable at September 30, 2019 |  | 768,712 | ​ | $ | 28.43 |  | 5.87 | ​ | $ | 8,385

​

The total intrinsic value of options exercised for the three months ended September 30, 2019 and 2018 was $0.5 million and $1.8 million, respectively.

The fair value of Adtalem’s stock option awards was estimated using a binomial model. This model uses historical cancellation and exercise experience of Adtalem to determine the option value. It also takes into account the illiquid nature of employee options during the vesting period.

20

Table of Contents

The weighted average estimated grant date fair value of options granted at market price under Adtalem’s stock-based incentive plans during the first three months of fiscal years 2020 and 2019 was $16.98 and $20.96, per share, respectively. The fair value of Adtalem’s stock option grants was estimated assuming the following weighted average assumptions:

​

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year | ​
​ |  | 2019 |  | 2018 | ​
Expected Life (in Years) |  | 6.51 |  | 6.50 |
Expected Volatility |  | 37.66 | % | 39.60 | %
Risk-free Interest Rate |  | 1.40 | % | 2.73 | %
Dividend Yield |  | 0.00 | % | 0.00 | %

​

The expected life of the options granted is based on the weighted average exercise life with age and salary adjustment factors from historical exercise behavior. Adtalem’s expected volatility is computed by combining and weighting the implied market volatility, the most recent volatility over the expected life of the option grant and Adtalem’s long-term historical volatility.

If factors change and different assumptions are employed in the valuation of stock-based grants in future periods, the stock-based compensation expense that Adtalem records may differ significantly from what was recorded in previous periods.

During the first three months of fiscal year 2020, Adtalem granted 370,280 RSUs to selected employees. Of these, 135,660 are performance-based RSUs and 234,620 are non-performance-based RSUs. Performance-based RSUs are earned by the recipients over a three-year period based on achievement of return on invested capital and free cash flow per share. Certain awards are subject to achievement of a minimum level of Adtalem’s earnings before interest, taxes, depreciation and amortization. Non-performance-based RSUs are subject to restrictions which lapse ratably over one, three or four-year periods on the grant anniversary date based on the recipient’s continued service on the Board, employment with Adtalem or upon retirement. During the restriction period, the recipient of the non-performance based RSUs has the right to receive dividend equivalents, if any. This right does not pertain to the performance-based RSUs. The following is a summary of RSU activity for the three months ended September 30, 2019:

​

​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant Date
​ | ​ | RSUs | ​ | Fair Value
Outstanding at July 1, 2019 |  | 878,030 | ​ | $ | 34.86
Granted |  | 370,280 | ​ |  | 43.39
Vested |  | (330,216) | ​ |  | 27.37
Forfeited |  | (40,611) | ​ |  | 37.83
Outstanding at September 30, 2019 |  | 877,483 | ​ | $ | 40.01

​

The weighted average estimated grant date fair value of RSUs granted at market price under Adtalem’s stock-based incentive plans during the first three months of fiscal years 2020 and 2019 was $43.39 and $49.03, per share, respectively.

21

Table of Contents

The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (Loss) (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
Cost of Educational Services | ​ | $ | 455 | ​ | $ | 395 | ​
Student Services and Administrative Expense | ​ |  | 4,768 | ​ |  | 3,742 | ​
​ | ​ |  | 5,223 | ​ |  | 4,137 | ​
Income Tax Benefit | ​ |  | (2,533) | ​ |  | (2,007) | ​
Net Stock-Based Compensation Expense | ​ | $ | 2,690 | ​ | $ | 2,130 | ​

​

As of September 30, 2019, $30.9 million of total pre-tax unrecognized stock-based compensation expense related to unvested grants is expected to be recognized over a weighted average period of 2.7 years. The total fair value of options and RSUs vested during the three months ended September 30, 2019 and 2018 was approximately $12.1 million and $11.1 million, respectively.

There was no capitalized stock-based compensation cost at each of September 30, 2019, June 30, 2019 and September 30, 2018.

Adtalem has an established practice of issuing new shares of common stock to satisfy stock-based grant exercises. However, Adtalem also may issue treasury shares to satisfy stock-based grant exercises under certain of its stock-based incentive plans.

NOTE 5: FAIR VALUE MEASUREMENTS

Adtalem has elected not to measure any assets or liabilities at fair value other than those required to be measured at fair value on a recurring basis. Assets measured at fair value on a nonrecurring basis include goodwill, intangible assets and assets of businesses where the long-term value of the operations have been impaired.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The guidance specifies a fair value hierarchy based upon the observability of inputs used in valuation techniques. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. The guidance establishes fair value measurement classifications under the following hierarchy:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Observable inputs other than prices included in Level 1, such as quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets.

Level 3 –Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable.

When available, Adtalem uses quoted market prices to determine fair value, and such measurements are classified within Level 1. In cases where market prices are not available, Adtalem makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates and yield curves. These measurements are classified within Level 3.

Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable.

22

Table of Contents

The carrying value of our Cash and Cash Equivalents approximates fair value because of their short-term nature.

Adtalem maintains a rabbi trust to fund obligations under a non-qualified deferred compensation plan. Amounts in the rabbi trust are invested in stock and bond mutual funds, which are designated as available-for-sale securities carried at fair value, and are included in Investments in Marketable Securities on the Consolidated Balance Sheets. All Investments in Marketable Securities are recorded at fair value based upon quoted market prices using Level 1 inputs.

As of September 30, 2019, June 30, 2019 and September 30, 2018, there were no assets or liabilities measured at fair value using Level 2 or Level 3 inputs.

Assets measured at fair value on a nonrecurring basis include goodwill and indefinite-lived intangibles arising from a business combination. These assets are not amortized and charged to expense over time. Instead, goodwill and indefinite-lived intangibles must be reviewed annually for impairment or more frequently if circumstances arise indicating potential impairment. This impairment review was most recently completed as of May 31, 2019. See “Note 9: Intangible Assets” for further discussion on the impairment review including valuation techniques and assumptions.

NOTE 6: FINANCING RECEIVABLES

Adtalem’s financing receivables consist of trade receivables related to institutional loan programs available to students at Chamberlain, AUC, RUSM and RUSVM. These loan programs are designed to assist students who are unable to completely cover educational costs consisting of tuition, books and fees and are available only after all other student financial assistance has been applied toward those purposes. In addition, AUC, RUSM and RUSVM loans may be used for students’ living expenses. Repayment plans for institutional loan program balances are developed to address the financial circumstances of the particular student. Interest charges at rates from 3.0% to 12.0% per annum accrue each month on the unpaid balance. Most students are required to begin repaying their loans while they are still in school with a minimum payment level designed to demonstrate their capability to repay, reduce the possibility of over borrowing and to minimize interest being accrued on the loan balance. Payments may increase upon completing or departing school. After a student leaves school, the student typically will have a monthly installment repayment plan. In addition, the Becker CPA Exam Review Course can be financed through Becker’s flexible payment plans with terms of up to 18-months.

Reserves for uncollectible loans are determined by analyzing the current aging of institutional loans and historical loss rates of loans at each institution. Management performs this analysis periodically throughout the year. Loans are considered nonperforming if they are more than 90 days past due. Since all of Adtalem’s institutional loans are generated through the extension of credit to fund educational costs, all such receivables are considered part of the same loan portfolio.

The following table details the institutional loan balances along with the related allowances for credit losses (in thousands).

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2019 | ​ | June 30, 2019 | ​ | September 30, 2018
Gross Institutional Loans |  | ​ | ​ |  | $ | 47,673 |  | ​ | ​ |  | $ | 47,937 |  | ​ | ​ |  | $ | 48,936
Allowance for Credit Losses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at July 1 |  | $ | (6,289) | ​ | ​ | ​ |  | $ | (10,003) | ​ | ​ | ​ |  | $ | (10,003) | ​ | ​ | ​
Charge-offs and Adjustments | ​ | ​ | 26 | ​ | ​ | ​ | ​ | ​ | 10,777 | ​ | ​ | ​ | ​ | ​ | 5,355 | ​ | ​ | ​
Recoveries | ​ | ​ | (24) | ​ | ​ | ​ | ​ | ​ | (83) | ​ | ​ | ​ | ​ | ​ | (32) | ​ | ​ | ​
Additional Provision | ​ | ​ | (3,291) | ​ | ​ | ​ | ​ | ​ | (6,980) | ​ | ​ | ​ | ​ | ​ | (2,462) | ​ | ​ | ​
Balance at End of Period | ​ | ​ | ​ | ​ | ​ | (9,578) | ​ | ​ | ​ | ​ | ​ | (6,289) | ​ | ​ | ​ | ​ | ​ | (7,142)
Net Institutional Loans | ​ | ​ | ​ |  | $ | 38,095 | ​ | ​ | ​ |  | $ | 41,648 | ​ | ​ | ​ |  | $ | 41,794

​

Of the net balances above, $14.1 million, $16.6 million and $12.7 million was classified as Accounts Receivable, Net on the Consolidated Balance Sheets at September 30, 2019, June 30, 2019 and September 30, 2018, respectively, and

23

Table of Contents

$24.0 million, $25.1 million and $29.1 million, representing amounts due beyond one year, was classified as Other Assets, Net on the Consolidated Balance Sheets at September 30, 2019, June 30, 2019 and September 30, 2018, respectively.

The following tables detail the credit risk profiles of the institutional loan balances based on payment activity and an aging of past due institutional loans (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | June 30, | ​ | September 30,
​ |  | 2019 |  | 2019 |  | 2018
Institutional Loans: |  | ​ |  | ​ | ​ |  |  | ​ |
Performing | ​ | $ | 36,712 | ​ | $ | 38,049 | ​ | $ | 41,963
Nonperforming | ​ |  | 10,961 | ​ |  | 9,888 | ​ |  | 6,973
Total Institutional Loans | ​ | $ | 47,673 | ​ | $ | 47,937 | ​ | $ | 48,936

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | Greater |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | 30-59 | ​ | 60-89 | ​ | Than 90 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Total
​ | ​ | 1-29 Days | ​ | Days Past | ​ | Days Past | ​ | Days Past | ​ | Total | ​ | ​ | ​ | ​ | Institutional
​ | ​ | Past Due | ​ | Due | ​ | Due | ​ | Due | ​ | Past Due | ​ | Current | ​ | Loans
Institutional Loans: | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |
September 30, 2019 | ​ | $ | 3,317 | ​ | $ | 1,342 | ​ | $ | 526 | ​ | $ | 10,961 | ​ | $ | 16,146 | ​ | $ | 31,527 | ​ | $ | 47,673
June 30, 2019 | ​ | $ | 3,578 | ​ | $ | 2,458 | ​ | $ | 687 | ​ | $ | 9,888 | ​ | $ | 16,611 | ​ | $ | 31,326 | ​ | $ | 47,937
September 30, 2018 | ​ | $ | 6,437 | ​ | $ | 757 | ​ | $ | 752 | ​ | $ | 6,973 | ​ | $ | 14,919 | ​ | $ | 34,017 | ​ | $ | 48,936

​

Allowances for credit losses on nonperforming loans as of September 30, 2019, June 30, 2019 and September 30, 2018 were $9.4 million, $6.1 million and $7.0 million, respectively.

​

In connection with the completion of the sale of DeVry University, Adtalem loaned $10.0 million to DeVry University under the terms of the Note. The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. The value of the DeVry University loan receivable included in Other Assets, Net on the Consolidated Balance Sheet as of September 30, 2019 and June 30, 2019 is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 4% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary.

On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep Foundation (“DePaul College Prep”). In connection with the sale, Adtalem holds a mortgage from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The value of the DePaul College Prep loan receivable included in Other Assets, Net on the Consolidated Balance Sheet as of September 30, 2019 is $40.4 million, which is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 7% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary.

NOTE 7: SHARE REPURCHASE PROGRAMS

On November 7, 2018, the Board authorized Adtalem’s eleventh share repurchase program, which allows Adtalem to repurchase up to $300 million of its common stock through December 31, 2021. The eleventh share repurchase program commenced in January 2019. During the three months ended September 30, 2019, a total of 918,807 shares were repurchased for an aggregate of $40.3 million under the eleventh share repurchase program. To date, a total of 3,463,963 shares were repurchased for an aggregate of $158.1 million under the eleventh share repurchase program, resulting in $141.9 million of authorized share repurchases remaining under the eleventh share repurchase program as of September 30, 2019. The timing and amount of any repurchases will be determined based on an evaluation of market conditions and other factors. These repurchases may be made through the open market, including block purchases, in privately negotiated transactions, or otherwise. The repurchases will be funded through available cash balances and/or borrowings and may be suspended or discontinued at any time.

Shares of stock repurchased under the programs are held as treasury shares. These repurchased shares have reduced the weighted average number of shares of common stock outstanding for basic and diluted earnings per share calculations.

24

Table of Contents

​

NOTE 8: BUSINESS COMBINATIONS

OnCourse Learning

On May 31, 2019, Adtalem completed the acquisition of 100% of the equity interests of OCL for $118.4 million, net of cash of $1.2 million. The payment for this purchase was made in the fourth quarter of fiscal year 2019, and was funded with available domestic cash balances and $100 million in borrowings under Adtalem’s revolving credit facility. OCL is a leading provider of compliance training, licensure preparation, continuing education and professional development in the banking and mortgage industries across the U.S. The acquisition furthers Adtalem’s growth strategy into financial services.

The operations of OCL are included in Adtalem’s Financial Services segment. The results of OCL’s operations have been included in the Consolidated Financial Statements of Adtalem since the date of acquisition.

The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands):

​ | ​ | ​ | ​
​ |  | May 31,
​ | ​ | 2019
Current Assets | ​ | $ | 5,260
Property and Equipment | ​ |  | 1,197
Intangible Assets | ​ |  | 63,100
Goodwill | ​ |  | 59,519
Total Assets Acquired | ​ |  | 129,076
Liabilities Assumed | ​ |  | 9,445
Net Assets Acquired | ​ | $ | 119,631

​

Goodwill, which represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired, was all assigned to the Financial Services reporting unit and reportable segment. Factors that contributed to a purchase price resulting in the recognition of goodwill include OCL’s strategic fit into Adtalem’s expanding presence in financial services, the reputation of the OCL brand as a leader in the industry and potential future growth opportunity. Of the $63.1 million of acquired intangible assets, $18.4 million was assigned to Trade Names, which has been determined not to be subject to amortization. The remaining acquired intangible assets were determined to be subject to amortization with an average useful life of approximately nine years. The values and estimated useful lives by asset type are as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​
​ |  | May 31, 2019
​ | ​ | Value | ​ | Estimated
​ |  | Assigned |  | Useful Life
Customer Relationships | ​ | $ | 26,400 | ​ | 11 years
Curriculum |  | ​ | 11,600 |  | 6 years
Course Delivery Technology |  | ​ | 6,700 |  | 5 years

​

There is no proforma presentation of operating results for this acquisition due to the insignificant effect on consolidated operations.

NOTE 9: INTANGIBLE ASSETS

Intangible assets relate mainly to acquired business operations. These assets consist of the acquisition fair value of certain identifiable intangible assets acquired and goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired.

25

Table of Contents

Intangible assets consist of the following (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2019 | ​ | ​
​ |  | Gross |  | ​ | ​ |  | Weighted Average
​ | ​ | Carrying | ​ | Accumulated | ​ | Amortization
​ | ​ | Amount | ​ | Amortization | ​ | Period
Amortizable Intangible Assets: |  | ​ |  |  | ​ |  |  |
Customer Relationships | ​ | $ | 68,900 | ​ | $ | (15,865) |  | 10 Years
Curriculum/Software | ​ |  | 11,600 | ​ |  | (644) |  | 6 Years
Course Delivery Technology | ​ |  | 7,200 | ​ |  | (853) |  | 5 Years
Total | ​ | $ | 87,700 | ​ | $ | (17,362) |  |
Indefinite-Lived Intangible Assets: | ​ |  |  | ​ |  |  |  |
Trade Names | ​ | $ | 95,746 | ​ |  |  |  |
Chamberlain Title IV Eligibility and Accreditations | ​ |  | 1,200 | ​ |  |  |  |
AUC Title IV Eligibility and Accreditations | ​ |  | 100,000 | ​ |  |  |  |
Ross Title IV Eligibility and Accreditations | ​ |  | 14,100 | ​ |  |  |  |
Intellectual Property | ​ |  | 13,940 | ​ |  |  |  |
Total | ​ | $ | 224,986 | ​ |  |  |  |

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2019
​ |  | Gross |  | ​ | ​
​ | ​ | Carrying | ​ | Accumulated
​ | ​ | Amount | ​ | Amortization
Amortizable Intangible Assets: | ​ |  | ​ | ​ |  | ​
Customer Relationships |  | $ | 69,300 |  | $ | (14,448)
Curriculum/Software |  | ​ | 16,600 |  | ​ | (5,193)
Course Delivery Technology |  | ​ | 7,200 |  | ​ | (487)
Total | ​ | $ | 93,100 | ​ | $ | (20,128)
Indefinite-Lived Intangible Assets: | ​ |  |  | ​ |  |
Trade Names | ​ | $ | 95,777 | ​ |  |
Chamberlain Title IV Eligibility and Accreditations | ​ |  | 1,200 | ​ |  |
AUC Title IV Eligibility and Accreditations | ​ |  | 100,000 | ​ |  |
Ross Title IV Eligibility and Accreditations | ​ |  | 14,100 | ​ |  |
Intellectual Property | ​ |  | 13,940 | ​ |  |
Total | ​ | $ | 225,017 | ​ |  |

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2018
​ |  | Gross | ​ | ​ | ​
​ |  | Carrying |  | Accumulated
​ |  | Amount |  | Amortization
Amortizable Intangible Assets: | ​ |  |  | ​ |  |
Customer Relationships | ​ | $ | 42,900 | ​ | $ | (10,756)
Curriculum/Software | ​ | ​ | 5,000 | ​ | ​ | (3,750)
Proprietary Technology | ​ | ​ | 500 | ​ | ​ | (281)
Total |  | $ | 48,400 |  | $ | (14,787)
Indefinite-Lived Intangible Assets: | ​ | ​ | ​ | ​ | ​ | ​
Trade Names |  | $ | 77,313 | ​ | ​ | ​
Chamberlain Title IV Eligibility and Accreditations | ​ | ​ | 1,200 | ​ | ​ | ​
AUC Title IV Eligibility and Accreditations | ​ | ​ | 100,000 | ​ | ​ | ​
Ross Title IV Eligibility and Accreditations | ​ | ​ | 14,100 | ​ | ​ | ​
Intellectual Property | ​ | ​ | 13,940 | ​ | ​ | ​
Total |  | $ | 206,553 | ​ | ​ | ​

​

26

Table of Contents

Amortization expense for amortized intangible assets was $2.5 million and $1.6 million for the three months ended September 30, 2019 and 2018, respectively. Estimated amortization expense for amortizable intangible assets for the next five fiscal years ending June 30 and in the aggregate, by reporting unit, is as follows (in thousands):

​

​ | ​ | ​ | ​ | ​
​ |  | Financial |
Fiscal Year | ​ | Services | ​
2020 (Remaining) | ​ | $ | 7,728 | ​
2021 | ​ |  | 10,073 | ​
2022 | ​ |  | 9,944 | ​
2023 | ​ |  | 9,792 | ​
2024 | ​ |  | 9,509 | ​
Thereafter | ​ |  | 23,292 | ​
Total | ​ | $ | 70,338 | ​

​

All amortizable intangible assets except ACAMS customer relationships are being amortized on a straight-line basis. The amount being amortized for customer relationships related to ACAMS is based on the estimated retention of the customers, giving consideration to the revenue and cash flow associated with these existing customers.

Indefinite-lived intangible assets related to trade names, Title IV eligibility, accreditations and intellectual property are not amortized, as there are no legal, regulatory, contractual, economic or other factors that limit the useful life of these intangible assets to the reporting entity.

In accordance with GAAP, goodwill and indefinite-lived intangibles arising from a business combination are not amortized and charged to expense over time. Instead, these assets must be reviewed annually for impairment or more frequently if circumstances arise indicating potential impairment. Adtalem’s annual impairment review was most recently completed as of May 31, 2019, at which time there was no impairment loss associated with recorded goodwill or indefinite-lived intangible assets for any reporting unit.

Adtalem has four reporting units that contained goodwill as of the first quarter of fiscal year 2020. These reporting units constitute components for which discrete financial information is available and regularly reviewed by segment management. If the carrying amount of a reporting unit containing the goodwill exceeds the fair value of that reporting unit, an impairment loss to goodwill is recognized. In analyzing the results of operations and business conditions of all the reporting units, as of September 30, 2019, it was determined that no triggering event had occurred that would indicate the carrying value of a reporting unit had exceeded its fair value.

Adtalem has four reporting units that contained indefinite-lived intangible assets as of the first quarter of fiscal year 2020. For indefinite-lived intangible assets, management first analyzes qualitative factors including results of operations and business conditions of the four reporting units that contained indefinite-lived intangible assets, significant changes in cash flows at the individual indefinite-lived intangible asset level, if applicable, as well as how much previously calculated fair values exceed carrying values to determine if it is more likely than not that the intangible assets associated with these reporting units have been impaired.

These interim triggering event conclusions were based on the fact that the annual impairment review of Adtalem’s reporting units and indefinite-lived intangible assets resulted in no impairment indicators as of the end of fiscal year 2019, and that no interim events or deviations from planned operating results occurred as of September 30, 2019, that would cause management to reassess these conclusions.

In January 2019, Adtalem relocated RUSM to Barbados from its temporary locations in Knoxville, Tennessee at facilities owned by Lincoln Memorial University (“LMU”) and at a facility in St Kitts. Management believes the values of RUSM’s goodwill and indefinite-lived intangible assets are not affected by this move. The Trade Name will continue to be used and the U.S. Department of Education (“ED”) has provided approval for RUSM to operate in Barbados. No new accreditation is necessary, as RUSM’s secondary accreditor, the Caribbean Accreditation Authority for Education in Medicine and other Health Professions (“CAAM-HP”), is now its primary accreditor as of the start of the January 2019 semester. CAAM-HP is authorized by the government of Barbados to accredit medical programs.

27

Table of Contents

Determining the fair value of a reporting unit or an intangible asset involves the use of significant estimates and assumptions. Management bases its fair value estimates on assumptions it believes to be reasonable at the time, but such assumptions are subject to inherent uncertainty. Actual results may differ from those estimates, which could lead to additional impairments of intangible assets or goodwill.

As of September 30, 2019, intangible assets from business combinations totaled $295.3 million and goodwill totaled $687.0 million. Together, these assets equaled 40% of total assets as of such date, and any impairment could significantly affect future results of operations.

The table below summarizes goodwill balances by reporting unit (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30, |  | September 30,
Reporting Unit | ​ | 2019 | ​ | 2019 | ​ | 2018
Chamberlain | ​ | $ | 4,716 | ​ | $ | 4,716 | ​ | $ | 4,716
AUC | ​ |  | 68,321 | ​ |  | 68,321 | ​ |  | 68,321
RUSM and RUSVM | ​ |  | 237,173 | ​ |  | 237,173 | ​ |  | 237,173
Financial Services | ​ |  | 376,782 | ​ |  | 377,046 | ​ |  | 317,029
Total | ​ | $ | 686,992 | ​ | $ | 687,256 | ​ | $ | 627,239

​

The table below summarizes goodwill balances by reportable segment (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30, |  | September 30,
Reportable Segment | ​ | 2019 | ​ | 2019 | ​ | 2018
Medical and Healthcare | ​ | $ | 310,210 | ​ | $ | 310,210 | ​ | $ | 310,210
Financial Services | ​ |  | 376,782 | ​ |  | 377,046 | ​ |  | 317,029
Total | ​ | $ | 686,992 | ​ | $ | 687,256 | ​ | $ | 627,239

​

The table below summarizes the changes in goodwill balances by reportable segment (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Medical and |  | Financial |  | ​ | ​
​ | ​ | Healthcare | ​ | Services | ​ | Total
Balance at June 30, 2018 | ​ | $ | 310,210 | ​ | $ | 317,699 | ​ | $ | 627,909
Foreign exchange rate changes |  | ​ | — |  | ​ | (670) |  | ​ | (670)
Balance at September 30, 2018 | ​ | ​ | 310,210 | ​ | ​ | 317,029 | ​ | ​ | 627,239
Acquisitions | ​ | ​ | — | ​ | ​ | 59,519 | ​ | ​ | 59,519
Foreign exchange rate changes |  | ​ | — |  | ​ | 498 |  | ​ | 498
Balance at June 30, 2019 | ​ | ​ | 310,210 | ​ | ​ | 377,046 | ​ | ​ | 687,256
Foreign exchange rate changes |  | ​ | — |  | ​ | (264) |  | ​ | (264)
Balance at September 30, 2019 | ​ | $ | 310,210 | ​ | $ | 376,782 | ​ | $ | 686,992

​

The decrease in the goodwill balance from June 30, 2019 in the Financial Services segment is the result of a change in the value of the Indian Rupee compared to the U.S. dollar. Since EduPristine’s goodwill is recorded in local currency, fluctuations in the values of the Indian Rupee in relation to the U.S. dollar will cause changes in the balance of this asset.

The table below summarizes the indefinite-lived intangible asset balances by reportable segment (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30, |  | September 30,
Reportable Segment | ​ | 2019 | ​ | 2019 | ​ | 2018
Medical and Healthcare | ​ | $ | 137,500 | ​ | $ | 137,500 | ​ | $ | 137,500
Financial Services | ​ |  | 87,486 | ​ |  | 87,517 | ​ |  | 69,053
Total | ​ | $ | 224,986 | ​ | $ | 225,017 | ​ | $ | 206,553

​

​

​

28

Table of Contents

NOTE 10: RESTRUCTURING CHARGES

During the first quarter of fiscal year 2020, Adtalem recorded restructuring charges primarily related to the sale of Becker’s courses for healthcare students and Adtalem’s home office real estate consolidations. During the first quarter of fiscal year 2019, Adtalem recorded restructuring charges primarily related to the impairment of the land, buildings and equipment at the Dominica campus of RUSM and severance related to workforce reductions in Dominica. In January 2019, RUSM relocated its campus operations to Barbados with no plans to return to Dominica. The land, buildings and equipment in Dominica have been fully impaired as management determined the market value less the costs to sell the facilities or move the equipment is zero (see “Note 3: Summary of Significant Accounting Policies”). In addition, during the first quarter of fiscal year 2019, Adtalem recorded restructuring charges primarily related to real estate consolidations at Adtalem’s home office. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and result in additional restructuring charges or reversals in future periods. Termination benefit charges, resulting from reducing Adtalem’s workforce by 15 and 176 positions in the first quarter of fiscal year 2020 and 2019, respectively, represented severance pay and benefits for these employees. Adtalem’s home office is classified as “Home Office and Other” in “Note 15: Segment Information.” Pre-tax restructuring charges by segment were as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019 | ​ | Three Months Ended September 30, 2018
​ |  | Real Estate |  | Termination |  | ​ | ​ |  | Real Estate |  | Termination |  | ​ | ​
​ | ​ | and Other | ​ | Benefits | ​ | Total | ​ | and Other | ​ | Benefits | ​ | Total
Medical and Healthcare | ​ | $ | 127 | ​ | $ | — | ​ | $ | 127 | ​ | $ | 37,753 | ​ | $ | 1,262 | ​ | $ | 39,015
Financial Services | ​ | ​ | 1,690 | ​ | ​ | 289 | ​ | ​ | 1,979 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Home Office and Other |  | ​ | 4,122 |  | ​ | 302 |  | ​ | 4,424 |  | ​ | 509 |  | ​ | (51) |  | ​ | 458
Total | ​ | $ | 5,939 | ​ | $ | 591 | ​ | $ | 6,530 | ​ | $ | 38,262 | ​ | $ | 1,211 | ​ | $ | 39,473

​

The following table summarizes the separation and restructuring plan activity for the fiscal years 2020 and 2019, for which cash payments are required (in thousands):

​ | ​ | ​ | ​
Liability balance at June 30, 2018 |  | $ | 38,927
Increase in liability (separation and other charges) | ​ |  | 8,870
Reduction in liability (payments and adjustments) | ​ |  | (22,714)
Liability balance at June 30, 2019 | ​ |  | 25,083
ASC 842 (Leases) Adjustment (1) | ​ | ​ | (25,030)
Liability balance at July 1, 2019 | ​ |  | 53
Increase in liability (separation and other charges) | ​ |  | 591
Reduction in liability (payments and adjustments) | ​ |  | (500)
Liability balance at September 30, 2019 | ​ | $ | 144

​

(1) Reflects amounts reclassified out of the opening balance of restructuring reserve accruals as of June 30, 2019, to operating lease assets that was recorded with the adoption of ASC 842. See “Note 3: Summary of Significant Accounting Policies” for further details.

The liability balance of $0.1 million as of September 30, 2019 is recorded as Accrued Liabilities on the Consolidated Balance Sheet. This liability balance represents costs for employees who have either not yet separated from Adtalem or for whom full severance has not yet been paid. All of these remaining costs are expected to be paid within the next 12 months.

​

NOTE 11: LEASES

Management determines if a contract contains a lease at inception. Adtalem has entered into operating leases for academic sites, housing facilities and office space which expire at various dates through February 2030, most of which include options to terminate for a fee or extend the leases for an additional five-year period. The lease term includes options to terminate or extend when it is reasonably certain that the option will be exercised. Management elected to account for lease and non-lease components (e.g., common-area maintenance costs) as a single lease component for all operating

29

Table of Contents

leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Adtalem has not entered into any financing leases.

Operating lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets represent our right to use an underlying asset during the lease term. Operating lease assets and liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Operating lease assets are adjusted for any prepaid or accrued lease payments, lease incentives, initial direct costs and impairments. Adtalem’s incremental borrowing rate is utilized in determining the present value of the lease payments when the implicit rate is not readily determinable based upon the information available at the commencement date. Adtalem’s incremental borrowing rate is determined using a secured borrowing rate for the same currency and term as the associated lease. Operating lease expense is recognized on a straight-line basis over the lease term.

As of September 30, 2019, an additional operating lease that has not yet commenced will result in an additional operating lease asset and lease liability of $10.0 million. This operating lease will commence during the third quarter of fiscal year 2020 and has an 11-year lease term.

The components of lease cost were as follows (in thousands):

​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended
​ |  | September 30,
​ | ​ | 2019
Operating Lease Cost | ​ | $ | 13,703
Sublease Income | ​ |  | (5,126)
Total Lease Cost | ​ | $ | 8,577

​

Maturities of lease liabilities by fiscal year were as follows as of September 30, 2019 (in thousands):

​ | ​ | ​ | ​
​ |  | Operating
Fiscal Year | ​ | Leases
2020 (Remaining) | ​ | $ | 50,344
2021 | ​ | ​ | 61,142
2022 | ​ | ​ | 56,349
2023 | ​ | ​ | 45,344
2024 | ​ | ​ | 28,880
Thereafter | ​ | ​ | 40,791
Total lease payments | ​ |  | 282,850
Less: imputed interest | ​ | ​ | (36,738)
Present value of lease liabilities | ​ | $ | 246,112

​

Lease term and discount rate were as follows:

​ | ​ | ​ | ​
​ |  | September 30,
​ | ​ | 2019
Weighted-average remaining operating lease term (years) | ​ | ​ | 5.1
Weighted-average operating lease discount rate | ​ | ​ | 5.4%

​

Supplemental disclosures of cash flow information related to leases were as follows (in thousands):

​ | ​ | ​ | ​
​ |  | September 30,
​ | ​ | 2019
Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts) | ​ | $ | 11,963
Operating lease assets obtained in exchange for operating lease liabilities | ​ | $ | 4,868

​

Adtalem maintains agreements to lease four facilities owned by Adtalem to DeVry University with various expiration dates through December 2023. Adtalem entered into agreements to sublease either a portion or the full leased space at 25 of its operating lease locations. Most of these subleases are a result of Adtalem retaining leases associated with restructured

30

Table of Contents

lease activities at DeVry University and Carrington prior to their divestitures during fiscal year 2019. All sublease expirations with DeVry University and Carrington coincide with Adtalem’s original head lease expiration dates. At that time, Adtalem will be relieved of its obligations. In addition, Adtalem has entered into subleases with non-affiliated entities for vacated or partially vacated space from restructuring activities. Adtalem sublease agreements expire at various dates through December 2025. Adtalem records sublease income as an offset against its lease expense recorded on the head lease. For leases which Adtalem vacated or partially vacated space, Adtalem recorded estimated restructuring charges in prior periods. Actual results may differ from these estimates, which could result in additional restructuring charges or reversals. Future minimum lease and sublease rental income under these agreements at September 30, 2019, are as follows (in thousands):

​

​ | ​ | ​ | ​
Fiscal Year |  | Amount
2020 (Remaining) | ​ | $ | 18,608
2021 | ​ | ​ | 20,099
2022 | ​ |  | 17,103
2023 | ​ |  | 16,368
2024 | ​ |  | 10,523
Thereafter | ​ | ​ | 7,308
Total | ​ | $ | 90,009

​

As previously disclosed in our 2019 Annual Report on Form 10-K and under the previous lease accounting, future minimum rental commitments for all noncancelable operating leases, adjusted to exclude Adtalem Brazil, having a remaining term in excess of one year at June 30, 2019, were as follows (in thousands):

​ | ​ | ​ | ​
Fiscal Year | ​ | Amount
2020 | ​ | $ | 67,109
2021 | ​ | ​ | 60,781
2022 | ​ | ​ | 55,982
2023 | ​ | ​ | 44,970
2024 | ​ | ​ | 28,374
Thereafter | ​ | ​ | 36,120
Total minimum lease payments | ​ | $ | 293,336

​

Rent expense, adjusted to exclude Adtalem Brazil, for the years ended June 30, 2019 and 2018 was $35.8 million and $25.0 million, respectively.

NOTE 12: INCOME TAXES

The effective tax rate on income from continuing operations was 17.6% in the first quarter of fiscal year 2020 compared to 32.4% on loss from continuing operations in the first quarter of fiscal year 2019. The effective tax rate in the first quarter of fiscal year 2019 included a pre-tax income special item of $39.0 million related to the write-offs of assets and restructuring charges in Dominica. The effective tax rates on income from continuing operations excluding this non-recurring special item was 16.4% in the first quarter of fiscal year 2019. The increase in the first quarter of fiscal year 2020 primarily reflects a decrease in the percentage of earnings from foreign operations, which are taxed at lower rates than domestic earnings. The provisions from the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) impacting the first quarter of fiscal year 2020 effective tax rate include a tax on global intangible low-taxed income (“GILTI”), a deduction for foreign derived intangible income (“FDII”), and a limitation of certain executive compensation. Our estimates may be revised in future periods as we obtain additional data and any new regulations or guidance is released.

Three of Adtalem’s operating units benefit from local tax incentives: AUC, which operates in St. Maarten, RUSM, which operates in Barbados, and RUSVM, which operates in St. Kitts. AUC’s effective tax rate reflects benefits derived from investment incentives. RUSM and RUSVM each have agreements with their respective domestic governments that exempt them from local income taxation. RUSM has an exemption in Barbados until 2039. RUSVM has an exemption in St. Kitts until 2037.

31

Table of Contents

NOTE 13: DEBT

Long-term debt consists of the following (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30, |  | September 30,
​ | ​ | 2019 | ​ | 2019 | ​ | 2018
Total Debt: |  | ​ |  |  | ​ |  |  | ​ |
Term B Loan | ​ | $ | 296,250 | ​ | $ | 297,000 | ​ | $ | 299,250
Revolver | ​ |  | 40,000 | ​ |  | 110,000 | ​ |  | —
Total Principal Payments Due | ​ |  | 336,250 | ​ |  | 407,000 | ​ |  | 299,250
Deferred Debt Issuance Costs | ​ |  | (5,650) | ​ |  | (5,906) | ​ |  | (6,671)
Total Amount Outstanding | ​ |  | 330,600 | ​ |  | 401,094 | ​ |  | 292,579
Less Current Portion: | ​ |  |  | ​ |  |  | ​ |  |
Term B Loan | ​ |  | (3,000) | ​ |  | (3,000) | ​ |  | (3,000)
Noncurrent Portion | ​ | $ | 327,600 | ​ | $ | 398,094 | ​ | $ | 289,579

​

Scheduled future maturities of long-term debt for the next five fiscal years ending June 30 and in the aggregate are as follows (in thousands):

​ | ​ | ​ | ​
​ |  | Maturity
Fiscal Year | ​ | Payments
2020 (Remaining) | ​ | $ | 2,250
2021 | ​ |  | 3,000
2022 | ​ |  | 3,000
2023 | ​ |  | 43,000
2024 | ​ |  | 3,000
Thereafter | ​ |  | 282,000
Total | ​ | $ | 336,250

​

Senior Secured Credit Facilities

On April 13, 2018, Adtalem entered into a Credit Agreement (the “Credit Agreement”) that provides for (1) a $300 million revolving facility (“Revolver”) with a maturity date of April 13, 2023, and (2) a $300 million senior secured Term B loan (“Term B Loan”) with a maturity date of April 13, 2025. We refer to the Revolver and Term B Loan collectively as the “Credit Facility.” The Revolver has availability for currencies other than U.S. dollars of up to $200 million and $100 million available for letters of credit. Subject to certain conditions set forth in the Credit Agreement, the Credit Facility may be increased by $250 million.

Interest on the Term B Loan and the Revolver is set based on the London Interbank Offered Rate (“LIBOR”) based on observable market transactions. The U.K. Financial Conduct Authority (“FCA”), which regulates LIBOR, has announced that it has commitments from panel banks to continue to contribute to LIBOR through the end of 2021, but that it will not use its powers to compel contributions beyond such date. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. Management is monitoring their efforts, and evaluating the need for an amendment to the Credit Agreement to accommodate a replacement rate.

Term B Loan

For Eurocurrency rate loans, Term B Loan interest is equal to LIBOR or a LIBOR-equivalent rate plus 3%. For base rate loans, Term B Loan interest is equal to the base rate plus 2%. The Term B Loan amortizes in equal quarterly installments of $750,000, with the balance due at maturity on April 13, 2025. As of September 30, 2019, June 30, 2019 and September 30, 2018, the interest rate for borrowings under the Term B Loan facility was 5.04%, 5.40% and 5.24%, respectively, which approximated the effective interest rate.

32

Table of Contents

Revolver

Revolver interest is equal to LIBOR or a LIBOR-equivalent rate for Eurocurrency rate loans or a base rate, plus an applicable rate based on Adtalem’s consolidated leverage ratio, as defined in the Credit Agreement. The applicable rate ranges from 1.75% to 2.75% for Eurocurrency rate loans and from 0.75% to 1.75% for base rate loans. As of September 30, 2019 and June 30, 2019, borrowings under the Revolver were $40 million and $110 million with a weighted average interest rate of 4.20% and 4.66%, respectively. There were no outstanding borrowings under the Revolver as of September 30, 2018.

Adtalem had a letter of credit outstanding of $68.4 million as of each of September 30, 2019, June 30, 2019 and September 30, 2018. This letter of credit was posted in the second quarter of fiscal year 2017 in relation to a settlement with the Federal Trade Commission (“FTC”). As of September 30, 2019, Adtalem is charged an annual fee equal to 2.25% of the undrawn face amount of the outstanding letters of credit under the Revolver, payable quarterly. Adtalem continues to post the letter of credit in relation to the settlement with the FTC on behalf of DeVry University and is reimbursed by DeVry University for 2.00% of the outstanding amount of this letter of credit. The Credit Agreement also requires payment of a commitment fee equal to 0.40% of the undrawn portion of the Revolver as of September 30, 2019. The amount undrawn under the Revolver, which includes the impact of the outstanding letters of credit, was $191.6 million as of September 30, 2019. The letter of credit fees and commitment fees are adjustable quarterly, based upon Adtalem’s achievement of certain financial ratios.

Debt Issuance Costs

Adtalem incurred $9.9 million in fees that were capitalized in relation to the Credit Agreement, $7.1 million of which was related to the Term B Loan facility and $2.7 million of which was related to the Revolver facility. The deferred debt issuance costs related to the Term B Loan are presented as a direct deduction from the face amount of the debt, while the deferred debt issuance costs related to the Revolver are classified as Other Assets, Net on the Consolidated Balance Sheets. The deferred debt issuance costs amortization is recorded in Interest Expense in the Consolidated Statements of Income (Loss). The following table summarizes the total deferred debt issuance costs for the Term B Loan and Revolver, which are being amortized over seven years and five years, respectively (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Term B Loan |  | Revolver |  | Total
Deferred Debt Issuance Costs at June 30, 2019 | ​ | $ | 5,906 | ​ | $ | 2,061 | ​ | $ | 7,967
Amortization of Deferred Debt Issuance Costs | ​ |  | (256) | ​ |  | (136) | ​ |  | (392)
Deferred Debt Issuance Costs at September 30, 2019 | ​ | $ | 5,650 | ​ | $ | 1,925 | ​ | $ | 7,575

​

Covenants and Guarantees

The Credit Agreement contains customary covenants, including restrictions on our restricted subsidiaries’ ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets.

The Credit Agreement contains covenants that, among other things, require maintenance of certain financial ratios, as defined in the agreement. Maintenance of these financial ratios could place restrictions on Adtalem’s ability to pay dividends. These financial ratios include a consolidated fixed charge coverage ratio, a consolidated leverage ratio and a U.S. Department of Education financial responsibility ratio based upon a composite score of an equity ratio, a primary reserve ratio and a net income ratio. Failure to maintain any of these ratios or to comply with other covenants contained in the Credit Agreement would constitute an event of default and could result in termination of the Credit Agreement and require payment of all outstanding borrowings and replacement of outstanding letters of credit. Adtalem was in compliance with the debt covenants as of September 30, 2019.

The stock of all U.S. and certain foreign subsidiaries of Adtalem is pledged as collateral for borrowings under the Credit Agreement.

The Term B Loan requires mandatory prepayments equal to a percentage of Excess Cash Flow, which is defined within the Credit Agreement, subject to incremental step-downs, depending on the consolidated leverage ratio. Beginning in

33

Table of Contents

fiscal year 2019, the Excess Cash Flow payment is due in the first quarter of each year and is based on the Excess Cash Flow and leverage ratio for the prior year. No payment was due as of September 30, 2019.

Our borrowings under the Credit Facility are guaranteed by us and all of our domestic subsidiaries (subject to certain exceptions) and secured by a first lien on our assets and the assets of our guarantor subsidiaries (excluding real estate), including capital stock of the subsidiaries.

NOTE 14: COMMITMENTS AND CONTINGENCIES

Adtalem is subject to lawsuits, administrative proceedings, regulatory reviews and investigations associated with financial assistance programs and other matters arising in the normal conduct of its business. As of September 30, 2019, Adtalem believes it has adequately reserved for potential losses. The following is a description of pending legal and regulatory matters that may be considered other than ordinary, routine and incidental to the business. Descriptions of certain matters from prior SEC filings may not be carried forward in this report to the extent we believe such matters no longer are required to be disclosed or there has not been, to our knowledge, significant activity relating to them. The timing or outcome of the following matters, or their possible impact on Adtalem’s business, financial condition or results of operations, cannot be predicted at this time. The continued defense, resolution or settlement of any of the following matters could require us to expend significant resources and could have a material adverse effect on our business, financial condition, results of operations and cash flows and result in the imposition of significant restrictions on us and our ability to operate.

On May 13, 2016, a putative class action lawsuit was filed by the Pension Trust Fund for Operating Engineers, individually and on behalf of others similarly situated, against Adtalem, Daniel Hamburger, Richard M. Gunst, and Timothy J. Wiggins in the United States District Court for the Northern District of Illinois. The complaint was filed on behalf of a putative class of persons who purchased Adtalem common stock between February 4, 2011 and January 27, 2016. The complaint cites the January 27, 2016 Notice of Intent to Limit (the “January 2016 Notice”) and a civil complaint (the “FTC lawsuit”) filed by the FTC on January 27, 2016 against Adtalem, DeVry University, Inc., and DeVry/New York Inc. (collectively, the “Adtalem Parties”), which was resolved with the FTC in 2017, that alleged that certain of DeVry University’s advertising claims were false or misleading or unsubstantiated at the time they were made in violation of Section 5(a) of the FTC Act, as the basis for claims that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. As a result of these alleged false or misleading statements, the plaintiff alleged that defendants overstated Adtalem’s growth, revenue and earnings potential and made false or misleading statements about Adtalem’s business, operations and prospects. The plaintiff alleged direct liability against all defendants for violations of §10(b) and Rule 10b-5 of the Securities Exchange Act of 1934 (the “Exchange Act”) and asserted liability against the individual defendants pursuant to § 20(a) of the Exchange Act. The plaintiff sought monetary damages, interest, attorneys’ fees, costs and other unspecified relief. On July 13, 2016, the Utah Retirement System (“URS”) moved for appointment as lead plaintiff and approval of its selection of counsel, which was not opposed by the Pension Trust Fund for Operating Engineers. URS was appointed as lead plaintiff on August 24, 2016. URS filed a second amended complaint (“SAC”) on December 23, 2016. The SAC sought to represent a putative class of persons who purchased Adtalem common stock between August 26, 2011 and January 27, 2016 and named an additional individual defendant, Patrick J. Unzicker, Adtalem’s former Chief Financial Officer. Like the original complaint, the SAC asserted claims against all defendants for alleged violations of §10(b) and Rule 10b-5 of the Exchange Act and asserted liability against the individual defendants pursuant to § 20(a) of the Exchange Act for alleged material misstatements or omissions regarding DeVry University graduate outcomes. On January 27, 2017, defendants moved to dismiss the SAC, which motion was granted on December 6, 2017, without prejudice. The plaintiffs filed a third amended complaint (“TAC”) on January 29, 2018. The defendants moved to dismiss the TAC on March 30, 2018. The court denied the motion to dismiss the TAC on December 20, 2018. On February 8, 2019, defendants filed their answer to the TAC wherein defendants denied all material allegations in the TAC. The parties engaged in mediation and reached a tentative resolution. On September 5, 2019, the court granted preliminary approval of the class action settlement. The final approval hearing is set for December 6, 2019.

On October 14, 2016, a putative class action lawsuit was filed by Debbie Petrizzo and five other former DeVry University students, individually and on behalf of others similarly situated, against the Adtalem Parties in the United States District Court for the Northern District of Illinois (the “Petrizzo Case”). The complaint was filed on behalf of a putative class of persons consisting of those who enrolled in and/or attended classes at DeVry University during and after 2002 and

34

Table of Contents

who were unable to find employment within their chosen field of study within six months of graduation. Citing the FTC lawsuit, the plaintiffs claimed that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserted claims for unjust enrichment and violations of six different states’ consumer fraud, unlawful trade practices, and consumer protection laws. The plaintiffs seek monetary, declaratory, injunctive, and other unspecified relief.

On October 28, 2016, a putative class action lawsuit was filed by Jairo Jara and eleven others, individually and on behalf of others similarly situated, against the Adtalem Parties in the United States District Court for the Northern District of Illinois (the “Jara Case”). The individual plaintiffs claimed to have graduated from DeVry University in 2001 or later and sought to proceed on behalf of a putative class of persons consisting of those who obtained a degree from DeVry University and who were unable to find employment within their chosen field of study within six months of graduation. Citing the FTC lawsuit, the plaintiffs claimed that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserted claims for unjust enrichment and violations of ten different states’ consumer fraud, unlawful trade practices, and consumer protection laws. The plaintiffs sought monetary, declaratory, injunctive, and other unspecified relief.

By order dated November 28, 2016, the district court ordered the Petrizzo Case and the Jara Case be consolidated under the Petrizzo caption for all further purposes. On December 5, 2016, plaintiffs filed an amended consolidated complaint on behalf of 38 individual plaintiffs and others similarly situated. The amended consolidated complaint sought to bring claims on behalf of the named individuals and a putative nationwide class of individuals for unjust enrichment and alleged violations of the Illinois Consumer Fraud and Deceptive Practices Act and the Illinois Private Businesses and Vocational Schools Act of 2012. In addition, it purported to assert causes of action on behalf of certain of the named individuals and 15 individual state-specific putative classes for alleged violations of 15 different states’ consumer fraud, unlawful trade practices, and consumer protection laws. Finally, it sought to bring individual claims under Georgia state law on behalf of certain named plaintiffs. The plaintiffs sought monetary, declaratory, injunctive, and other unspecified relief. A motion to dismiss the amended complaint was filed by the Adtalem Parties and granted by the court, without prejudice, on February 12, 2018.

On April 12, 2018, the Petrizzo plaintiffs refiled their complaint with a new lead plaintiff, Renee Heather Polly. The plaintiffs’ refiled complaint is nearly identical to the complaint previously dismissed by the court on February 12, 2018. The Adtalem Parties moved to dismiss this refiled complaint on May 14, 2018. The court granted defendants’ motion and dismissed the amended complaint with prejudice on February 13, 2019. On March 15, 2019, plaintiffs filed a notice of appeal and this matter is currently pending on appeal before the Seventh Circuit.

On January 17, 2017, Harriet Myers filed a complaint derivatively on behalf of Adtalem in the United States District Court for the Northern District of Illinois against individual defendants Daniel M. Hamburger, Timothy J. Wiggins, Richard M. Gunst, Patrick J. Unzicker, Christopher B. Begley, David S. Brown, Lisa W. Wardell, Ann Weaver Hart, Lyle Logan, Alan G. Merten, Fernando Ruiz, Ronald L. Taylor and James D. White. Adtalem was named as a nominal defendant only. The plaintiff agreed to a stipulated order moving the case to the United States District Court for the District of Delaware. Citing the FTC lawsuit and settlement, the January 2016 Notice, the negotiated agreement reached by DeVry University and ED on October 13, 2016 (the “ED Settlement”), and the allegations in the lawsuit filed by the Pension Trust Fund for Operating Engineers, each referenced above, the plaintiff has alleged that the individual defendants have breached their fiduciary duties and violated federal securities law since at least 2011. The plaintiff has asserted that the individual defendants permitted Adtalem to engage in unlawful conduct, failed to correct misconduct or prevent its recurrence, and failed to ensure the accurate dissemination of information to shareholders. The complaint attempts to state three claims: (i) breach of fiduciary duty by all named defendants for allegedly allowing the illegal conduct to occur, (ii) unjust enrichment by all individual defendants in the receipt of compensation, and (iii) violation of Section 14(a) of the Exchange Act by failing to disclose the alleged illegal scheme in proxy statements and falsely stating that compensation was based on “pay for performance” where those performance results were allegedly false. The plaintiff seeks on behalf of Adtalem monetary, injunctive and other unspecified relief. The parties reached an agreement to settle this matter along with the City of Hialeah matter (described below). The settlement approval hearing for the City of Hialeah matter was held on May 17, 2019. The court approved the settlement and the matter was dismissed.

On June 20, 2017, the City of Hialeah Employees Retirement System filed a complaint derivatively on behalf of Adtalem in the Court of Chancery of the State of Delaware against individual defendants Daniel M. Hamburger,

35

Table of Contents

Christopher B. Begley, Lisa W. Wardell, Lyle Logan, Fernando Ruiz, Ronald L. Taylor and James D. White. Adtalem was named as a nominal defendant only. Citing the FTC lawsuit and settlement, the January 2016 Notice and ED Settlement, and documents produced in response to plaintiff’s request under Section 220 of the Delaware General Corporation Law, the plaintiff alleges that the individual defendants have breached their fiduciary duties. The plaintiff asserts that the individual defendants permitted Adtalem and DeVry University to make, and failed to stop, false and misleading advertisements in breach of their fiduciary duties and in bad faith. The plaintiff seeks on behalf of Adtalem monetary and other unspecified relief. A motion to dismiss the complaint was filed by the Adtalem Parties on September 1, 2017, which was partially granted as to one count and partially denied as to another count on April 20, 2018. The parties reached an agreement to settle this matter along with the Myers matter (described above). The settlement approval hearing for the City of Hialeah matter was held on May 17, 2019. The court approved the settlement and the matter was dismissed.

On April 13, 2018, a putative class action lawsuit was filed by Nicole Versetto, individually and on behalf of other similarly situated, against the Adtalem Parties in the Circuit Court of Cook County, Illinois, Chancery Division. The complaint was filed on behalf of herself and three separate classes of similarly situated individuals who were citizens of the State of Illinois and who purchased or paid for a DeVry University program between January 1, 2008 and April 8, 2016. The plaintiff claims that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserts causes of action under the Illinois Uniform Deceptive Trade Practices Act, Illinois Consumer Fraud and Deceptive Trade Practices Act, and Illinois Private Business and Vocational Schools Act, and claims of breach of contract, fraudulent misrepresentation, concealment, negligence, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief as to violations of state law. The plaintiff seeks compensatory, exemplary, punitive, treble, and statutory penalties and damages, including pre-judgment and post-judgment interest, in addition to restitution, declaratory and injunctive relief, and attorneys’ fees. The Adtalem Parties moved to dismiss this complaint on June 20, 2018. On March 11, 2019, the court granted plaintiff’s motion for leave to file an amended complaint. Plaintiff filed an amended complaint that same day, asserting similar claims, with new lead plaintiff, Dave McCormick. Defendants filed a motion to dismiss plaintiff’s amended complaint on April 15, 2019 and the court granted Defendants’ motion on July 29, 2019, with leave to amend. The plaintiff has filed an amended complaint on August 26, 2019. Defendants’ intend to move to dismiss this complaint as it is substantially similar to the one the court previously dismissed.

On May 8, 2018, the Carlson Law Firm (“Carlson”) filed a lawsuit against Adtalem and DeVry University, Inc., on behalf of 71 individual former DeVry University students in Rangel v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. Plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. The defendants moved to dismiss this complaint on June 5, 2018. On June 27, 2018, Carlson filed a second lawsuit on behalf of 32 former DeVry University students against Adtalem and DeVry University, Inc. in Lindberg v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. The allegations are identical to the allegations in the lawsuit Carlson filed on May 8, 2018. Specifically, plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. The defendants moved to dismiss this complaint on August 28, 2018. The court consolidated these two lawsuits on December 10, 2018. The defendants moved to dismiss the consolidated action on December 18, 2018. On January 2, 2019, Carlson filed a motion to intervene on behalf of 13 additional former DeVry University students seeking to join the consolidated lawsuit. The parties re-filed their briefing on the motions to dismiss so that the motion would apply to all three groups of plaintiffs. On April 24, 2019, the Court granted Adtalem’s and DeVry University’s motions to dismiss, with leave to amend. The plaintiffs filed an amended complaint on June 7, 2019. Defendants moved to dismiss the complaint on July 5, 2019. That motion is fully briefed and set for oral argument on November 20, 2019.

On April 4, 2019, the Carlson Law Firm sent notice pursuant to California Legal Remedies Act, Civil Code § 1750, of 105 individuals who purportedly have claims against DeVry University and Adtalem based on allegedly deceptive comments made about the benefits of obtaining a DeVry University degree; specifically, that 90% of graduates obtained a job in their chosen field of study within six months of graduation, and that graduates were paid more than graduates of other universities. On July 16, 2019, the Carlson Law Firm filed a lawsuit in the United States District Court for the Northern District of California – San Jose Division against Adtalem and DeVry University on behalf of 102 individual former DeVry University students in Alvarez v. Adtalem and DeVry University, Inc. The plaintiffs contend that defendants

36

Table of Contents

misrepresented the benefits of graduating from DeVry University and falsely and misleadingly advertised the employment rate and income rate of their graduates to induce potential students to purchase educational products and services, and to remain students through graduation. The lawsuit seeks exemplary damages, restitution, economic damages, punitive damages, pre- and post-judgment interest, attorneys’ fees and the cost of suit. The plaintiffs brought claims for fraud by misrepresentation, fraud by concealment, negligent misrepresentation, civil theft, violation of the California Consumer Legal Remedies Act, violation of California’s Unfair Competition Law, and violation of California’s False Advertising Law. Defendants filed a motion to dismiss the complaint on October 1, 2019, and are awaiting Plaintiffs’ response to that motion.

On August 13, 2019, a plaintiff, Magana, filed a putative class action lawsuit against Adtalem and DeVry University, Inc. in the United States District Court for the Eastern District of California, alleging damages based on allegedly deceptive statements made about the benefits of obtaining a DeVry University degree. Plaintiffs assert claims under the California Unfair Competition Law, California False Advertising Law, and claims of fraud/material misrepresentation, fraudulent concealment/intentional omission of material facts, negligent misrepresentation, breach of contract, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. Defendants intend to file a motion to dismiss plaintiffs’ complaint.

On June 21, 2018, Stoltmann Law Offices filed a lawsuit against Adtalem in Cook County Circuit Court, alleging that Adtalem breached a contract with Stoltmann Law Offices to pay filing fees associated with arbitration claims Stoltmann Law Offices has filed with the Judicial Arbitration and Mediation Services, Inc. (“JAMS”). Stoltmann Law Offices is seeking specific performance from the court. Adtalem moved to dismiss this complaint on August 3, 2018. Prior to the court ruling on Adtalem’s motion to dismiss, Stoltmann Law Offices and 399 individuals filed an amended complaint on August 9, 2018, asserting claims for specific performance, declaratory judgment and a petition to compel arbitration. Adtalem moved to dismiss the amended complaint on August 31, 2018. The court granted Adtalem’s motion to dismiss on November 30, 2018, but granted plaintiffs leave to file a second amended complaint. A single individual plaintiff filed a second amended complaint on January 3, 2019. Adtalem moved to dismiss the complaint on May 23, 2019. While the motion to dismiss has been fully briefed, a hearing date has not yet been set.

On June 7, 2019, Stoltmann Law Offices filed a complaint in the Northern District of Illinois on behalf of Michael Forsythe seeking to compel arbitration of his consumer claims before JAMS. Adtalem moved to dismiss the complaint on July 1, 2019. The motion to dismiss is fully briefed, however, a hearing date has not yet been set.

Stoltmann Law Offices is representing hundreds of individuals who have filed claims with JAMS alleging fraud-based claims based on DeVry University’s graduate employment statistics. Stoltmann Law Offices has paid the filing fees for eight of these arbitrations to move forward. On June 14, 2019, JAMS sent commencement letters initiating the arbitration process for the claims of James Archibald and Gilbert Caro. Defendants filed their answers to these two claims on June 28, 2019. An arbitration hearing is tentatively scheduled for March 9-12, 2020, to adjudicate the claims of James Archibald, and February 3-6, 2020, to adjudicate the claims of Gilbert Caro. On August 2, 2019, JAMS sent commencement letters initiating the arbitration process for the claims of Sterling Bridges, David Cobb, and Lacresha Houser. Defendants filed their answers to these claims on August 16, 2019. An arbitration hearing is tentatively scheduled to begin on April 14, 2020, to adjudicate the claims of David Cobb. An arbitration hearing is tentatively scheduled to begin on May 11, 2020, to adjudicate the claims of Lacresha Houser. On August 5, 2019, JAMS sent commencement letters initiating the arbitration process for the claims of Micael Pizzo, Damion Tilghman, and Rickya Tillery. Defendants filed their answers on August 19, 2019. An arbitration hearing is tentatively scheduled to begin on July 13, 2020, to adjudicate the claims of Rickya Tillery.

On March 29, 2019, a putative class action lawsuit was filed by Robby Brown, individually and on behalf of all others similarly situated, against Adtalem and DeVry University, Inc., in the Western District of Missouri. The complaint was filed on behalf of himself and two separate classes of similarly situated individuals who were citizens of the State of Missouri and who purchased or paid for and received any part of a DeVry University program. The plaintiffs claim that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and assert claims of breach of contract, negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. The plaintiffs seek compensatory, exemplary, punitive, treble, and statutory penalties and damages as allowed by law, including pre-judgment and post-judgment interest disgorgement, restitution, injunctive and declaratory relief, and attorneys’ fees. Defendants filed a motion to dismiss the

37

Table of Contents

complaint on May 31, 2019. On October 9, 2019, the court granted in part and denied in part the motion to dismiss. The court dismissed plaintiffs’ claims for unjust enrichment and conversion, allowing the remaining claims to proceed.

On or about April 1, 2019, Adtalem, Chamberlain and DeVry University received similar Civil Investigative Demands (“CID”) from the U.S. Department of Justice (the “DOJ”). The CIDs were issued pursuant to a False Claims Act inquiry concerning allegations that Adtalem, in particular Chamberlain and Adtalem’s former subsidiary DeVry University, submitted or caused the submission of false claims to the U.S. Department of Defense and U.S. Department of Veteran Affairs for federal funds under the GI Bill Programs and Tuition Assistance Program from 2011 to the date of the CIDs. It is specifically alleged that Chamberlain and DeVry University engaged in unlawful recruitment tactics, and provided incentive payments based directly or indirectly on securing federal financial aid. At this time, we cannot predict the duration or outcome of this investigation, but Adtalem is cooperating fully with this DOJ inquiry and is providing documents and other information requested by the DOJ.

On April 3, 2019, a putative class action lawsuit was filed by T’Lani Robinson, individually and on behalf of all others similarly situated, against Adtalem and DeVry University, Inc., in the Northern District of Georgia. The complaint was filed on behalf of herself and three separate classes of similarly situated individuals who were citizens of the State of Georgia who purchased or paid for and received any part of a DeVry University program. The plaintiffs claim that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and assert claims of breach of contract, negligent misrepresentation, fraudulent misrepresentation, fraudulent concealment, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief. The plaintiffs seek compensatory, exemplary, punitive, treble, and statutory penalties and damages as allowed by law, including pre-judgment and post-judgment interest disgorgement, restitution, injunctive and declaratory relief, and attorneys’ fees. Defendants filed a motion to dismiss the complaint on May 31, 2019. The motion to dismiss has been fully briefed and the parties are awaiting a decision by the court.

NOTE 15: SEGMENT INFORMATION

During the fourth quarter of fiscal year 2019, Adtalem renamed two of its segments: Professional Education was renamed Financial Services, and Technology and Business was renamed Business and Law.

Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See “Note 2: Discontinued Operations and Assets Held for Sale” for further information. Segment information presented excludes the results of Adtalem Brazil. Adtalem eliminated its Business and Law reportable segment during the first quarter of fiscal year 2020 when Adtalem Brazil was classified as discontinued operations. Discontinued operations assets are included in the table below to reconcile to Total Consolidated Assets presented on the Consolidated Balance Sheets. In addition, certain expenses previously allocated to Adtalem Brazil within our former Business and Law segment have been reclassified to the Home Office and Other segment based on discontinued operations reporting guidance regarding allocation of corporate overhead.

Adtalem presents two reportable segments: “Medical and Healthcare,” which includes the operations of Chamberlain and the medical and veterinary schools (which include AUC, RUSM and RUSVM); and “Financial Services,” which includes the operations of ACAMS, Becker, OCL and EduPristine. “Home Office and Other” includes activity not allocated to a reportable segment.

These segments are consistent with the method by which the Chief Operating Decision Maker (Adtalem’s Chairman, President and Chief Executive Officer) evaluates performance and allocates resources. Performance evaluations are based, in part, on each segment’s operating income. Intersegment sales are accounted for at amounts comparable to sales to nonaffiliated customers and are eliminated in consolidation. “Home Office and Other” includes activity not allocated to a reportable segment and is included to reconcile segment results to the Consolidated Financial Statements. Segments may have allocated depreciation expense related to depreciable assets reported as an asset in a different segment. The accounting policies of the segments are the same as those described in “Note 3: Summary of Significant Accounting Policies.”

38

Table of Contents

Summary financial information by reportable segment is as follows (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
Revenue: |  | ​ |  |  | ​ |  |
Medical and Healthcare | ​ | $ | 207,487 | ​ | $ | 202,100 | ​
Financial Services | ​ |  | 47,126 | ​ |  | 35,646 | ​
Home Office and Other | ​ |  | — | ​ |  | (807) | ​
Total Consolidated Revenue | ​ | $ | 254,613 | ​ | $ | 236,939 | ​
Operating Income (Loss) from Continuing Operations: | ​ |  |  | ​ |  |  | ​
Medical and Healthcare | ​ | $ | 28,500 | ​ | $ | 1,656 | ​
Financial Services | ​ |  | 2,128 | ​ |  | 4,750 | ​
Home Office and Other | ​ |  | (4,887) | ​ |  | (9,638) | ​
Total Consolidated Operating Income (Loss) from Continuing Operations | ​ | $ | 25,741 | ​ | $ | (3,232) | ​
Segment Assets: | ​ |  |  | ​ |  |  | ​
Medical and Healthcare | ​ | $ | 1,006,655 | ​ | $ | 872,108 | ​
Financial Services | ​ |  | 582,820 | ​ |  | 452,054 | ​
Home Office and Other | ​ |  | 261,205 | ​ |  | 401,643 | ​
Discontinued Operations | ​ |  | 609,644 | ​ |  | 624,060 | ​
Total Consolidated Assets | ​ | $ | 2,460,324 | ​ | $ | 2,349,865 | ​
Additions to Long-Lived Assets: | ​ |  |  | ​ |  |  | ​
Medical and Healthcare | ​ | $ | 6,467 | ​ | $ | 11,776 | ​
Financial Services | ​ |  | 539 | ​ |  | 962 | ​
Home Office and Other | ​ |  | 3,430 | ​ |  | 583 | ​
Total Consolidated Additions to Long-Lived Assets | ​ | $ | 10,436 | ​ | $ | 13,321 | ​
Reconciliation to Consolidated Financial Statements: | ​ |  |  | ​ |  |  | ​
Capital Expenditures | ​ | $ | 10,436 | ​ | $ | 13,321 | ​
Total Consolidated Additions to Long-Lived Assets | ​ | $ | 10,436 | ​ | $ | 13,321 | ​
Depreciation Expense: | ​ |  |  | ​ |  |  | ​
Medical and Healthcare | ​ | $ | 7,231 | ​ | $ | 6,260 | ​
Financial Services | ​ |  | 294 | ​ |  | 367 | ​
Home Office and Other | ​ |  | 868 | ​ |  | 1,100 | ​
Total Consolidated Depreciation Expense | ​ | $ | 8,393 | ​ | $ | 7,727 | ​
Intangible Asset Amortization Expense: | ​ |  |  | ​ |  |  | ​
Financial Services | ​ | $ | 2,534 | ​ | $ | 1,605 | ​
Total Consolidated Intangible Asset Amortization Expense | ​ | $ | 2,534 | ​ | $ | 1,605 | ​

​

​

39

Table of Contents

Adtalem conducts its educational and financial services operations in the U.S., Barbados, St. Kitts, St. Maarten, India, Europe, China, Canada, and the Middle East. Other international revenue was less than 5% of total revenue for each of the three months ended September 30, 2019 and 2018. Revenue and long-lived assets by geographic area are as follows (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
Revenue from Unaffiliated Customers: |  | ​ |  |  | ​ |  |
Domestic Operations | ​ | $ | 161,397 | ​ | $ | 146,662 | ​
International Operations: | ​ |  |  | ​ |  |  | ​
Barbados, Dominica, St. Kitts and St. Maarten | ​ |  | 90,969 | ​ |  | 88,447 | ​
Other | ​ |  | 2,247 | ​ |  | 1,830 | ​
Total International | ​ |  | 93,216 | ​ |  | 90,277 | ​
Total Consolidated Revenue | ​ | $ | 254,613 | ​ | $ | 236,939 | ​
Long-Lived Assets: | ​ |  |  | ​ |  |  | ​
Domestic Operations | ​ | $ | 196,331 | ​ | $ | 152,427 | ​
International Operations: | ​ |  |  | ​ |  |  | ​
Barbados, Dominica, St. Kitts and St. Maarten | ​ |  | 173,793 | ​ |  | 161,136 | ​
Other | ​ |  | 1,785 | ​ |  | 2,012 | ​
Total International | ​ |  | 175,578 | ​ |  | 163,148 | ​
Total Consolidated Long-Lived Assets | ​ | $ | 371,909 | ​ | $ | 315,575 | ​

​

No one customer accounted for more than 10% of Adtalem’s consolidated revenue.

​

NOTE 16: REAL ESTATE TRANSACTIONS

On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep for $52.0 million. Adtalem received $5.2 million of cash at the time of closing and holds a mortgage, secured by the property, from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The buyer has an option to make prepayments. Due to Adtalem’s involvement with financing the sale, the transaction did not qualify as a sale for accounting purposes. Adtalem continues to maintain the assets associated with the sale on the Consolidated Balance Sheets. Adtalem has recorded a note receivable of $40.4 million and a financing payable of $45.6 million, which are classified as Other Assets, Net and Other Liabilities, respectively, on the Consolidated Balance Sheets. See “Note 6: Financing Receivables” for a discussion on the discounting of the note receivable. The $5.2 million received during the first quarter of fiscal year 2020 is classified as a financing activity on the Consolidated Statements of Cash Flows.

On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus facility. Net proceeds from the sale of $6.4 million resulted in a gain on the sale of $4.8 million. This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in “Note 15: Segment Information.”

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

​

Through its website, Adtalem Global Education Inc. (“Adtalem,” “we,” “our,” or “us”) offers its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the Securities and Exchange Commission (“SEC”). Adtalem’s website is http://www.adtalem.com. Except as otherwise stated in these reports, the information contained on our website or available by hyperlink from our website is not incorporated into our Annual Report on Form 10-K, this Quarterly Report on Form 10-Q, or other documents we file with, or furnish to, the SEC.

The following discussion of Adtalem’s results of operations and financial condition should be read in conjunction with Adtalem’s Consolidated Financial Statements and the related Notes thereto in “Item 1 – Financial Statements” in this Quarterly Report on Form 10-Q and Adtalem’s Consolidated Financial Statements and related Notes thereto in “Item 8 –

40

Table of Contents

Financial Statements and Supplementary Data” in Adtalem’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019. Adtalem’s Annual Report on Form 10-K includes a description of critical accounting policies and estimates and assumptions used in the preparation of Adtalem’s financial statements. These assumptions include, but are not limited to, the use of estimates and assumptions that affect the reported amounts of assets and liabilities; revenue and expense recognition; allowance for uncollectible accounts; internal-use developed software; land, building and equipment; stock-based compensation; valuation of goodwill and other intangible assets; valuation of long-lived assets; and income taxes.

The seasonal pattern of Adtalem’s enrollments and its educational programs’ starting dates affect the results of operations and the timing of cash flows. Therefore, management believes that comparisons of its results of operations should primarily be made to the corresponding period in the preceding year. Comparisons of financial position should be made to both the end of the previous fiscal year and to the end of the corresponding quarterly period in the preceding year.

Unless indicated, or the context requires otherwise, references to “net income” refers to “net income attributable to Adtalem Global Education.”

During the fourth quarter of fiscal year 2019, Adtalem renamed two of its segments to better reflect our focus on growth strategies: Professional Education was renamed Financial Services, and Technology and Business was renamed Business and Law. As of September 30, 2019, Adtalem eliminated its Business and Law reportable segment when Adtalem Education of Brazil (“Adtalem Brazil”) was classified as discontinued operations and assets held for sale (see further details below under the heading "Divestitures"). As a result, Adtalem now has two reportable segments: "Medical and Healthcare," which includes the operations of Chamberlain University ("Chamberlain") and the medical and veterinary schools (which include American University of the Caribbean School of Medicine ("AUC"), Ross University School of Medicine ("RUSM") and Ross University School of Veterinary Medicine ("RUSVM")); and "Financial Services," which includes the operations of the Association of Certified Anti-Money Laundering Specialists ("ACAMS"), Becker Professional Education ("Becker"), OnCourse Learning (“OCL”) and EduPristine. “Home Office and Other” includes activity not allocated to a reportable segment. Financial and descriptive information about Adtalem’s reportable segments is presented in “Note 15: Segment Information” to the Consolidated Financial Statements.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this Quarterly Report on Form 10-Q, including those statements concerning Adtalem’s expectations or plans, may constitute forward-looking statements subject to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. These forward-looking statements generally can be identified by phrases such as Adtalem or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” “plans,” “intends,” “continues,” “may,” “will,” “should,” “could,” or other words or phrases of similar import which predict or indicate future events or trends or that are not statements of historical matters. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances.

These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause or contribute to a material difference are described throughout this report and from time to time in our filings with the SEC, including those in this Quarterly Report on Form 10-Q: “Note 14: Commitments and Contingencies” to the Consolidated Financial Statements, Part II, Item 1 “Legal Proceedings,” and in the subsection of Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” titled “Liquidity and Capital Resources” and in our most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2019 filed with the SEC on August 28, 2019: in the subsections of Item 1 “Business” titled “Market Trends and Competition,” “Student Admissions,” “Accreditation,” “Financial Aid and Financing Student Education,” “Legislative and Regulatory Requirements,” “Seasonality” and “Employees” and in Item 1A “Risk Factors.” Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. All forward-looking statements set forth in this Quarterly Report on Form 10-Q are qualified by these cautionary statements, and should be considered in the context of the risk factors referred to above and discussed elsewhere in this Quarterly Report on Form 10-Q. There can

41

Table of Contents

be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Forward-looking statements set forth in this Quarterly Report on Form 10-Q speak only as of the date hereof, and we do not undertake any obligation to update forward-looking statements to reflect subsequent events or circumstances, changes in expectations or the occurrence of unanticipated events, except to the extent required by law or the rules and regulations of the SEC.

OVERVIEW

Adtalem’s financial results for the first quarter of fiscal year 2020 reflect revenue growth of $17.7 million, or 7.5%, compared to the year-ago quarter, driven by increased revenue in both Medical and Healthcare and Financial Services segments. Net income from continuing operations increased to $17.5 million compared to a net loss of $4.8 million in the year ago quarter. Excluding special items, net income from continuing operations decreased 29.2% in the first quarter of fiscal year 2020 compared to the year-ago quarter (see “Use of Non-GAAP Financial Information and Supplemental Reconciliation Schedule” below). Operational and financial highlights for the first quarter of fiscal year 2020 include:

| ● | For the September 2019 session, new and total student enrollment at Chamberlain increased 2.9% and 1.4%, respectively, compared to the same term last year. Chamberlain continues to invest in its programs, student services and campus locations. Chamberlain’s newest campus in San Antonio, Texas, began instruction in October 2019.

​

| ● | The addition of OCL and the shift of revenue from the largest annual ACAMS conference to the first quarter of fiscal year 2020 from the second quarter of fiscal year 2019, contributed to revenue growth in the Financial Services segment of 32.2% in the first quarter of fiscal year 2020 compared to the year-ago quarter. ACAMS memberships have increased to more than 75,000 as of September 30, 2019.

​

| ● | Adtalem continued its eleventh share repurchase program by repurchasing a total of 918,807 shares of Adtalem’s common stock at an average cost of $43.81 per share during the first quarter of fiscal year 2020.

​

| ● | Adtalem’s financial position remains strong. Operating cash flows were $47.5 million during the first quarter of fiscal year 2020. As of September 30, 2019, cash and cash equivalents totaled $121.1 million and outstanding borrowings totaled $336.3 million.

​

DIVESTITURES

On October 18, 2019, Adtalem entered into a Stock Purchase Agreement (“Purchase Agreement”) with Estácio Participações S.A. (“Estácio”) and Sociedade de Ensino Superior Estaćio de Sá Ltda, a wholly owned subsidiary of Estácio (“Purchaser”). Pursuant to the terms and subject to the conditions set forth in the Purchase Agreement, Adtalem will sell all of the issued and outstanding shares of Adtalem Brasil Holding S.A. (a/k/a Adtalem Brazil) to the Purchaser for approximately $465 million in cash. In addition, Adtalem expects to receive approximately $74 million in settlement of cash balances as of June 30, 2019 of $89 million, net of indebtedness of $15 million, resulting in total proceeds of $539 million. This transaction is expected to be completed in the first half of fiscal year 2021. This sale advances Adtalem’s strategy to become a leading workforce solutions provider in the medical and healthcare and financial services industries, aligning Adtalem’s portfolio to better address the global workforce skills gap and serve its markets in a more competitive and comprehensive way. In connection with the announced proposed sale of Adtalem Brazil, Adtalem entered into certain deal contingent foreign exchange forward contracts to economically hedge the Brazilian Real denominated purchase price through mitigation of the currency exchange rate risk. Management does not expect this contract to qualify for hedge accounting treatment under Accounting Standards Codification (“ASC”) 815, and as a result, all changes in fair value will be recorded to the income statement.

Adtalem Brazil was an operating segment and was the only component of the former Business and Law reportable segment. Subject to the terms and conditions of the Purchase Agreement, Adtalem Brazil will be sold in its entirety. The potential strategic sale of Adtalem Brazil is expected to have a significant effect on the operations and financial results of Adtalem (See “Note 2: Discontinued Operations and Assets Held for Sale” to the Consolidated Financial Statements).

In addition to the potential sale of Adtalem Brazil, during the second quarter of fiscal year 2019, Adtalem divested DeVry University and Carrington College (“Carrington”). In accordance with U.S. Generally Accepted Accounting

42

Table of Contents

Principles (“GAAP”), we have classified the DeVry University, Carrington and Adtalem Brazil entities as “Held for Sale” and “Discontinued Operations” in all periods presented as applicable. As a result, all financial results, disclosures and discussions of continuing operations in this Quarterly Report on Form 10-Q exclude DeVry University, Carrington and Adtalem Brazil operations, unless otherwise noted.

USE OF NON-GAAP FINANCIAL INFORMATION AND SUPPLEMENTAL RECONCILIATION SCHEDULE

During the first quarter of fiscal year 2020, Adtalem recorded special items related to the following:

| ● | Gain on the sale of Adtalem’s Columbus, Ohio, campus facility.

| ● | Restructuring charges at Becker related to the sale of Becker’s courses for healthcare students and at Adtalem’s home office related to real estate consolidations.

During the first quarter of fiscal year 2019, Adtalem recorded special items relating to the following:

| ● | Restructuring charges related to the closing of the RUSM campus in Dominica and real estate consolidations at Adtalem’s home office.

The following table illustrates the effects of discontinued operations and special items on Adtalem’s net income (loss). Management believes that the non-GAAP disclosure of net income from continuing operations excluding special items and adjusted earnings per share excluding discontinued operations and special items provides investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations and is useful for period-over-period comparisons of such operations given the nature of discontinued operations, gain on sale of assets and restructuring charges. Adtalem uses these supplemental financial measures internally in its management and budgeting process. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, Adtalem’s reported results prepared in accordance with GAAP. The following table reconciles these non-GAAP measures to the most directly comparable GAAP information (in thousands, except per share amounts):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | September 30, | ​
​ |  | 2019 |  | 2018 | ​
​ | ​ | (in thousands, except per share amounts) | ​
Net Income (Loss) | ​ | $ | 14,361 | ​ | $ | (9,530) | ​
Earnings (Loss) per Share (diluted-2019, basic-2018) | ​ | $ | 0.26 | ​ | $ | (0.16) | ​
Continuing Operations: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Restructuring Expense | ​ | $ | 6,530 | ​ | $ | 39,473 | ​
Effect on Earnings per Share (diluted) | ​ | $ | 0.12 | ​ | $ | 0.64 | ​
Gain on Sale of Assets | ​ | $ | (4,779) | ​ | $ | — | ​
Effect on Earnings per Share (diluted) | ​ | $ | (0.09) | ​ | $ | — | ​
Income Tax Impact on Non-GAAP Adjustments (1) | ​ | $ | (343) | ​ | $ | (7,952) | ​
Effect on Earnings per Share (diluted) | ​ | $ | (0.01) | ​ | $ | (0.13) | ​
Discontinued Operations, net of tax | ​ | $ | 3,156 | ​ | $ | 4,743 | ​
Effect on Earnings per Share (diluted) | ​ | $ | 0.06 | ​ | $ | 0.08 | ​
Net Income from Continuing Operations Excluding Special Items, net of tax | ​ | $ | 18,925 | ​ | $ | 26,734 | ​
Earnings per Share from Continuing Operations Excluding Special Items, net of tax (diluted) | ​ | $ | 0.34 | ​ | $ | 0.44 | ​
Shares used in Basic EPS Calculation | ​ | ​ | NA | ​ | ​ | 60,328 | ​
Shares used in Diluted EPS Calculation | ​ | ​ | 56,140 | ​ | ​ | 61,202 | ​

(1) | Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

43

Table of Contents

RESULTS OF OPERATIONS

The following table presents information with respect to the relative size to revenue of certain items in the Consolidated Statements of Income (Loss) for the three months ended September 30, 2019 and 2018. Percentages may not add because of rounding.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | ​ | ​
​ | ​ | September 30, | ​ | ​ | ​
​ | ​ | 2019 |  | 2018 | ​ | ​ | ​
Revenue | ​ | 100.0 | % | 100.0 | % | ​ | ​
Cost of Educational Services | ​ | 50.3 | % | 47.1 | % | ​ | ​
Student Services and Administrative Expense | ​ | 38.9 | % | 37.6 | % | ​ | ​
Restructuring Expense | ​ | 2.6 | % | 16.7 | % | ​ | ​
Gain on Sale of Assets | ​ | (1.9) | % | 0.0 | % | ​ | ​
Total Operating Cost and Expense | ​ | 89.9 | % | 101.4 | % | ​ | ​
Operating Income (Loss) from Continuing Operations | ​ | 10.1 | % | (1.4) | % | ​ | ​
Net Other Expense | ​ | (1.8) | % | (1.7) | % | ​ | ​
Income (Loss) from Continuing Operations Before Income Taxes | ​ | 8.3 | % | (3.0) | % | ​ | ​
Income Tax (Provision) Benefit | ​ | (1.5) | % | 1.0 | % | ​ | ​
Income (Loss) from Continuing Operations | ​ | 6.8 | % | (2.0) | % | ​ | ​
Loss from Discontinued Operations, Net of Tax | ​ | (1.2) | % | (2.0) | % | ​ | ​
Net Income (Loss) | ​ | 5.6 | % | (4.0) | % | ​ | ​
Net Loss Attributable to Noncontrolling Interest | ​ | 0.0 | % | 0.0 | % | ​ | ​
Net Income (Loss) Attributable to Adtalem Global Education | ​ | 5.6 | % | (4.0) | % | ​ | ​

​

REVENUE

All discussions of the results of operations exclude the results of DeVry University, Carrington and Adtalem Brazil, which are included in the discontinued operations section of the Consolidated Statements of Income (Loss) for all periods presented.

The following table presents revenue by segment detailing the changes from the year-ago period including disclosures of the effect of the acquisition of OCL. Total consolidated revenue for the first quarter of fiscal year 2020 of $254.6 million increased 7.5%, or $17.7 million, compared to the year-ago quarter. Excluding the revenue added from OCL, which was acquired in the fourth quarter of fiscal year 2019, revenue grew 4.2% or $10.1 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Revenue results by segment are discussed in more detail in the sections below.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019 |
​ | ​ | (in thousands) |
Revenue: | ​ | Medical and Healthcare |  | Financial Services |  | Home Office and Other | ​ | Consolidated |
Fiscal Year 2019 as Reported | ​ | $ | 202,100 | ​ | $ | 35,646 | ​ | $ | (807) | ​ | $ | 236,939 | ​
Organic Growth | ​ | ​ | 5,387 | ​ | ​ | 3,867 | ​ | ​ | 807 | ​ | ​ | 10,061 | ​
Effect of Acquisitions | ​ | ​ | — | ​ | ​ | 7,613 | ​ | ​ | — | ​ | ​ | 7,613 | ​
Fiscal Year 2020 as Reported | ​ | $ | 207,487 | ​ | $ | 47,126 | ​ | $ | — | ​ | $ | 254,613 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fiscal Year 2020 % Change: | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Organic Growth | ​ | ​ | 2.7 | % | ​ | 10.8 | % | ​ | NM | ​ | ​ | 4.2 | %
Effect of Acquisitions | ​ | ​ | — | ​ | ​ | 21.4 | % | ​ | NM | ​ | ​ | 3.2 | %
Fiscal Year 2020 % Change as Reported | ​ | ​ | 2.7 | % | ​ | 32.2 | % | ​ | NM | ​ | ​ | 7.5 | %

​

44

Table of Contents

Medical and Healthcare

Revenue in the Medical and Healthcare segment increased 2.7%, or $5.4 million, to $207.5 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Revenue in the first quarter of fiscal year 2020 increased at Chamberlain driven primarily by increasing total student enrollment and increased revenue at the medical and veterinary schools primarily driven by increased housing revenue at RUSM from its Barbados campus. Key trends for Chamberlain and the medical and veterinary schools are set forth below.

Chamberlain

Chamberlain Student Enrollment:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year 2020 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
Term |  | July 2019 |  | Sept. 2019 |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
New Students | ​ | 2,396 | ​ | 5,595 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
% Change from Prior Year | ​ | (5.0) | % | 2.9 | % | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Students | ​ | 28,691 | ​ | 31,736 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
% Change from Prior Year | ​ | 2.3 | % | 1.4 | % | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year 2019 | ​
Term |  | July 2018 |  | Sept. 2018 |  | Nov. 2018 |  | Jan. 2019 |  | Mar. 2019 |  | May 2019 |
New Students | ​ | 2,523 | ​ | 5,435 | ​ | 2,617 | ​ | 4,759 | ​ | 2,726 | ​ | 3,997 | ​
% Change from Prior Year | ​ | 1.0 | % | 9.5 | % | (6.7) | % | 6.4 | % | (3.7) | % | 2.6 | %
Total Students | ​ | 28,037 | ​ | 31,295 | ​ | 30,833 | ​ | 32,354 | ​ | 32,104 | ​ | 30,867 | ​
% Change from Prior Year | ​ | 4.6 | % | 4.1 | % | 3.7 | % | 3.3 | % | 3.4 | % | 1.8 | %

​

Chamberlain revenue increased 2.5%, or $2.9 million, to $116.5 million in the first quarter of fiscal year 2020 compared to the year-ago quarter, driven by increases in total student enrollment in the July 2019 and September 2019 sessions. Chamberlain admitted its largest class of campus students in September 2019.

Chamberlain currently operates 22 campuses in 15 states. Chamberlain’s newest campus in San Antonio, Texas, began instruction in October 2019.

Tuition Rates:

Tuition is $675 per credit hour for the Bachelor of Science in Nursing (“BSN”) onsite degree program. Tuition for the Registered Nurse to BSN (“RN-to-BSN”) online degree program is $590 per credit hour. Tuition for the online Master of Science in Nursing (“MSN”) degree program is $650 per credit hour. For students enrolled in the Family Nurse Practitioner (“FNP”) degree program, tuition is $665 per credit hour. Tuition for the online Doctor of Nursing Practice (“DNP”) degree program is $750 per credit hour. Tuition for the Master of Public Health (“MPH”) degree program is $550 per credit hour. Tuition for the online Master of Social Work (“MSW”) degree program that began in September 2019 is $695 per credit hour. All of these tuition rates are unchanged from the prior year. These tuition rates do not include the cost of books, supplies, transportation or living expenses.

Medical and Veterinary Schools

Medical and Veterinary Schools Student Enrollment:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year 2020 | ​ | Fiscal Year 2019 | ​
Term |  | Sept. 2019 |  | Sept. 2018 |  | Jan. 2019 |  | May 2019 |
New Students | ​ | 872 | ​ | 889 | ​ | 471 | ​ | 496 | ​
% Change from Prior Year | ​ | (1.9) | % | 9.5 | % | (8.5) | % | (0.6) | %
Total Students | ​ | 5,608 | ​ | 5,887 | ​ | 5,548 | ​ | 5,220 | ​
% Change from Prior Year | ​ | (4.7) | % | 2.5 | % | (6.6) | % | (6.0) | %

​

45

Table of Contents

The medical and veterinary schools’ revenue increased 2.9%, or $2.5 million, to $91.0 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. The principal driver of the increase was higher housing revenue at the new Barbados campus of RUSM. This increase was partially offset by lower tuition revenue at AUC and RUSM driven by lower enrollment and increased discounts and scholarships from listed tuition rates.

In the September 2019 semester, total student enrollment declined at AUC, RUSM and RUSVM, and new student enrollment increased at AUC and RUSVM and declined at RUSM. The lower enrollment is the result of heightened competition. Management is executing its plan to differentiate the medical and veterinary schools from the competition, with a core goal of increasing international students, increasing RUSM affiliations with historically black colleges and universities (“HBCU”) and Hispanic-serving institutions (“HSI”), expanding AUC’s medical education program based in the U.K. in partnership with the University of Central Lancashire (“UCLAN”), and improving the effectiveness of marketing investments. Management believes the demand for medical and veterinary education remains strong and can support management’s longer-term expectations to grow new enrollments in the low-single digit range; however, heightened competition may continue to adversely affect the medical and veterinary schools’ ability to continue to attract qualified students to its programs resulting in lower tuition revenue.

In September 2019, AUC opened its medical education program in the U.K. in partnership with UCLAN. The program offers students a postgraduate diploma in International Medical Sciences (“PGIMS”) from UCLAN, followed by their Doctor of Medicine degree with AUC. Students will then be eligible to do clinical rotations at AUC’s clinical sites, which include hospitals in the U.S., the U.K. and Canada. This program is aimed at preparing students for the U.S. Medical Licensing Examination (“USMLE”).

In January 2019, RUSM moved its basic science instruction to a new location in Barbados. The academic facility is located in Bridgetown and student housing is located close to the academic facility in the parish of Christ Church and includes amenities, student services and convenient transportation to campus.

Tuition Rates:

| ● | Effective for semesters beginning in September 2019, tuition rates for the beginning basic sciences and final clinical rotation portions of AUC’s medical program are $23,240 and $26,000, respectively, per semester. These tuition rates represent a 3.5% increase over the prior academic year.

| ● | Effective for semesters beginning in September 2019, tuition rates for the beginning basic sciences and Internal Medicine Foundations/final clinical portion of the programs at RUSM are $24,170 and $26,676, respectively, per semester. These tuition rates represent a 4.0% increase over the prior academic year.

| ● | For students who entered the RUSVM program in September 2018 or later, the tuition rate for the pre-clinical (Semesters 1-7) and clinical curriculum (Semesters 8-10) is $20,873 per semester effective September 2019. For students who entered RUSVM before September 2018, tuition rates for the pre-clinical and clinical curriculum are $19,387 and $24,339, respectively, per semester effective September 2019. The tuition rates effective September 2019 represent a 2.8% increase over the prior academic year.

The respective tuition rates for AUC, RUSM and RUSVM do not include the cost of transportation, living expenses or health insurance.

Financial Services

Revenue in the Financial Services segment increased 32.2%, or $11.5 million, to $47.1 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding the revenue added from OCL, which was acquired in the fourth quarter of fiscal year 2019, revenue grew 10.8% or $3.9 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. The increase is driven by revenue growth at ACAMS, partially due to the timing of their largest conference of the year taking place in the first quarter of fiscal year 2020 compared to it taking place in the second quarter of fiscal year 2019. The increase was partially offset with revenue declines related to Becker’s courses for healthcare students, which were divested in August 2019. ACAMS memberships have increased to more than 75,000

46

Table of Contents

as of September 30, 2019, driven by strong domestic growth as well as expansion in the Asia Pacific and European regions.

COSTS AND EXPENSES

Cost of Educational Services

The largest component of Cost of Educational Services is the cost of faculty and staff who support educational operations. This expense category also includes the costs of facilities, adjunct faculty, supplies, housing, bookstore and other educational materials, student education-related support activities and the provision for bad debts.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019 |
​ | ​ | (in thousands) |
Cost of Educational Services: |  | Medical and Healthcare |  | Financial Services |  | Home Office and Other | ​ | Consolidated | ​
Fiscal Year 2019 as Reported |  | $ | 105,640 | ​ | $ | 5,944 |  | $ | (50) |  | $ | 111,534 | ​
Cost Increase |  |  | 11,099 | ​ |  | 3,095 |  |  | 667 |  |  | 14,861 | ​
Effect of Acquisitions |  |  | — | ​ |  | 1,639 |  |  | — |  |  | 1,639 | ​
Fiscal Year 2020 as Reported |  | $ | 116,739 | ​ | $ | 10,678 |  | $ | 617 |  | $ | 128,034 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fiscal Year 2020 % Change: |  | ​ |  | ​ |  |  |  |  |  |  | ​ |  | ​
Cost Increase |  | ​ | 10.5 | % |  | 52.1 | % |  | NM |  | ​ | 13.3 | %
Effect of Acquisitions |  | ​ | — | ​ |  | 27.6 | % |  | NM |  | ​ | 1.5 | %
Fiscal Year 2020 % Change as Reported |  | ​ | 10.5 | % |  | 79.6 | % |  | NM |  | ​ | 14.8 | %

​

Cost of Educational Services increased 14.8%, or $16.5 million, to $128.0 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding the costs added with the acquisition of OCL, which occurred in the fourth quarter of fiscal year 2019, Cost of Educational Services increased 13.3% or $14.9 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Cost increased in the first quarter of fiscal year 2020 due to increased housing costs at RUSM’s Barbados campus, increased institutional loan program bad debt expense resulting from increased aging of balances, primarily at the medical and veterinary schools, costs associated with the largest ACAMS conference of the year taking place in the first quarter of fiscal year 2020 compared to it taking place in the second quarter of fiscal year 2019, and increased investment in growth across all reportable segments.

As a percentage of revenue, Cost of Educational Services was 50.3% in the first quarter of fiscal year 2020 compared to 47.1% in the year-ago quarter. The increase in the percentage was primarily the result of revenue growth in the lower margin sources of RUSM housing and ACAMS conferences.

Student Services and Administrative Expense

The Student Services and Administrative Expense category includes expenses related to sales, student admissions, marketing and advertising, general and administrative, curriculum development and amortization expense of finite-lived intangible assets related to acquisitions of businesses.

47

Table of Contents

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019 |
​ | ​ | (in thousands) |
Student Services and Administrative Expense: |  | Medical and Healthcare |  | Financial Services |  | Home Office and Other | ​ | Consolidated | ​
Fiscal Year 2019 as Reported | ​ | $ | 55,789 | ​ | $ | 24,952 | ​ | $ | 8,423 | ​ | $ | 89,164 | ​
Cost Increase (Reduction) | ​ |  | 6,331 | ​ |  | 1,234 | ​ |  | (3,797) | ​ |  | 3,768 | ​
Effect of Acquisitions | ​ |  | — | ​ |  | 6,155 | ​ |  | — | ​ |  | 6,155 | ​
Fiscal Year 2020 as Reported | ​ | $ | 62,120 | ​ | $ | 32,341 | ​ | $ | 4,626 | ​ | $ | 99,087 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fiscal Year 2020 % Change: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​
Cost Increase (Reduction) | ​ | ​ | 11.3 | % |  | 4.9 | % |  | NM |  | ​ | 4.2 | %
Effect of Acquisitions | ​ |  | — | ​ |  | 24.7 | % |  | NM | ​ |  | 6.9 | %
Fiscal Year 2020 % Change as Reported | ​ |  | 11.3 | % |  | 29.6 | % |  | NM | ​ |  | 11.1 | %

​

Student Services and Administrative Expense increased 11.1%, or $9.9 million, to $99.1 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding the costs added with the acquisition of OCL, which occurred in the fourth quarter of fiscal year 2019, Student Services and Administrative Expense increased 4.2% or $3.8 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Cost increases to support future enrollment growth at the medical and veterinary schools, Chamberlain, ACAMS and Becker were the main drivers of the increase in costs. Amortization of finite-lived intangible assets increased $0.9 million in the first quarter of fiscal year 2020 compared to the year-ago quarter, driven by OCL intangible asset amortization. Amortization expense is included entirely in the Student Services and Administrative Expense category.

As a percentage of revenue, Student Services and Administrative Expense was 38.9% in the first quarter of fiscal year 2020 compared to 37.6% in the year-ago quarter. Amortization expense for OCL intangible assets and costs to support enrollment growth caused the increase in this percentage.

Restructuring Expense

During the first quarter of fiscal year 2020, Adtalem recorded restructuring charges primarily related to the sale of Becker’s courses for healthcare students and Adtalem’s home office real estate consolidations. During the first quarter of fiscal year 2019, Adtalem recorded restructuring charges primarily related to the impairment of the land, buildings and equipment at the Dominica campus of RUSM and severance related to workforce reductions in Dominica. In January 2019, RUSM relocated its campus operations to Barbados with no plans to return to Dominica. The land, buildings and equipment in Dominica have been fully impaired as management determined the market value less the costs to sell the facilities or move the equipment is zero (see “Note 3: Summary of Significant Accounting Policies” to the Consolidated Financial Statements). In addition, during the first quarter of fiscal year 2019, Adtalem recorded restructuring charges primarily related to real estate consolidations at Adtalem’s home office. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and result in additional restructuring charges or reversals in future periods. Termination benefit charges, resulting from reducing Adtalem’s workforce by 15 and 176 positions in the first quarter of fiscal year 2020 and 2019, respectively, represented severance pay and benefits for these employees. Adtalem’s home office is classified as “Home Office and Other” in “Note 15: Segment Information” to the Consolidated Financial Statements. Pre-tax restructuring charges by segment were as follows (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019 | ​ | Three Months Ended September 30, 2018
​ |  | Real Estate |  | Termination |  | ​ | ​ |  | Real Estate |  | Termination |  | ​ | ​
​ | ​ | and Other | ​ | Benefits | ​ | Total | ​ | and Other | ​ | Benefits | ​ | Total
Medical and Healthcare | ​ | $ | 127 | ​ | $ | — | ​ | $ | 127 | ​ | $ | 37,753 | ​ | $ | 1,262 | ​ | $ | 39,015
Financial Services | ​ | ​ | 1,690 | ​ | ​ | 289 | ​ | ​ | 1,979 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Home Office and Other |  | ​ | 4,122 |  | ​ | 302 |  | ​ | 4,424 |  | ​ | 509 |  | ​ | (51) |  | ​ | 458
Total | ​ | $ | 5,939 | ​ | $ | 591 | ​ | $ | 6,530 | ​ | $ | 38,262 | ​ | $ | 1,211 | ​ | $ | 39,473

​

48

Table of Contents

Additional restructuring expense is expected to be recorded in the remainder of fiscal year 2020 as Adtalem plans to continue to reduce home office costs.

Gain on Sale of Assets

On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus facility. Net proceeds from the sale of $6.4 million resulted in a gain on the sale of $4.8 million. This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in “Note 15: Segment Information” to the Consolidated Financial Statements. There is no corresponding gain in the first quarter of fiscal year 2019.

OPERATING INCOME (LOSS) FROM CONTINUING OPERATIONS

Total consolidated operating income from continuing operations increased $29.0 million, to $25.7 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding the decrease in restructuring expense of $32.9 million and the gain on sale of assets of $4.8 million, consolidated operating income from continuing operations decreased 24.1% or $8.8 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. The primary drivers of this decrease were an increase in bad debt expense at the medical and veterinary schools and costs of returning to a normal level of expense at AUC and RUSM as operations returned to St. Maarten and moved to Barbados, respectively.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, 2019
​ | ​ | (in thousands)
Operating Income (Loss): | ​ | Medical and Healthcare |  | Financial Services |  | Home Office and Other | ​ | Consolidated
Fiscal Year 2019 as Reported | ​ | $ | 1,656 | ​ | $ | 4,750 | ​ | $ | (9,638) | ​ | $ | (3,232)
Organic Change | ​ | ​ | (12,044) | ​ | ​ | (462) | ​ | ​ | 3,938 | ​ | ​ | (8,568)
Effect of Acquisitions | ​ |  | — | ​ |  | (181) | ​ |  | — | ​ |  | (181)
Restructuring Expense Change | ​ | ​ | 38,888 | ​ | ​ | (1,979) | ​ | ​ | (3,966) | ​ | ​ | 32,943
Gain on Sale of Assets Change | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 4,779 | ​ | ​ | 4,779
Fiscal Year 2020 as Reported | ​ | $ | 28,500 | ​ | $ | 2,128 | ​ | $ | (4,887) | ​ | $ | 25,741

​

Medical and Healthcare

Medical and Healthcare segment operating income increased $26.8 million, to $28.5 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding restructuring charges, segment operating income decreased 29.6%, or $12.0 million, in the first quarter of fiscal year 2020 compared to the year-ago quarter. The primary drivers of the decrease in operating income relate to increased marketing expense to drive future enrollment growth, increased bad debt expense for the institutional loan programs, primarily at the medical and veterinary schools, costs of returning to a normal level of expense at AUC and RUSM as post-hurricane operations returned to St. Maarten and moved to Barbados, respectively, and an increase of approximately $3.8 million in home office costs reallocated from Home Office and Other to the Medical and Healthcare segment in the first quarter of fiscal year 2020 compared to the year-ago quarter.

Financial Services

Financial Services segment operating income decreased 55.2%, or $2.6 million, to $2.1 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Excluding restructuring charges, segment operating income decreased 13.5%, or $0.6 million, to $4.1 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Operating income decreased at Becker driven by increased costs to support future growth. In addition, approximately $0.9 million in home office costs were reallocated from Home Office and Other to the Medical and Healthcare segment in the first quarter of fiscal year 2020 compared to the year-ago quarter. The decreases in operating income were partially offset by increased operating income at ACAMS driven by an increase in revenue.

49

Table of Contents

NET OTHER EXPENSE

Net other expense in the first quarter of fiscal year 2020 was $4.6 million compared to $3.9 million in the year-ago quarter. The net other expense increase was primarily the result of increased borrowings under Adtalem’s Credit Facility (as discussed in “Note 13: Debt” to the Consolidated Financial Statements).

INCOME TAXES

The effective tax rate on income from continuing operations was 17.6% in the first quarter of fiscal year 2020 compared to 32.4% on loss from continuing operations in the first quarter of fiscal year 2019. The effective tax rate in the first quarter of fiscal year 2019 included a pre-tax income special item of $39.0 million related to the write-offs of assets and restructuring charges in Dominica. The effective tax rates on income from continuing operations excluding this non-recurring special item was 16.4% in the first quarter of fiscal year 2019. The increase in the first quarter of fiscal year 2020 primarily reflects a decrease in the percentage of earnings from foreign operations, which are taxed at lower rates than domestic earnings. The provisions from the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) impacting the first quarter of fiscal year 2020 effective tax rate include a tax on global intangible low-taxed income (“GILTI”), a deduction for foreign derived intangible income (“FDII”), and a limitation of certain executive compensation. Our estimates may be revised in future periods as we obtain additional data and any new regulations or guidance is released.

Three of Adtalem’s operating units benefit from local tax incentives: AUC, which operates in St. Maarten, RUSM, which operates in Barbados, and RUSVM, which operates in St. Kitts. AUC’s effective tax rate reflects benefits derived from investment incentives. RUSM and RUSVM each have agreements with their respective domestic governments that exempt them from local income taxation. RUSM has an exemption in Barbados until 2039. RUSVM has an exemption in St. Kitts until 2037.

As of June 30, 2019, Adtalem had an indefinite reinvestment assertion with respect to accumulated and future earnings in Brazil. Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. As such, Adtalem no longer maintains this assertion. The tax impact of the reversal of the assertion is immaterial.

DISCONTINUED OPERATIONS

Loss from discontinued operations includes $4.2 million in costs associated with the divested DeVry University operations, primarily consisting of ongoing litigation costs and settlements. In addition, beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See “Note 2: Discontinued Operations and Assets Held for Sale” to the Consolidated Financial Statements for further information. Management will continue to disclose and discuss Adtalem Brazil operations in its public filings until the period in which the sale closes as Adtalem Brazil operations continue to have an effect on Adtalem’s reported net income.

Adtalem Brazil

Revenue at Adtalem Brazil decreased 3.4%, or $1.6 million, to $45.7 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. The decrease in value of the Brazilian Real compared to the U.S. dollar decreased reported revenue in the first quarter of fiscal year 2020 by $0.6 million compared to the year-ago quarter. Constant currency calculations assume conversions of local currency amounts at exchange rates in effect in the year-ago period compared to those conversions at exchange rates in effect during the current fiscal year period. On a constant currency basis, revenue decreased 2.2% in the first quarter of fiscal year 2020 compared to the year-ago quarter. Declines in enrollment at Wyden Educational institutions (“Wyden”) and in law exam test preparation courses, along with increased discounting were the primary drivers of the revenue decrease.

Brazil’s economy presented challenges for enrollment growth and created pricing pressures in the education sector. Adtalem Brazil’s revenue results have been negatively impacted by these conditions as well as reductions in Brazil’s government-funded loan program, “Fundo de Financiamento Estudantil” or “Students Financing Fund” (“FIES”) and increased competition. Adtalem Brazil students are eligible for loans under the FIES program, which is financed by the Brazilian government. As of September 30, 2019, approximately 16% of Adtalem Brazil’s degree-seeking students have obtained financing under the FIES program. This represents approximately 18% of Adtalem Brazil’s revenue. The

50

Table of Contents

Brazilian government has stated that it is supportive of the FIES program, which is an important factor in helping to increase the number of college graduates. However, the changes enacted during fiscal year 2018 reducing the number of contracts available for grant under the FIES program by approximately 31% to all higher education institutions in Brazil, have impacted Adtalem Brazil’s growth. Adtalem Brazil institutions have increased efforts to attract more non-FIES program students in order to diversify their payer mix. Also, Adtalem Brazil is working with private lenders to increase funding sources for prospective students. Management believes Adtalem Brazil institutions offer programs of study and operate in areas of the country that the Brazilian government favors in issuing loans under the FIES program. Should economic conditions continue to weaken and additional austerity measures be instituted by the Brazilian government, Adtalem Brazil’s ability to grow its student enrollment may be further impacted.

Key trends for Adtalem Brazil are set forth below.

Adtalem Brazil Student Enrollment:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year 2020 | ​ | Fiscal Year 2019 |
Term |  | Sept. 2019 |  | Sept. 2018 |  | Mar. 2019 |
New Students | ​ | 17,588 | ​ | 17,956 | ​ | 27,505 | ​
% Change over Prior Year | ​ | (2.0) | % | 23.8 | % | 17.7 | %
Total Students | ​ | 76,904 | ​ | 81,088 | ​ | 79,919 | ​
% Change over Prior Year | ​ | (5.2) | % | 3.5 | % | 5.6 | %

​

These enrollment figures include students enrolled in degree-granting programs and exclude students enrolled in test preparation programs at Damásio Educacional (“Damasio”). The decrease in enrollment in the September 2019 term is driven by a decline in new and continuing onsite enrollment at Wyden and the degree granting operations of Damasio, partially offset with increases in new and continuing online enrollment and enrollment increases at Grupo Ibmec Educacional S.A. (“Ibmec”). Enrollment increases in online students are less beneficial to revenue growth due to lower tuition pricing of the online programs.

Adtalem Brazil operating income increased $2.6 million to $3.3 million in the first quarter of fiscal year 2020 compared to the year-ago quarter. Operating income was reduced by the effect of exchange rate changes by $0.3 million in the first quarter of fiscal year 2020. Excluding the effect of the exchange rate changes and restructuring charges, Adtalem Brazil operating income increased $2.9 million in the first quarter of fiscal year 2020 compared to the year-ago quarter, primarily driven by cost reduction measures implemented to offset declining enrollment and the need for higher discounting. These operating income amounts in fiscal years 2020 and 2019 have been adjusted for the reduction in home office expenses allocated to Adtalem Brazil within discontinued operations and now allocated to continuing operations. For fiscal year 2020, these costs are being allocated to the Medical and Healthcare and Financial Services segments. For fiscal year 2019, these costs were allocated to Home Office and Other. See “Note 15: Segment Information” to the Consolidated Financial Statements for further details.

Beginning in the second quarter of fiscal year 2018, DeVry University operations were classified as discontinued operations. In addition, beginning in the fourth quarter of fiscal year 2018, Carrington operations were classified as discontinued operations. See “Note 2: Discontinued Operations” to the Consolidated Financial Statements in Item 8 of Adtalem's Annual Report on Form 10-K for the fiscal year ended June 30, 2019 for further information. The divestiture of both of these operations was completed in the second quarter of fiscal year 2019. As a result, management discontinued discussion of the DeVry University and Carrington operating results beginning with the second quarter of fiscal year 2019 Quarterly Report on Form 10-Q as comparable results are no longer meaningful.

LIQUIDITY AND CAPITAL RESOURCES

Student Payments

Adtalem’s primary source of liquidity is the cash received from payments for student tuition, books, other educational materials and fees. These payments include funds originating as financial aid from various federal and state loan and grant programs, student and family educational loans (“private loans”), employer educational reimbursements, scholarships and

51

Table of Contents

student and family financial resources. Adtalem continues to provide financing options for its students, including Adtalem’s institutional loan programs.

The following table, which excludes DeVry University, Carrington and Adtalem Brazil revenue, summarizes Adtalem’s revenue by fund source as a percentage of total revenue for fiscal years 2018 and 2017. Final data for fiscal year 2019 is not yet available.

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year |
Funding Source: |  | 2018 |  | 2017 |
Federal Assistance (Title IV) Program Funding (Grants and Loans) |  | 59 | % | 60 | %
Private Loans |  | 2 | % | 2 | %
Student accounts, cash payments, private scholarships, employer and military provided tuition assistance and other |  | 39 | % | 38 | %
Total |  | 100 | % | 100 | %

The pattern of cash receipts during the year is seasonal. Adtalem’s cash collections on accounts receivable peak at the start of each institution’s term. Accounts receivable reach their lowest level at the end of each term, dropping to the lowest point at the end of December.

Financial Aid

Like other higher education institutions, Adtalem is highly dependent upon the timely receipt of federal financial aid funds. All financial aid and assistance programs are subject to political and governmental budgetary considerations. In the U.S., the Higher Education Act (“HEA”) guides the federal government’s support of postsecondary education. If there are changes to financial aid programs that restrict student eligibility or reduce funding levels, Adtalem’s financial condition and cash flows could be materially and adversely affected. See “Item 1A – Risk Factors” in Adtalem’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 filed with the SEC on August 28, 2019, for a discussion of student financial aid related risks.

In addition, government-funded financial assistance programs are governed by extensive and complex regulations in the U.S. Like any other educational institution, Adtalem’s administration of these programs is periodically reviewed by various regulatory agencies and is subject to audit or investigation by other governmental authorities. Any violation could be the basis for penalties or other disciplinary action, including initiation of a suspension, limitation or termination proceeding.

If the U.S. Department of Education (“ED”) determines that we have failed to demonstrate either financial responsibility or administrative capability in any pending program review, or otherwise determines that an institution has violated the terms of its Program Participation Agreement (“PPA”), we could be subject to sanctions including: fines, penalties, reimbursement for discharged loan obligations, a requirement to post a letter of credit and/or suspension or termination of our eligibility to participate in the Title IV programs.

On October 13, 2016, DeVry University and ED reached a negotiated agreement (the “ED Settlement”) to settle the claims asserted in a Notice of Intent to Limit from the Multi-Regional and Foreign School Participation Division of the Federal Student Aid office of the Department of Education (“ED FSA”). Under the terms of the ED Settlement, among other things, without admitting wrongdoing, DeVry University agreed to certain compliance requirements regarding its past and future advertising, that DeVry University’s participation in Title IV programs is subject to provisional certification for five years and that DeVry University is required to post a letter of credit equal to the greater of 10% of DeVry University’s annual Title IV disbursements or $68.4 million for a five-year period. The posted letter of credit continues to be posted by Adtalem following the closing of the sale of DeVry University and reduces Adtalem’s borrowing capacity dollar-for-dollar under its Credit Facility.

An ED regulation known as the “90/10 Rule” affects only proprietary postsecondary institutions, such as Chamberlain, AUC, RUSM and RUSVM. Under this regulation, an institution that derives more than 90% of its revenue on a cash basis from Title IV student financial assistance programs in two consecutive fiscal years loses eligibility to participate in these programs for at least two fiscal years. The following table details the percentage of revenue on a cash basis from federal

52

Table of Contents

financial assistance programs (excluding the U.S. Department of Veterans Affairs and military tuition assistance benefits) for each of Adtalem’s Title IV-eligible institutions for fiscal years 2018 and 2017. Final data for fiscal year 2019 is not yet available.

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fiscal Year |
​ |  | 2018 |  | 2017 |
Chamberlain University |  | 62 | % | 63 | %
American University of the Caribbean School of Medicine |  | 74 | % | 80 | %
Ross University School of Medicine |  | 81 | % | 82 | %
Ross University School of Veterinary Medicine |  | 82 | % | 83 | %

​

In September 2016, Adtalem committed to voluntarily limit to 85% the amount of revenue that each of its four Title IV-eligible institutions derive from federal funding, including the U.S. Department of Veterans Affairs and military tuition assistance benefits. As disclosed in the third party review report that has been made publicly available, Adtalem’s institutions have met this lower threshold for fiscal year 2018. Final data for fiscal year 2019 is not yet available. Adtalem is committed to implementing measures to promote responsible recruitment and enrollment, successful student outcomes, and informed student choice. Management believes students deserve greater transparency to make informed choices about their education. This commitment builds upon a solid foundation and brings Adtalem to a new self-imposed level of public accountability and transparency.

Under the terms of Adtalem institutions’ participation in financial aid programs, certain cash received from state governments and ED is maintained in restricted bank accounts. Adtalem receives these funds either after the financial aid authorization and disbursement process for the benefit of the student is completed, or just prior to that authorization. Once the authorization and disbursement process for a particular student is completed, the funds may be transferred to unrestricted accounts and become available for Adtalem to use in operations. This process generally occurs during the academic term for which such funds have been authorized. Cash in the amount of $0.7 million, $1.0 million and $0.9 million was held in restricted bank accounts at September 30, 2019, June 30, 2019 and September 30, 2018, respectively.

A financial responsibility test is required for continued participation by an institution’s students in U.S. federal financial assistance programs. For Adtalem’s participating institutions, this test is calculated at the consolidated Adtalem level. The test is based upon a composite score of three ratios: an equity ratio that measures the institution’s capital resources; a primary reserve ratio that measures an institution’s ability to fund its operations from current resources; and a net income ratio that measures an institution’s ability to operate profitably. A minimum score of 1.5 is necessary to meet ED’s financial standards. Institutions with scores of less than 1.5 but greater than or equal to 1.0 are considered financially responsible, but require additional oversight. These schools are subject to heightened cash monitoring and other participation requirements. An institution with a score of less than 1.0 is considered not financially responsible. However, a school with a score of less than 1.0 may continue to participate in the Title IV programs under provisional certification. In addition, this lower score typically requires that the school be subject to heightened cash monitoring requirements and post a letter of credit (equal to a minimum of 10% of the Title IV aid it received in the institution's most recent fiscal year).

For the past several years, Adtalem’s composite score has exceeded the required minimum of 1.5. If Adtalem becomes unable to meet requisite financial responsibility standards or otherwise demonstrate, within the regulations, its ability to continue to provide educational services, then Adtalem could be subject to heightened cash monitoring or be required to post a letter of credit to enable its students to continue to participate in federal financial assistance programs.

53

Table of Contents

Cash Provided by Operating Activities

The following table provides a summary of cash flows from operations (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | September 30,
​ |  | 2019 |  | 2018
Net Income (Loss) from Continuing Operations | ​ | $ | 17,408 | ​ | $ | (4,851)
Non-cash Items | ​ |  | 34,143 | ​ |  | 60,963
Changes in Assets and Liabilities | ​ |  | (18,250) | ​ |  | (2,595)
Net Cash Provided by Operating Activities-Continuing Operations | ​ | $ | 33,301 | ​ | $ | 53,517

​

Cash generated from operating activities by continuing operations in the first three months of fiscal year 2020 was $33.3 million compared to $53.5 million in the year-ago period. Net income from continuing operations increased by $22.3 million in the first three months of fiscal year 2020 compared to the year-ago period.

The decrease in non-cash items of $26.8 million in the first three months of fiscal year 2020 compared to the year-ago period was the result of the following:

| ● | A decrease of $36.3 million in depreciation and write-offs of building, building improvements, leasehold improvements, furniture and equipment. This was primarily the result of recording $37.8 million in impairment write-downs of land, buildings and equipment at RUSM’s Dominica campus in the first three months of fiscal year 2019.

| ● | An increase of $12.8 million in amortization and adjustments to operating lease assets which results from the implementation of ASC 842 on July 1, 2019.

| ● | An increase of $4.4 million in provision for bad debts due to increases in reserves for institutional student loans.

| ● | An increase of $1.1 million in stock-based compensation expense.

| ● | An increase of $0.9 million in amortization expense of intangible assets.

| ● | A decrease of $4.9 million in the deferred income tax provision related to the timing of deductions.

| ● | An increase in realized gain on the sale of assets of $4.8 million from the sale of the Columbus, Ohio, campus facility.

​

Changes in Assets and Liabilities from June 30, 2019 reduced operating cash flow by $18.3 million, driven by the following:

| ● | A $38.2 million decrease resulting from an increase in accounts receivable balances (excluding provisions for bad debts) due to higher accounts receivable balances at the Medical and Healthcare segment. These balances are seasonally higher at September 30, 2019 compared to June 30, 2019 due to the timing of cash receipts at Chamberlain, AUC, RUSM and RUSVM resulting from the timing of academic terms.

| ● | A $72.6 million increase resulting from an increase in deferred revenue balances due to the timing of the Chamberlain, AUC, RUSM and RUSVM academic terms at September 30, 2019 compared to June 30, 2019.

| ● | A $13.7 million decrease in operating lease liabilities which results from the payments under operating lease liabilities recorded upon the implementation of ASC 842 on July 1, 2019.

| ● | A $40.2 million decrease resulting from a change in prepaid expense and other current assets, accounts payable and accrued salaries, wages, benefits and liabilities balances due to the timing of disbursements in the normal processing cycles.

Cash Used in Investing Activities

Capital expenditures in the first three months of fiscal year 2020 were $10.4 million compared to $13.3 million in the year-ago period. The capital expenditures in fiscal year 2020 include spending for Chamberlain new campus development, maintenance and Adtalem’s home office reorganization.

Capital spending for the remainder of fiscal year 2020 will support continued investment for new campus development at Chamberlain and maintenance at the medical and veterinary schools. Management anticipates full fiscal year 2020

54

Table of Contents

capital spending to be in the $45 to $50 million range, including $10.4 million spent during the first quarter of fiscal year 2020.

On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus facility. Net proceeds from the sale of $6.4 million resulted in a gain on the sale of $4.8 million. This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in “Note 15: Segment Information” to the Consolidated Financial Statements.

Cash Used in Financing Activities

The following table provides a summary of cash flows from financing activities (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | September 30,
​ |  | 2019 |  | 2018
Proceeds from Exercise of Stock Options | ​ | $ | 828 | ​ | $ | 10,492
Repurchase of Common Stock for Treasury | ​ |  | (40,255) | ​ |  | (59,175)
Net Payments Under Credit Facility | ​ |  | (70,750) | ​ |  | (750)
Payment for Purchase of Noncontrolling Interest of Subsidiary | ​ | ​ | (6,247) | ​ | ​ | —
Other | ​ |  | 155 | ​ |  | (5,029)
Net Cash Used in Financing Activities-Continuing Operations | ​ | $ | (116,269) | ​ | $ | (54,462)

​

Proceeds from Exercise of Stock Options - Cash received from option holders for price paid at time of exercise.

Repurchase of Common Stock for Treasury - Cash paid for the repurchase of Adtalem’s common stock.

Net Payments Under Credit Facility - Net borrowings and repayments under its Credit Facility (see “Note 13: Debt” to the Consolidated Financial Statements).

Payment for Purchase of Noncontrolling Interest of Subsidiary - On July 1, 2019, the Adtalem Brazil management noncontrolling interest members exercised their put option and sold their remaining ownership interests in Adtalem Brazil to Adtalem.

Historically, Adtalem has produced positive cash flows from operating activities sufficient to fund the delivery of its educational programs and services as well as to fund capital investment and share repurchases. Adtalem’s consolidated cash balances of $121.1 million as of September 30, 2019 included $102.1 million of cash held at Adtalem’s international operations, which is available to Adtalem for general company purposes. As of September 30, 2019, the cash balance attributable to Adtalem Brazil was $96.9 million, which is excluded from the balances above as they are classified as assets held for sale and are not available for Adtalem general company purposes. In accordance with the terms of the Adtalem Brazil Purchase Agreement (see “Note 2: Discontinued Operations and Assets Held for Sale”), Adtalem expects to receive approximately $89 million in settlement of cash balances as of June 30, 2019 upon the close of the sale transaction.

Management believes current balances of unrestricted cash, cash generated from operations and the Credit Facility will be sufficient to fund both Adtalem’s current domestic and international operations, growth plans and current share repurchase program for the foreseeable future unless significant investment opportunities should arise.

Other Contractual Arrangements

Adtalem’s long-term contractual obligations consist of its $600 million Credit Facility (discussed in “Note 13: Debt” to the Consolidated Financial Statements), operating leases on facilities and agreements for various services.

In fiscal year 2018, Adtalem recorded a liability of $96.3 million for the one-time transition tax on the deemed repatriation of foreign earnings, pursuant to the Tax Act. This amount was reduced to $8.7 million after utilization of tax credits and current and prior year tax losses, and is payable over eight years. The first installment will be required in fiscal year 2021.

55

Table of Contents

On December 11, 2018, Adtalem completed the sale of DeVry University to Cogswell Education, LLC (“Cogswell”). In connection with the closing of the sale, Adtalem loaned to DeVry University $10.0 million under the terms of the promissory note, dated as of December 11, 2018 (the “Note”). The Note bears interest at a rate of 4% per annum, payable annually in arrears and has a maturity date of January 1, 2022. DeVry University may make prepayments on the Note.

On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep Foundation (“DePaul College Prep”) for $52.0 million. Adtalem received $5.2 million of cash at the time of closing and holds a mortgage, secured by the property, from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The buyer has an option to make prepayments.

Adtalem is leasing space to DeVry University at four facilities owned by Adtalem and subleasing space, in full or in part, at an additional 25 facilities, of which 17 are subleased to DeVry University and/or Carrington. Adtalem remains the primary lessee on the 25 underlying leases. These lease and sublease agreements were entered into at comparable market rates and the terms range from one to six years. Future minimum lease and sublease rental income under these agreements at September 30, 2019, are as follows (in thousands):

​ | ​ | ​ | ​
Fiscal Year |  | Amount
2020 (Remaining) | ​ | $ | 18,608
2021 | ​ | ​ | 20,099
2022 | ​ |  | 17,103
2023 | ​ |  | 16,368
2024 | ​ |  | 10,523
Thereafter | ​ | ​ | 7,308
Total | ​ | $ | 90,009

​

Adtalem also assigned certain leases to DeVry University and Carrington but remains contingently liable under these leases.

OFF-BALANCE SHEET ARRANGEMENTS

Adtalem is not a party to any off-balance sheet financing or contingent payment arrangements, nor are there any unconsolidated subsidiaries. Adtalem has not extended any loans to any officer, director or other affiliated person. Adtalem has not entered into any synthetic leases, and there are no residual purchase or value commitments related to any facility lease. Adtalem did not enter into any derivatives, swaps, futures contracts, calls, hedges or non-exchange traded contracts during the first three months of fiscal year 2020. Adtalem had no open derivative positions at September 30, 2019.

CRITICAL ACCOUNTING ESTIMATES

There have been no material changes in the Company’s Critical Accounting Estimates, as disclosed in its Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

RECENT ACCOUNTING PRONOUNCEMENTS

For a discussion of recent accounting pronouncements, see “Note 3: Summary of Significant Accounting Policies” to the Consolidated Financial Statements.

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Adtalem is not dependent upon the price levels, nor affected by fluctuations in pricing, of any particular commodity or group of commodities. However, more than 50% of Adtalem’s costs are in the form of wages and benefits. Changes in employment market conditions or escalations in employee benefit costs could cause Adtalem to experience cost increases at levels beyond what it has historically experienced.

The financial position and results of operations of AUC, RUSM and RUSVM Caribbean operations are measured using the U.S. dollar as the functional currency. Substantially all of these financial transactions are denominated in U.S. dollars.

56

Table of Contents

The assets and liabilities held for sale and results of discontinued operations of Adtalem Brazil are measured using the Brazilian Real as the functional currency. Adtalem Brazil has not entered into any material long-term contracts to purchase or sell goods and services, other than the lease agreements on teaching facilities and contingencies relating to prior acquisitions. As of September 30, 2019, Adtalem did not have any foreign exchange contracts or derivative financial instruments designed to mitigate changes in the value of the Brazilian Real. Brazilian-based assets held for sale constitute 24.8% of Adtalem’s overall assets, and Adtalem’s Brazilian liabilities held for sale constitute 11.2% of overall liabilities. The value of the Brazilian Real has been volatile in relation to the U.S. dollar over the past several years. The value during the first quarter of fiscal year 2020 averaged roughly 1% lower compared to the year-ago quarter. Based upon the current value of the net assets in Adtalem Brazil’s operations, a change of $0.01 in the value of the U.S. dollar relative to the Brazilian Real results in a translation adjustment to Accumulated Other Comprehensive Loss of approximately $17.5 million.

The interest rate on Adtalem’s Credit Facility is based upon LIBOR or a LIBOR-equivalent rate for Eurocurrency rate loans or a base rate for periods typically ranging from one to three months. As of September 30, 2019, Adtalem had $336.3 million in outstanding borrowings under the Term B Loan and Revolver with a weighted average interest rate of 4.94%. Based upon borrowings of $336.3 million, a 100 basis point increase in short-term interest rates would result in $3.4 million of additional annual interest expense.

Adtalem’s customers are principally individual students enrolled in its various educational programs. Accordingly, concentration of accounts receivable credit risk is small relative to total revenue and accounts receivable. However, the Adtalem Brazil FIES accounts receivable balance has remained elevated for the past several years due to changes in government funding of the program. As of September 30, 2019, June 30, 2019 and September 30, 2018, the FIES accounts receivable balance was $17.8 million, $26.2 million and $22.8 million, respectively. These accounts receivable balances are classified as held for sale.

Adtalem’s cash is held in accounts at various large, financially secure depository institutions. Although the amount on deposit at a given institution typically will exceed amounts subject to guarantee, Adtalem has not experienced any deposit losses to date, nor does management expect to incur such losses in the future.

ITEM 4 – CONTROLS AND PROCEDURES

Principal Executive and Principal Financial Officer Certificates

The required compliance certificates signed by Adtalem’s Chief Executive Officer and Chief Financial Officer are included as Exhibits 31 and 32 of this Quarterly Report on Form 10-Q.

Disclosure Controls and Procedures

Disclosure controls and procedures are designed to help ensure that all the information required to be disclosed in Adtalem’s reports filed under the Securities Exchange Act of 1934 (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified by the applicable rules and forms.

Adtalem’s Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that Adtalem’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are effective to ensure that information required to be disclosed in the reports that Adtalem files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) is accumulated and communicated to Adtalem’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in internal control over financial reporting that occurred during our latest fiscal quarter that materially affected, or are reasonably likely to materially affect, Adtalem’s internal control over financial reporting.

​

57

Table of Contents

PART II – OTHER INFORMATION

ITEM 1 – LEGAL PROCEEDINGS

For a discussion of legal proceedings, see “Note 14: Commitments and Contingencies” to the Consolidated Financial Statements in Part I, Item 1, of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

ITEM 1A – RISK FACTORS

In addition to the other information set forth in this report, the factors discussed in “Item 1A – Risk Factors” in Adtalem’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, which could materially affect Adtalem’s business, financial condition or future results, should be carefully considered. Such risks are not the only risks facing Adtalem. Additional risks and uncertainties not currently known to Adtalem or that management currently deems to be immaterial also may materially adversely affect its business, financial condition and/or operating results. Except for the risk factor discussed below, there have been no material changes to Adtalem’s risk factors since its Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

​

A delayed or unsuccessful sale of Adtalem Brazil could have a material adverse effect on the stock valuation of Adtalem or may impact the growth prospects or financial resources of Adtalem.

​

Adtalem has entered into a binding stock purchase agreement to sell its Brazilian portfolio, Adtalem Brazil, to Estácio Participações S.A. (“Estácio”) and Sociedade de Ensino Superior Estaćio de Sá Ltda, a wholly owned subsidiary of Estácio (“Purchaser”) (the “Transaction”). Adtalem’s transfer of ownership to the Purchaser is subject to numerous closing conditions, including the approval by Brazil’s Administrative Council of Economic Defense (“CADE”), the Brazilian antitrust authority. Additionally, the Purchaser is not required to close the Transaction in certain circumstances, including in the event that the closing has not occurred by 270 days following the filing with CADE of all required notification and report forms (subject to each party’s right to extend for an additional 90 days under certain conditions. There is no assurance that the conditions to closing will be satisfied in a timely manner or at all. If the Transaction is not completed, the valuation of Adtalem common stock may materially and adversely decline.

​

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Total Number of Shares |  | Approximate Dollar
​ | ​ | ​ | ​ | ​ | ​ | ​ | Purchased as Part of | ​ | Value of Shares that May
​ | ​ | Total Number of | ​ | Average Price Paid | ​ | Publicly Announced | ​ | Yet Be Purchased Under
Period | ​ | Shares Purchased | ​ | per Share | ​ | Plans or Programs (1) | ​ | the Plans or Programs (1)
July 2019 | ​ | 240,714 | ​ | $ | 46.69 | ​ | 240,714 | ​ | $ | 170,881,305
August 2019 | ​ | 253,302 | ​ | $ | 46.66 | ​ | 253,302 | ​ | $ | 159,062,529
September 2019 | ​ | 424,791 | ​ | $ | 40.49 | ​ | 424,791 | ​ | $ | 141,864,748
Total | ​ | 918,807 | ​ | $ | 43.81 | ​ | 918,807 | ​ | $ | 141,864,748

(1) On November 7, 2018, the Board of Directors of Adtalem authorized a share repurchase program to repurchase up to $300 million of Adtalem common stock through December 31, 2021. The eleventh share repurchase program commenced in January 2019. The timing and amount of any repurchases will be determined based on an evaluation of the market and other factors. The total remaining authorization under this share repurchase program was $141,864,748 as of September 30, 2019.

58

Table of Contents

Other Purchases of Equity Securities

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Total Number of Shares |  | Approximate Dollar
​ | ​ | ​ | ​ | ​ | ​ | ​ | Purchased as Part of | ​ | Value of Shares that May
​ | ​ | Total Number of | ​ | Average Price Paid | ​ | Publicly Announced | ​ | Yet Be Purchased Under
Period | ​ | Shares Purchased (1) | ​ | per Share | ​ | Plans or Programs | ​ | the Plans or Programs
July 2019 | ​ | 947 | ​ | $ | 44.98 | ​ | NA | ​ | NA
August 2019 | ​ | 112,572 | ​ | $ | 44.80 | ​ | NA | ​ | NA
September 2019 | ​ | 66 | ​ | $ | 41.70 | ​ | NA | ​ | NA
Total | ​ | 113,585 | ​ | $ | 44.80 | ​ | NA | ​ | NA

(1) | Represents shares delivered back to Adtalem for payment of withholding taxes from employees for vesting restricted stock units and shares swapped for payment on exercise of incentive stock options pursuant to the terms of Adtalem's stock incentive plans.

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4 – MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5 – OTHER INFORMATION

None.

ITEM 6 – EXHIBITS

​ | ​ | ​
Exhibit 10 | ​ | Executive Employment Agreement dated as of August 23, 2019 between Adtalem and Michael Randolfi (incorporated by reference to Exhibit 10.1 to Adtalem’s Current Report on Form 8-K dated August 27, 2019)*
​ | ​ | ​
Exhibit 31 | ​ | Certifications Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Amended
| ​ |
Exhibit 32 | ​ | Certification Pursuant to Title 18 of the United States Code Section 1350**
| ​ |
101.INS | ​ | XBRL Instance Document
101.SCH | ​ | XBRL Taxonomy Extension Schema Document
101.CAL | ​ | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF | ​ | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB | ​ | XBRL Taxonomy Extension Label Linkbase Document
101.PRE | ​ | XBRL Taxonomy Extension Presentation Linkbase Document
104 | ​ | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Designates management contract and compensatory plan or arrangement.

** Furnished herewith.

​

​

​

59

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​ | ​ | ​
​ | Adtalem Global Education Inc.
​ | ​
Date: October 29, 2019 | ​ | /s/ Michael Randolfi
​ | ​ | Michael Randolfi
​ | ​ | Senior Vice President and Chief Financial Officer
​ | ​ | (Principal Financial Officer and Principal Accounting Officer)

​

​

​

60